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Background:  Inflammation, if uncontrolled, can promote the formation of colon 
cancer. Intestinal lymphocytes (IL) are immune cells that can participate in inflammation 
through the generation of cytokines and by causing direct cellular injury. Apoptosis, or 
programmed cell death, regulates the population of lymphocytes and dysregulation of this 
process results in the prolonged activation of IL that occurs during inflammation. 
Therefore, inducing apoptosis of IL is a viable mechanism by which inflammation and 
possibly colon carcinogenesis could be prevented. Experimentally, inflammation may be 
induced in mice by: 1) the addition of the chemical rritant dextran sulfate sodium (DSS) 
to drinking water or 2) exposure to acute exercise (AE; intense treadmill running).  
Bovine lactoferrin (bLf) is a dietary whey protein with demonstrated ability to 
promote anti-inflammatory responses by reducing pro-inflammatory or increasing anti-
inflammatory cytokine concentrations within the intestine. There are also reports that bLf 
can alter apoptotic proteins in the intestinal epithel um to favour cell death. Moreover, 
athletes have been reported to supplement their diets with whey protein; it is also known 
clinically that after heavy competition some athletes may experience gastrointestinal 
distress. The role, however, of bLf in reducing inflammation by initiation of apoptosis or 
alteration of cytokine levels in IL has not been examined.  
Objectives: The primary objective of this research was to determine whether 
dietary bLf affects mouse IL apoptosis and cytokine concentrations in: 1) a normal, non-
inflamed state, 2) following AE challenge and 3) following DSS treatment. A second 





inflammatory damage caused by DSS and AE challenge when administered alone or in 
combination with a carcinogen. 
Methods: A total of 252 female C57BL/6 mice were used in the experiments. 
Apoptotic proteins (Bcl-2, caspase 3, Bax, cytochrome c), inflammatory cytokine 
proteins (TNF-α and IL-10) and a transcription factor for pro-inflammatory cytokines 
(NFκB) were determined in isolated mouse IL by Western blot analysis. Flow cytometry 
was used to determine the extent of apoptosis in mouse IL subsets by measuring 
phosphatidylserine surface expression using Annexin V+ (ANN+) and propidium iodide 
staining. Tissue inflammation was determined by histology (H&E staining) on segments 
of mouse small and large intestine. Diets were prepared and pelletted to contain 20% total 
protein and contained either bLf or were the control formulation (no bLf). Mice were 
exposed to bLf containing diets for 4 d or 12 d prior to sacrifice. DSS was provided at 5% 
in the drinking water for 4 consecutive days prior to sacrifice. Animals were subjected to 
three repeated bouts of AE (each separated by 24 h rest) involving treadmill running and 
sacrificed either immediately or 24 h after the final exercise bout. In the experiment 
involving carcinogenesis, mice were given two subcutaneous injections of azoxymethane 
(AOM), followed by a two week incubation period, and subsequently exposed to bLf or 
the control diet. 
Results: Results from the first experiment determined that 2.0% bLf was effective 
at reducing mouse IL levels of TNF-α (p<0.05) (pro-inflammatory) and increasing the 
percentage of apoptotic CD4+ IL (CD4+/ANN+, p<0.05) in healthy mice. Thus, 2.0% bLf 
was used for the subsequent experiments. Dietary bLf administration in mice exposed to 





(p<0.01) and of TNF-α (p<0.05) and NFκB (p<0.05), both pro-inflammatory proteins. 
Further, the exercise protocol resulted in oxidative stress, as measured by 8-iso 
prostaglandin F2α levels in plasma, but did not induce intestinal inflammation, evident by 
the absence of both tissue damage and infiltration of immune cells. Following DSS 
treatment, mice supplemented with bLf enriched diets had lower levels of both TNF-α 
(non-significant, 34% reduction) and NFκB (p<0.05) and increased concentrations 
(p<0.01) of cytochrome c, a mitochondrial protein associated with cell death. DSS 
exposure in mice resulted in gross morphological alter tions and infiltration of immune 
cells in the small and large intestine; these changes in tissue histology were not affected 
by the addition of bLf. Mice injected with AOM and then subjected to DSS, but not AE, 
had increased numbers (p<0.001) of aberrant crypts, preneoplastic colonic lesions, 
compared to animals only receiving AOM injection. Dietary bLf did not affect any of 
these carcinogenic processes.   
Conclusions: Collectively, these results suggest that dietary bLf administration 
reduces pro-inflammatory cytokine levels and has limited effects on apoptosis of mouse 
IL. Moreover, these modifying effects of bLf did not result in mucosal protection, as 
evident in the inability of this protein to reduce DSS-induced tissue damage or formation 
of aberrant crypts.    
Physiological and Clinical Implications: Although the long term physiological 
consequences of bLf supplementation in the regulation of intestinal immune homeostasis 
require further study, the following clinical implications are tentatively suggested by the 
findings from this thesis research. First, dietary bLf supplementation does not provide 





the carcinogen (i.e., AOM); hence, bLf (at least in he dietary concentration and exposure 
used in these experiments) may not be useful in reducing the formation of aberrant crypts 
and carcinogenesis. Second, dietary bLf should not be recommended as a supplement at 
this time for athletes experiencing intestinal distre s since it had no impact on tissue 
indicators of disease in a model (DSS) shown to produce extensive inflammation and 
tissue pathology. Nonetheless, the findings raise the possibility that bLf can modify both 
cytokines and apoptotic protein expression in IL and may influence some aspects of 
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Intestinal inflammation is characterized by tissue damage caused by the 
recruitment and excessive activation of intestinal lymphocytes. Under normal conditions 
lymphocytes contribute to mucosal protection. During prolonged inflammation, however; 
these cells could contribute to the creation of an environment that increases the risk of 
colon carcinogenesis. Apoptosis, or programmed cell death, is essential in regulating the 
immune response and dysregulation of this vital process perpetuates lymphocyte 
activation. Therefore, inducing apoptosis of activated intestinal lymphocytes could result 
in decreased inflammation and, by extension, reducing the risk of colon carcinogenesis. 
 Bovine lactoferrin (bLf) is a dietary milk protein with demonstrated ability to 
reduce inflammation mainly through modifying cytokine production. Addition of bLf 
reduces colonic tumour numbers in rats and has beenshown to affect apoptotic proteins 
within the colonic epithelium. However, the ability of this important dietary constituent 
to influence apoptotic parameters in intestinal lymphocytes has not been examined.   
Inflammation may be induced experimentally by several different protocols. The 
gold standard for induction of experimental intestinal inflammation is by the 
administration of dextran sulfate sodium (DSS) to the drinking water of rodents. Another 
possible strategy is by subjecting mice to strenuous exhaustive acute exercise (AE).  Both 
protocols result in an excessive production of pro-inflammatory cytokines, a common 
characteristic of inflammation.  The objectives of this research were: 1) to characterize 
the effect of dietary bLf on intestinal lymphocyte apoptosis and cytokine levels during a 





examine the ability of bLf to protect the intestinal mucosa from alterations induced by 
DSS or AE and when these protocols were provided following tumour initiation events. 
Chapter 1 is a literature review aimed at providing a general overview of the 
important concepts and topics germane to this thesis. Chapter 2 provides an explanation 
of the study rationale and the working hypotheses. Chapters 3-7 are the results from 
experiments conducted from this thesis research. These chapters were written as scientific 
papers for publication and include a detailed design and outlined hypotheses for each 
study. Chapter 8 is an integrated discussion of the res arch findings and includes study 






Chapter 1: Literature Review 
 
 The purpose of this literature review is to provide a background into the current 
state of knowledge regarding lactoferrin, apoptosis, inflammation and the intestinal 
immune system. This is not an exhaustive review but a summary focused on providing 
context into the potential influence of lactoferrin on apoptosis and intestinal 
inflammation. A list of abbreviations is found in Appendix I and may aid in the reading 
of this thesis.  
1.1. Intestinal Immune System 
 
The intestinal immune system is an integral component of overall host protection 
as it governs the immunological response in the most h tile environment in the human 
body. Intestinal lymphocytes are central in the maintenance of intestinal homeostasis as 
they participate in both regulator and effector functions.   In this section a brief overview 
of the intestinal immune system, specifically focusing on intestinal lymphocytes, is 
presented. 
The gastrointestinal mucosa is in constant contact with bacterial and dietary 
antigens. Given this anatomical location it is not surprising that the gut associated 
lymphoid tissue (GALT) is the largest and most complex lymphoid population in 
mammals (Abreu-Martin and Targan, 1996). GALT consists of organized tissues [e.g., 
Peyer’s patches (PP) and mesenteric lymph nodes (MLN)] responsible for the induction 
phase of the immune response and effector sites which contain immune cells (i.e., 
leukocytes) within the epithelium and lamina propria (Mowat, 2003).  A single layer of 





intestinal tissue and the luminal contents. This epith lium provides the first active line of 
defense against infection by segregating the luminal contents from the underlying 
complex immune network (Baumgart and Carding, 2007).  The intestinal epithelium, 
however; is not impervious to luminal antigens and there are several methods by which 
the underlying lymphoid follicles (e.g., PP) sample luminal antigen: 1) dendritic cells 
(DC) within the lamina propria extend dendrites into the lumen, 2) antigens transverse the 
epithelia via microfold cells and encounter DC, and 3) intestinal epithelial cells (IEC) 
uptake antigen and present antigen to the DC together with proteins of the major 
histocompatibility complex (MHC) (Kunisawa and Kiyon , 2005).   Once the antigen is 
in contact with the DC it can either be processed within PP or transported to MLN where 
lymphocytes are encountered and the fate of the immune response (i.e., tolerance or 
immunity) is decided (Mowat, 2003).   
 
1.1.1. Intestinal Lymphocytes 
 
There are two classes of intestinal lymphocytes (IL) that are differentiated based 
on immunological properties and location. In the lamina propria (LP) are lamina propria 
lymphocytes (LPL). Within the intestinal epithelium, above the basement membrane, 
resides a highly specialized population of intraepithel al lymphocytes (IEL). Together 
IEL and LPL perform critical effector and inducer functions and are integral components 
in maintaining immunological intestinal homoeostasis (Hershberg and Blumberg, 2003).  
IEL account for about half of the peripheral T cell pool in mammals, and the 
small intestine of mice has an estimated IEL population of 50-500 x 106 cells depending 





cells are 80-90% CD3+T cells, and of these, 80% are CD8+ IEL. The T-cell receptor 
(TCR) is essential for T-cell function and is classified as either αβ or γδ.  All γδCD8 IEL 
express the CD8αα homodimer co-receptor whereas αβCD8 IEL expresses either the 
CD8αα homodimer or CD8αβ heterodimer (Beagley and Husband, 1998). Indeed two 
distinctive features of IEL from other peripheral blood lymphocytes (PBL) are that they 
exclusively express the CD8αα homodimer co-receptor and contain large numbers of γδ 
T cells (e.g., 53% vs. 3%, in mouse IEL vs. PBL, respectively) (Abreu-Martin and 
Targan, 1996; Ishikawa et al., 2007). Along the intstinal tract, populations of IEL share 
identical cellular phenotypes, which led to their characterization as oligoclonal (derived 
from only a few clones) (Gross et al., 1994). This feature of IEL may account for their 
restricted ability to respond and proliferate to previously unseen antigen (Fiocchi, 2001).  
A unique feature of the IEL population is the expression of the memory 
phenotype (85% express CD45RO+) and markers of activation (e.g., CD69, CT antigen 
and CD11c) which together indicate prior antigen exposure (Abreu-Martin and Targan, 
1996). IEL are rapidly activated in the presence of anti-CD3+ stimuli (Wang et al., 2002) 
and collectively these observations have led to the description of IEL as ‘partially 
activated’ T cells. Although the mechanism of activation is not fully understood, it has 
been suggested that IEL “wait” for the appropriate signals (e.g., antigenic stimuli, co-
stimulatory molecules) to push them into full activa on (Montufar-Solis et al., 2007).  
Once activated IEL are capable of lysing target cells ( .g., virally infected cells or foreign 
bacteria) and contain cytoplasmic granules with perforin and granzyme (Beagley and 
Husband, 1998).  Apart from cytotoxcity, IEL secrete cytokines which are important 





dependent on the type of activation signal, in the active state IEL tend to favour a TH1, 
cell mediated cytotoxic responses (Beagley and Husband, 1998).  Thus, IEL are a very 
distinctive and critical lymphocyte population for the maintenance of immune 
homoeostasis through both cytotoxic and regulatory cytokine functions. 
In comparison to IEL, LPL are more similar to convetional PBL. As in PBL, 
LPL are predominantly (95%) αβ TCR with small numbers of cells expressing the γδ 
receptor.  Approximately 40-90% of LPL are T cells (CD3+) with the greater majority 
(65-85%) expressing the CD4+ co-receptor.  Similar to PBL, LPL ratios of CD4+/CD8+ 
are approximately 65%:35% (Abreu-Martin and Targan, 1996). Within the LPL there is 
also a large percentage (70-90%) of IgA secreting plasma cells that aid in anti-
inflammatory responses (Beagley and Elson, 1992).  LPL are thought to be a population 
of highly activated lymphocytes, as they express a large percentage (66-96%) of the 
CD45RO+ memory phenotype and share similar surface markers found on activated cells 
(Fiocchi, 2001).  
LPL participate in both effector and regulator functions (Rothkotter et al., 1999). 
These lymphocytes express Fas ligand, and contain gr nules with perforin and granzyme, 
which can induce apoptosis in target cells (Melgar et al., 2002).  In response to antigen, 
the proliferation and cytotoxicity of LPL is lower than in PBL, which may be a default 
mechanism attributed to the surrounding environment (i.e., constant presence of luminal 
antigen) (Fiocchi, 2001).  Given the large population of CD4+ cells in the LP 
compartment, it is not surprising that LPL function largely as regulatory cells. That LPL 
are critical to regulation is supported by their rest icted capacity to clonally expand (i.e., 





inflammatory and tolerogenic TH2 cytokines (Abreu-Martin and Targan, 1996). In furthe  
support of this argument is the finding that LPL produce large concentrations of TH2 
cytokines that support anti-inflammatory responses (Fiocchi, 2001; Beagley and Elson, 
1992). Cytokine balance is important in the regulation of inflammatory events (see 
section 1.2.1) and CD4+ LPL in inflamed tissues show a predominance to produce TH1 
cytokines [e.g., increased IL-1β, IL-6 and tumour necrosis factor-α (TNF-α)] (Reinecker 
et al., 1993).  In summary, LPL are more similar to PBL than IEL, represent an activated 
lymphocyte population with limited proliferative cap city, and have regulatory and 
cytotoxic functions.  
 
1.2. Intestinal Inflammation  
 
 
Inflammation is the complex physiologic response to tissue damage caused by 
pathogens, wounding, or irritation (Philip et al., 2004).  It is a protective mechanism by 
which the individual attempts to remove or limit the armful stimuli and initiate the 
healing process (Kelsall, 2008). The inflammatory reaction is initiated by a cascade of 
chemical mediators (e.g., cytokines) secreted by local macrophages, epithelial and mast 
cells that coordinate a response by which altered blood flow, increased vascular 
permeability and up-regulation of adhesion molecules lead to the recruitment of immune 
cells (Linden, 2001). The movement of leukocytes from the circulation to the interstitial 
space is explained by a multi-step paradigm of cellular events: 1) circulating leukocytes 
are slowed as they align and interact with the endothelium wall at sites of injury, 2) 
leukocyte interaction with adhesion molecules increases and leads to improved contact 





into tissues (Bianchi et al., 1997; Springer, 1994).  Inflamed tissues are dominated by 
neutrophils, macrophages and lymphocytes, which generate large amounts of growth 
factors, cytokines and reactive oxygen and nitrogen species that contribute to tissue 
breakdown and strengthen the defense against potential infection (Philip et al., 2004; 
Coussens and Werb, 2002; Lu et al., 2006). Under normal conditions, inflammation is 
self-limiting so that once the harmful stimulus is cleared and the damaged tissue repaired, 
the same cells that initiated inflammation are respon ible for its down-regulation (i.e., 
negative feedback). The production of pro-inflammatory mediators is shifted towards 
production of anti-inflammatory mediators, which inhibit further activation and 
recruitment of immune cells (Philip et al., 2004). The healing process is initiated and 
there is rapid clearance of inflammatory cells (Lu et al., 2006).   
The intestine is resident to over 500 different species of bacteria. Coupled with 
the constant presence of dietary constituents, the intestine is believed to be in a constant 
state of controlled inflammation termed ‘physiological inflammation’ (Fiocchi, 2001).  
This has been suggested because of the relatively paceful co-existence between 
intestinal bacteria and the large numbers of mature and partially activated IL. The 
intestine has control mechanisms that limit GALT exposure to luminal antigen. These 
include: 1) physical control mechanisms such as an active epithelial lining and the 
organized structure of GALT that limit antigen exposure and 2) physiological control 
mechanisms such as increased IgA secretion, the tend ncy of LPL and IEL to have low 
proliferative capacity, and the propensity of LPL to act as helper cells through active 
immune suppression (i.e., secretion of IL-10 and TGF-β) (Beagley and Elson, 1992).  





Oral tolerance is defined as the state of immune unr sponsiveness to orally administered 
antigen such that an immune response (i.e., prolifeat on and activation of immune cells) 
does not occur (MacDonald and Monteleone, 2005; Chehad  and Mayer, 2005). Immune 
unresponsiveness following antigen recognition is achieved through several cellular 
mechanisms including clonal anergy (lack of T-cell proliferation and activation), clonal 
deletion (death of T-cells) and active suppression (secretion of anti-inflammatory 
cytokines) (Mowat, 2003).  
The balance between activation and regulation of lymphocytes is essential to the 
delicate balance of intestinal immunological homeostasi . Alterations to this balance, 
which could include excessive inflammatory stimuli (e.g., incorrect recognition of a 
harmless luminal antigen as foreign, alteration of intestinal barrier permeability) or 
failure of regulatory mechanisms (e.g., failed apoptosis of activated lymphocytes, 
breakdown in oral tolerance) could result in inappro riate immune activation and 
potentially detrimental inflammation (MacDermott, 1996).  This could lead to 
pathological inflammation resulting in host tissue damage and, possibly, disease. For 
example, individuals with inflammatory bowel diseass (IBD) have recurring bouts of 
intestinal inflammation; although the etiology is unknown, it is believed to involve 
multiple factors (such as diet, genetics and enviromental) that participate in altering this 
balance to favour disease pathogenesis (Neuman, 2007).   
 
1.2.1. Cytokines   
 
 
 Cytokines are low molecular weight glycoproteins secreted by various immune 





have important roles in biological processes. Cytokines involved in inflammation can be 
divided into two generic groups: pro-inflammatory cytokines, which include interferon-γ 
(IFN-γ), TNF-α, and interleukin (IL-) 1β and anti-inflammatory cytokines, which include 
IL-4, IL-5, and IL-10 (Williams, 2001). CD4+ T cells are a main source of cytokines and 
they can be further classified into TH1 or TH2 cells based on the cytokines they secrete: 
TH1 cells secrete pro-inflammatory cytokines and TH2 cells secrete anti-inflammatory 
cytokines (Strober et al., 2002).   
The release of pro-inflammatory cytokines results in the activation of immune 
cells (e.g., neutrophils and lymphocytes), enhancement of T-cell proliferation, increases 
in vascular permeability and up-regulation of adhesion molecules on the endothelial 
surface to facilitate leukocyte transmigration (Goldsby et al., 2003). An important TH1 
cytokine in intestinal inflammation is TNF-α, which is synthesized as a 26kDa membrane 
bound protein (mbTNF-α). Cleavage by TNF-α converting enzyme results in soluble 
TNF-α (17kDa) that acts on downstream targets expressing cognate receptors (Bradley, 
2008). There are several functions of TNF-α, dependent on whether it is the soluble or 
receptor form. When available as a membrane bound receptor, mbTNF-α, through direct 
contact may confer cell survival. The more common sluble form (sTNF-α) participates 
in a wide variety of biological processes that include apoptosis, proliferation and 
differentiation, activation of proteases, promotion f angiogenesis and activation of 
immune cells (Aggarwal et al., 2006; Goetz et al., 2004).  TNF-α is a potent TH1 cytokine 
that is important in normal host defense against infection. When inappropriately or 
excessively produced, however, TNF-α is harmful and has been experimentally and 





was found elevated in the serum and stools of patients with IBD (Murch et al., 1991; 
Braegger et al., 1992) and in mice is overexpressed in LP macrophages (Neurath et al., 
2001) and inflamed colonic tissues (Tomoyose et al., 1998).   Moreover, several 
investigators have shown that treatment with neutralizing anti-TNF-α antibodies results 
in decreased disease indicators. For example, Van Dullemen and colleagues (1995) 
observed a decrease in Crohn’s disease activity index scores and healing of mucosal 
ulcerations in patients following a single infusion of an anti-TNF-α human/mouse 
chimeric monoclonal antibody (cA2). Improvements in tissue histology and reduced 
numbers of infiltrating neutrophils and lymphocytes were observed following a single 
dose of infliximab (anti-TNF-α antibody) in patients with Crohn’s disease compared to 
placebo controls (Baert et al., 1999). Thus, it appears that TNF-α may have an important 
role in inflammation induced tissue damage and the ability to reduce its expression has 
been correlated with decreased intestinal inflammation. 
 TH2 cytokines are involved in regulating the inflammatory response. IL-10, 
secreted by CD4+ cells, macrophages, dendritic cells and B cells, terminates 
inflammation by inhibiting activation and effector functions of T cells and macrophages 
(Moore et al., 2001).  In addition to these activities, IL-10 regulates the growth and/or 
differentiation of natural killer (NK) cells, cytotxic and CD4+ cells, B cells, 
granulocytes, mast cells and dendritic cells (Moore et al., 2001).  It is a potent inhibitor of 
TNF-α and IL-1β (Rosatto et al., 2007) and Crepaldi et al., (2002) demonstrated that in 
vitro stimulation of human neutrophils with IL-10 can further enhance an anti-
inflammatory environment by inducing the production f an IL-1 antagonist.  The 





deficient mice. These animals develop severe intesti al colitis characterized by massive 
infiltration of lymphocytes, macrophages and neutrophils as well as show increased 
concentrations of pro-inflammatory cytokines; amelioration of colitis occurs upon 
addition of IL-10 (Wirtz and Neurath, 2000). Moreovr, mice treated with recombinant 
IL-10 had reduced extensiveness of tissue damage and less of an increase in TNF-α and 
IL-1 following the addition of a chemical irritant known to cause intestinal inflammation 
(Tomoyose et al., 1998). Thus, the relationship betwe n the pro- (TH1) and anti- (TH2) 
inflammatory cytokines is such that a shift towards a TH1 response can result in a state of 
inflammation whereas a shift towards a TH2 response confers an anti-inflammatory 
environment (Elson et al., 2005; Wirtz and Neurath, 2000).  
 
1.2.2. Nuclear Factor κ B 
 
 
 Transcription factors (TF) are proteins responsible for regulating the transfer of 
information from DNA to messenger RNA (mRNA) (Lewin, 2002). TF bind to DNA and 
assist in transcription which may eventually result in the production of proteins that 
perform cellular functions. One TF central to the inflammatory process is nuclear factor κ 
B (NFκB). NFκB is actually the general name for a family of transcription factors that 
influence biological processes such as inflammation, apoptosis and tissue repair 
(Nakanishi and Toi, 2005).  Its relative importance as a therapeutic target is highlighted 
in several diseases, including IBD and colon cancer in which patients exhibit elevated 
levels of the activated TF (Karin, 2006; Tak and Firestein, 2001). NFκB is composed of 
various homo or heterodimer combinations of protein subunits and several target genes 





factors, immunoreceptors, anti-apoptotic proteins ad transcription factors (Lee and 
Burckart, 1998; Barnes and Karin, 1999). 
NFκB is found in the cytoplasm in an inactive state and it is associated with the 
inhibitory protein IκB.  Upon activation from an external signal (e.g., TNF-α, IL-1, 
lipopolysaccharide (LPS), UV radiation or free radicals), the IκB protein is 
phosphorylated by the I kappa β kinase (IKKβ) which liberates NFκB from its inhibitor 
(Barkett and Gilmore, 1999).  IκB is degraded and NFκB translocates to the nucleus 
where it exerts its role in transcriptional regulation. The link between inflammation, 
cancer and increased NFκB is well established.  In knockout mice devoid of IKK β in 
enterocytes there is a dramatic 75% decrease in tumour number compared to wild-type 
mice; reduced inflammation (e.g., reduced COX-2, IL-6 mRNA and IL-1β mRNA) and a 
50% reduction in tumour number also occurred in mice that were lacking IKKβ in 
myeloid cells (Greten et al., 2004). NFκB was found elevated in hepatic tumours and this 
increase was attenuated by treatment with ibuprofen, a on-steroidal anti-inflammatory 
drug (NSAID). Complete absence of NFκB did not influence atypical proliferation but 
decreased tumour progression indicating a role of NFκB in tumour promotion rather than 
initiation (Pikarsky et al., 2004).  Therefore, targeting and down-regulating NFκB 




1.2.3. Inflammation as a Promoter of Colon Carcinogenesis  
 
  
Colon carcinogenesis is a complex multistep process that can be divided into three 





accumulation of the so called ‘hallmarks of cancer’ that convert a normal cell to an 
autonomous cell capable of uncontrolled growth and invasion of neighbouring tissues 
(Trosko, 2006). The hallmark features of cancer, as described by Hanahan and Weinberg 
(2000) are: 1) self-sufficiency in growth signals, 2) insensitivity to antigrowth signals, 3) 
evasion of apoptosis, 4) limitless proliferation, 5) sustained angiogenesis, and 6) tissue 
invasion and metastasis.  The multi-step progression of carcinogenesis is a framework to 
outline and define possible molecular events associated with the transformation of a 
normal, ‘mortal’ cell to a cell capable of limitless growth (i.e., immortal cell). Initiation 
involves the irreversible primary damage to, or alter ion of, DNA in normal cells caused 
either by spontaneous mutation or from carcinogen exposure (Oliveira et al., 2007).  The 
consequence of initiation is that the cell begins to accumulate some of the characteristics 
of transformed cells, which lead to the possibility that the cell could escape the typical 
limits of normal growth (Trosko, 2006). Experimentally, initiation events can be induced 
by injection with a known colon specific carcinogen such as 1, 2-dimethylhydrazine 
(DMH) or azoxymethane (AOM).  
The initiated cell can persist in otherwise normal tissue for extended periods of 
time (Farber and Rubin, 1991). However, the conversion of this atypical cell into an 
immortal cell can be accelerated by events that create a favourable growth environment. 
These so called “promotional events”, which include inflammation, cause the clonal 
expansion of the atypical cells (Farber and Ruben, 1991). The end result may be the 
eventual accumulation of all the hallmarks of cancer and, therefore, promotion is the 
process that allows the initiated cell to escape the suppressing and regulatory effects of 





confers the ability of the immortal cell to sustain its own growth, which may result in 
tumour formation, and to invade neighbouring tissue (Oliveira et al., 2007).  
Colon cancer prevention strategies can be targeted against any of the stages of 
carcinogenesis. However, as Trosko (2006) points out, whereas initiation and progression 
may be irreversible and occur within a short duration, the promotion phase occurs over 
decades and may be reversible. Thus, appropriate therapeutic interventions would be 
directed against promotional events. Focusing on inflammation, there is ample evidence 
that implicates it is a promoter of colon carcinogenesis. Experimentally, inflammation 
can be induced by several methods such as rectal injection with the hapten 
trinitrobenzenesulfonic acid (TNBS), feeding of carrageenan (CAR), or administration of 
dextran sulfate sodium (DSS) in the drinking water (St ober et al., 2002).   Okayasu et al. 
(1996) using DSS and D’Argernio et al. (1996) using TNBS, as promotional events 
following AOM injection observed increased numbers of colonic tumours when 
compared to animals receiving AOM alone. Similarly, AOM injected mice treated with 
DSS had a greater appearance of several inflammatory indicators (i.e., increased TNF-α, 
increased immune cell infiltration, enhanced COX-2 expression, body weight loss, 
bloody stools) and increased tumour numbers  (Popivano a et al., 2008). 
Perhaps the most striking evidence to support inflamm tion as a promoter of 
carcinogenesis are animal and human studies that show a reduction in the number of 
colon tumours after treatment with anti-inflammatory agents. For example, Seril et al. 
(2002) demonstrated a 20% reduction in the number of colon tumours in DSS-treated 
mice supplemented with N-acetylcysteine, an antioxidant with known free radical 





tumour incidence and the number of invasive carcinomas in the colon of AOM injected 
rats (Reddy et al., 1993). Studies also support the notion that anti-inflammatory agents 
protect against colon cancer development in humans. Flo smann and Rothwell (2007) 
[British Doctors Aspirin Trial, N=5139 and UK-TIA Aspirin Trial, N=2449] and Logan 
et al. (2008) [N=945, in patients with colorectal adenomas] reported that individuals 
ingesting 300 mg/day of aspirin was sufficient to reduce colon cancer risk and risk of 
recurrence of colorectal adenomas, respectively.  Taken together, there is evidence from 
human and animal studies suggestive that inflammation promotes increased tumour 
number and that the addition of anti-inflammatory agents may reduce tumour number.  
The mechanism by which inflammation promotes carcinogenesis is unknown, but 
in recent reviews by Philip et al. (2004), Lu et al. (2006) and Coussens and Werb (2004), 
inflammation is suggested to create an environment that favours cells to accumulate DNA 
and cellular damage through the persistent generation of reactive oxygen species (ROS). 
Moreover, this environment also favours proliferation since a consequence of tissue 
damage is a drive toward tissue repair. Therefore, the increased likelihood of cellular and 
DNA damage coupled with the tendency for increased c llular division results in the 
potential for atypical cell development and the accumulation of the hallmarks of cancer 
that may eventually lead to carcinogenesis.  
 
1.2.3.1. Aberrant Crypts 
 
Aberrant crypts (AC) are established pre-cancerous lesions in the colonic mucosa 





(aberrant crypt foci - ACF).  AC are distinguished from their normal counterparts in 
many ways that include changes in width, height and thickness of the epithelial lining, 
depletion of goblet cells, and irregular luminal openings (Bird, 1987; 1995; Bird and 
Good, 2000; Augenlicht et al., 2002). AC are the first known observable mucosal lesions 
that may develop into adenomas (Bird, 1987; Mori et al., 2005) and are a commonly used  
biomarker for colon carcinogenesis (Takayama et al., 2005).  Several investigators 
demonstrated that inflammation enhances AC formation. Flynn et al. (2007) found that 
deoxycholic acid, a secondary bile acid and suspected tumour promoter, enhanced ACF 
formation when provided in the diet of mice following AOM injection. Addition of 2.5 % 
carrageenan (CAR) to the diet of rats injected with AOM resulted in increased numbers 
of ACF compared to rats on CAR-free diets (Tache et al., 2000).  Sutherland and Bird 
(1994) reported increased ACF in AOM treated rats fed diets containing 
chenodeoxycholic acid (CDC), a primary bile acid and known tumour promoter; 
increased proliferation was also evident in CDC groups indicating accelerated cellular 
growth.  AC are thus reliable and important markers of early tumourigenesis that increase 
during inflammation. 
 
1.2.4. Methods of Inducing Intestinal Inflammation 
 
1.2.4.1. Dextran Sulfate Sodium  
 
 
As noted earlier in this literature review, animals given dextran sulfate sodium (DSS) 
develop intestinal inflammation.  DSS is a sulfated polysaccharide that directly damages 





inflammation (Strober et al., 2002). Animals receiving DSS develop several pathological 
changes such as intestinal bleeding, loss of body weight, shortening of the intestine, 
mucosal ulcers and other epithelial changes including fibrosis and crypt loss (Hibi et al., 
2002; Elson et al., 2005).  The mechanism of DSS induced intestinal inflammation is not 
known but likely involves multiple pathways. DSS may damage the intestinal epithelial 
barrier allowing luminal bacteria to penetrate within the lamina propria, thus activating 
an immune response (Strober et al., 2002). DSS has also been shown to alter intestinal 
microflora (Okayasu et al., 1990), stimulate B cell expansion (Minchin et al., 1990), 
accumulate in macrophages (Kitajima et al., 1999) and lter adhesion molecules on 
intestinal epithelial cells that favour IL attachment (Ni et al., 1996). Whatever the 
mechanism, DSS induced colitis is characterized by an excessive TH1 response attributed 
to activated neutrophils, macrophages and lymphocytes that accumulate within the 
damaged segments (Boismenu and Chen, 2000; Dieleman t l., 1998; Pizarro et al., 
2003).   
The conventional means of administering DSS to animls is through the drinking 
water. The concentration and duration of administration determines the extent of 
intestinal mucosal damage (Egger et al., 2000).  Acute inflammation is usually triggered 
by exposure to DSS (1-5%) for a few days (usually between 4 and 7) and this is followed 
by euthanasia (Kullmann et al., 2001; Melgar et al., 2005).  Chronic inflammation 
develops when periods (e.g., 1-2 weeks) of regular (DSS-free) drinking water is 






1.2.4.2. Acute Exercise 
 
Gastrointestinal disturbances such as abdominal pain, diarrhea and intestinal 
bleeding are common adverse effects of strenuous exercise in athletes (Peters et al., 
2001b; Bi and Triadafilopoulos, 2003). These effects may be related to alterations of 
intestinal homeostasis caused by exercise. Indeed, oxidative stress and ischemia-
reperfusion (IR) injury are two consequences of exercis  that are implicated in the 
induction of intestinal inflammation (Shek and Shepard, 1998).  These two processes 
may cause death of intestinal epithelial cells leading to a loss of intestinal barrier 
function. Failure of the epithelial layer to segregate the immune network from the luminal 
bacteria allows bacteria to penetrate into the lamin  propria and interact with the 
intestinal immune network. The result would be the activation of immune cells and the 
induction of intestinal inflammation, which may contribute to the gastrointestinal 
problems associated with strenuous exercise in athletes (Marshall, 1998; Shek and 
Shephard, 1998).   
During exercise intestinal ischemia occurs as blood is iverted away from the 
intestine to metabolically active skeletal muscle.  Peters et al. (2001a) reported that blood 
flow in the superior mesenteric artery (SMA), which supplies blood to the intestine, was 
reduced by 49% compared to pre-exercise values in volunteers subjected to a cycling test 
(70% VO2 max). A damaging effect of intestinal ischemia is death of epithelial cells. 
Following surgical occlusion of the rat SMA, Noda et al. (1998) and Giakoustidis et al. 
(2008) reported increased DNA fragmentation and apoptosis of intestinal epithelial cells 
(IEC); infiltration of inflammatory cells into the lamina propria was also evident. 





was also associated with elevated serum and intestial mucosal levels of pro-
inflammatory cytokines (TNF-α and IL-6) (Grotz et al., 1995). Therefore, exercise 
associated intestinal ischemia may lead to death of e IEC and loss of intestinal barrier 
function.  
During aerobic exercise there is an increase in the production of reactive oxygen 
species (ROS). When this production alters the balance in favour of ROS over the 
endogenous cellular antioxidant defense enzymes which are capable of neutralizing ROS, 
a state of oxidative stress occurs (Opara, 2006).  Sources of ROS during exercise include 
the electron transport chain, which also creates ROS during normal cellular respiration, 
the xanthine and NADPH oxidase enzyme systems, phagocytes and the iron catalyzed 
Fenton reaction (Niess et al., 1999; Jackson, 2008). ROS, such as the superoxide anion, 
the hydroxyl radical, and hydrogen peroxide can induce cellular damage and thus there 
are several defense mechanisms by which ROS are removed. For example, superoxide 
dismutase (SOD) converts the superoxide anion to hydrogen peroxide which is 
subsequently converted to water via catalase enzymes (e.g., peroxidase) or is broken 
down by glutathione peroxidase (Hensley et al., 2000). These important cellular defenses 
(i.e., SOD, catalase and glutathione) are critical in cellular protection and if these 
defenses are overwhelmed, which can occur during exercise, the resultant state of 
oxidative stress can impart tissue damage.  
Another important cellular defense mechanism is heat shock protein (e.g., HSP 
70). It is rapidly induced in response to both oxidative stress and ischemia reperfusion 
injury and offers cellular protection against intestinal mucosal damage (Fehrenbach and 





protein misfolding and aggregation and also reducing DNA fragmentation and apoptosis 
(Yenari et al., 2005). During exercise HSP 70 is elevated in human blood leukocytes 
(Fehrenbach et al., 2000) and in mouse intestinal lymphocytes (Hoffman-Goetz and 
Spagnuolo, 2007a); increased HSP 70 has been associted with reduced intestinal 
mucosal damage and neutrophil infiltration following ischemia (Sakamoto et al., 2005). 
The consequences of ROS production include DNA damage, loss of both cellular 
integrity (via lipid peroxidation) and enzyme function, and cell death (Phaneuf and 
Leeuwenburgh, 2001; Hensley et al., 2000).  Thus, similar to intestinal ischemia, 
oxidative stress can induce death of the IEC leading to loss of intestinal barrier function. 
Indeed, oxidative stress as a result of exercise is associated with physiological alterations 
suggestive of inflammation. For example, phagocyte infiltration, damage to plasma 
membrane lipids, proteins and DNA, and activity of NFκB are all increased as a result of 
exercise induced oxidative stress (Aoi et al., 2004).  Mastaloudis and colleagues (2004) 
showed that antioxidant supplementation (e.g., vitamin C and RRR-alpha-tocopheryl 
acetate) attenuated the increase in plasma 8-iso prostaglandin F2α, a reliable marker of 
membrane lipid peroxidation caused by oxidative stress, in ultramarathon (50km) 
runners; the expression of pro-inflammatory markers ( .g., IL-6, TNF-α and C-reactive 
protein) were also observed post-exercise.  
The suggestion that intense exercise induces intesti al inflammation may thus rely 
on the ability of the exercise regimen to induce damage to the intestinal epithelium. Such 
damage would result in the inability of the epithelium to segregate the bacteria from the 





cells would be activated, and provide the stimulus necessary to induce the inflammatory 
response.  
 
1.3. Cell Death 
 
Two terms frequently used to describe cell death are apoptosis and necrosis. 
Apoptosis is a rapid, genetically controlled process characterized by distinct cellular 
morphology such as: cell shrinkage, chromatin condensation, budding, little or no 
swelling of organelles and DNA degradation (Kerr et al., 1972). Necrosis is characterized 
by cellular swelling and eventual cellular and nuclear lysis that is accompanied by 
inflammation (Savill et al., 2002; Majno and Joris, 1995; Van Cruchten and Van Den 
Broeck, 2002).  The following section is a brief review of apoptosis and necrosis with a 





Apoptosis, or programmed cell death, is an essential biological process involved 
in embryonic development, regulation of the immune response and tissue homeostasis 
(Hoffman-Goetz et al., 2005).  It is orchestrated by a cascade of cellular events primarily 
carried out by a family of cysteine proteinase enzymes called caspases. These enzymes 
specifically cleave substrates at residues that follow aspartic acid and are classified as 
either initiator or executioner caspases. Initiator caspases (such as caspase 8 and caspase 
9) function in upstream regulatory events and are responsible for the activation of the 





coordinate the apoptotic response (Danial and Korsmeyer, 2004; Baumann et al., 2002; 
Pinkoski and Green, 2005). Executioner caspases also activate DNA fragmentation factor 
(DFF) which is responsible for DNA degradation (Huppertz et al., 1999).  
The complex apoptotic process can be broken down into three sequential phases: 
initiation, execution and death (Hoffman-Goetz et al., 2005). In the initiation phase 
cellular signaling results in activation of initiator caspase enzymes. The execution stage 
begins with the activation of executioner caspases; during this stage the cell reaches a 
point of no return and becomes committed to death. Finally, during the death stage, the 
nucleus collapses and apoptotic bodies are formed (Huppertz et al., 1999).  One key event 
in this process is the translocation of phosphatidylserine from the inner leaflet of the 
plasma membrane to the surface (Vermes et al., 1995). This occurs early in the apoptotic 
cascade (during the initiation stage) and acts a signal to phagocytes that death is 
imminent (Huppertz et al., 1999; Krysko et al., 2006).  This signaling is important as the 
recognition of dying cells facilitates their removal and prevents the onset of inflammation 
(Savill and Fadok, 2000).   
Under certain conditions, failure to remove apoptotic cells results in a specific 
type of death known as secondary or apoptotic necrosis (Majno and Joris, 1995). The late 
apoptotic cells lose membrane integrity and leak intracellular components that may result 
in inflammation (Cohen et al., 2002). The conflicting reports about whether secondary 
necrosis can cause inflammation may be partly explained by the properties of the 
intracellular fragments. Krysko et al. (2006) argues that the intracellular contents of 
secondary apoptotic cells have undergone degradation by the apoptotic cellular 





upon phagocytosis apoptotic cells release IL-10 (Gao et al., 1998) and TGF-β (Chen et 
al., 2001), thereby, promoting an anti-inflammatory environment. The loss of the 
suppressing activity of the phagocytes engulfing the apoptotic bodies could also skew the 
response towards inflammation.  
The two main pathways of apoptosis are the death receptor or extrinsic pathway 
and the mitochondrial or intrinsic pathway.  The intrinsic pathway of apoptosis is induced 
by various stimuli that include chemotherapeutic agents, UV radiation, oxidant stress 
molecules, glucocorticoids, and growth factor withdrawal (Gupta, 2005; Hoffman-Goetz 
et al., 2005).  The permeability of the outer mitoch ndrial membrane, which is controlled 
by the ratio of the Bcl-2 family of proteins, mediates apoptosis by the intrinsic pathway 
(Hengartner, 2000; Youle and Strasser, 2008). Proteins of the Bcl-2 family include both 
pro- (e.g., Bax) and anti- (e.g., Bcl-2) apoptotic proteins. Pro-apoptotic proteins reside 
within the mitochondrial outer membrane and upon activ tion these proteins undergo 
conformational changes that contribute to pore formation (van Loo et al., 2002). This 
pore formation increases mitochondrial outer membrane permeability (MOMP) and 
allows the contents of the intermembrane space to be released into the cytoplasm. The 
anti-apoptotic effect of Bcl-2 is attributed to its ability to bind and prevent the 
conformational changes associated with pro-apoptotic protein activation (Youle and 
Strasser, 2008). Therefore, anti-apoptotic proteins negatively regulate MOMP, inhibiting 
pore formation, and preventing the escape of important down-stream proteins responsible 
for carrying out apoptosis.   
Intermembrane space contents include cytochrome c and pro-caspases.  Once in 





1), ATP (adenosine triphosphate), and pro-caspase 9; together they form a complex 
known as the apoptosome (Adams and Cory, 2002).  The apoptosome activates caspase 9 
and initiates a series of enzymatic reactions that results in the eventual conversion of pro-
caspase 3 to the active executioner caspase 3 (Hoffman-Goetz et al., 2005).   
In contrast, the extrinsic pathway of apoptosis is induced by death signals which 
are provided by interaction between a ligand and its cellular receptor. Cellular death 
receptors include Fas (CD95/APO-1) and tumour necrosis factor receptor (TNFR), and 
their ligands: Fas ligand (Fas L) and TNF- α (Huerta et al., 2006). Upon ligation, death 
signals initiate a cascade involving recruitment of adaptor proteins and the eventual 
activation of initiator (e.g., caspase 8) and executioner (e.g., caspase 3) caspases. 
Cross-talk may occur between the intrinsic and extrinsic pathways. When pro-
caspase 8 levels are low in the cytoplasm, the cell amplifies the caspase cascade via the 
mitochondrial pathway using the protein Bid (Hoffman-Goetz et al., 2005).  In this 
pathway Bid is cleaved producing a truncated protein (tBid) that translocates from the 
cytoplasm to the mitochondria. Once in the mitochondria tBid exerts a pro-apoptotic 
effect by inducing conformational changes in Bax (pro-apoptotic protein) and inhibiting 
the activity of Bcl-2 (anti-apoptotic protein). This results in the release of cytochrome c 
and the eventual activation of caspase 3 (Budd, 2002; Gupta, 2005).  
 
 
1.3.2. Alternative Apoptotic Pathways 
 
The above section highlights the sequential and step-wise apoptotic process that 
results in the eventual activation of caspase 3. Although caspase activation is the 





example, apoptosis inducing factor (AIF) and endonuclease G (endoG) are proteins 
located in the mitochondrial intermembrane space and are released following increased 
MOMP. These enzymes are capable of directly inducing apoptosis via nuclear 
translocation and DNA degradation (Kim et al., 2005). Other organelles such as 
lysosomes and endoplasmic reticulum are both capable of inducing apoptosis (Ferri and 
Kroemer, 2001).  Lysosomes are “suicide” vacuoles which contain a large number of 
hydrolase enzymes that upon release damage integral cellular components. Alterations in 
the integrity of the lysosomal membrane facilitate the release of enzymes, such as 
cathepsins, that are directly involved in apoptosis (Guicciardi et al., 2004). Cathepsins are 
also capable of participating in up-stream apoptotic events that eventually result in an 
increased MOMP (Chwieralski et al., 2006).  
The endoplasmic reticulum (ER) is capable of sensing cellular stresses through 
two mechanisms: accumulation of misfolded proteins a d perturbation of intracellular 
calcium levels. Together these signals activate ER associated caspase 12, an executioner 
caspase capable of directly inducing apoptosis (Broker et al., 2005). Increases in 
intracellular calcium levels can activate calpains, which are cysteine proteases with 
similar activity to caspases (Wang, 2000). Calpains induce apoptosis by either activation 
of caspase 12 or by activating pro-apoptotic proteins (e.g., Bax) that increase MOMP 
(Ferri and Kroemer, 2001). In addition, calpains may alter lysosomal permeability 
leading to cathepsin release and apoptosis (Yamashi, 2004). 
To summarize, at any point multiple apoptotic pathways may occur 





between pathways may occur and the sensing of cellular events by various organelles 
allows for a coordinated and organized controlled form of cell death.  
 
1.3.3. Necrosis  
 
  
 Necrosis does not involve DNA or protein degradation and is characterized by 
cytoplasmic and mitochondrial swelling prior to rupt re of the plasma membrane 
(Kroemer et al., 1998).  It occurs following cellular injury (e.g., ischemia-reperfusion, 
drug induced) and is described as a passive process, mainly because of its independence 
from ATP. Necrosis affects groups of cells rather than occurring on an individual cellular 
level as in apoptosis (Jaeschke and Lemasters, 2003). Necrosis may also occur if ATP is 
rapidly depleted at the onset of apoptotic stimuli (N cotera and Melino, 2004). Thus, 
apoptosis and necrosis may occur following the same tr atment such as 
ischemia/reperfusion induced hepatocyte death (Malhi et al., 2006) and DSS-induced 
colonic epithelial death (Renes et al., 2002).  In necrosis, plasma membrane disruption 
and the resultant release of cellular contents cause inflammation and is a distinctive 
feature between necrosis and apoptosis (Gibson, 2004). 
 
1.4. Intestinal Lymphocyte Apoptosis and Inflammation 
 
Apoptosis of lymphocytes is an important step in removing the vast number of 
potent antigen specific T cells generated during an inflammatory response. Failure to 
execute apoptosis of activated IL results in prolonged inflammation leading to increased 





response, apoptosis of lymphocytes can be induced by active or passive mechanisms. 
Active methods of apoptosis include activated induced ell death, whereby Fas L binds to 
Fas located on the surface of the T cells. Passive methods involve withdrawal of 
cytokines required for lymphocyte survival (Neurath e  al., 2001).  
LPL are susceptible to Fas mediated apoptosis and exhibit higher degrees of 
spontaneous apoptosis compared to PBL (Neurath et al., 2001).  Apoptotic resistance of 
LPL is a common observation in individuals with IBD. For example, colonic T cells of 
patients suffering from Crohn's Disease (CD) had increased Bcl-2/Bax ratios and 
increased numbers of CD3+ T cells; these cells were also resistant to Fas and TNF-α 
mediated death (Ina et al., 1999). Similarly, in both CD and ulcerative colitis (UC) 
patients, Fas-induced apoptosis was defective upon stimulation with CD2 (Boirivant et 
al., 1999) and apoptotic resistant T cells in inflamed tissues had increased levels of the 
anti-apoptotic protein Bcl-2 (Atreya et al., 2000).  
Given the resistance to apoptosis of LPL in IBD, a potential therapeutic approach 
may be by inducing apoptosis of activated IL. Currently, the primary approach is the use 
of anti-cytokine treatments to indirectly induce apoptosis (Van Den Brande et al., 2002). 
However, any molecule capable of receptor binding, i ternalization and activation of the 
apoptotic machinery should theoretically be able to initiate IL death. Successful anti-
cytokine treatments include those directed at TNF-α. Lugering et al. (2001) reported that 
following anti-TNF-α antibody treatment in patients with active CD, there was elevated 
expression of cytochrome c, Bax and Bak and the induction of caspase 9 and caspase 3 in 
blood monocytes. Similar observations were reported by Di Sabatino and colleagues 





improved disease activity index scores in CD patients.  Myers et al. (2003) demonstrated 
that antisense oligonucleotides specific for TNF-α mRNA effectively reduced TNF-α 
expression and resulted in a 44% reduction in the dis ase activity scores and prevented 
colonic shortening in mice following DSS treatment. Collectively, these results imply 
that induction of lymphocyte apoptosis during periods of inflammation may provide 
some degree of protection in the bowel from these pot ntially tissue damaging cells (or 
their products).  
 
1.4.1. Acute Exercise and Intestinal Lymphocyte Apoptosis  
 
In response to strenuous and prolonged exercise ther  is a well documented 
increase in plasma levels of the adrenal glucocorticoid (GC) hormone corticosterone 
(CORT) (see for example, Murosaki et al., 1997; Quadril tero and Hoffman-Goetz, 2005; 
Mastorakos et al., 2005). The role of GC is to recruit important energy reserves required 
for exercise through the stimulation of gluconeogenesis and the mobilization of amino 
and fatty acids (Tharp, 1975). GC hormones are alsopotent anti-inflammatory and 
apoptosis inducing agents used to treat a wide variety of ailments including IBD 
(Tuckermann et al., 2005). Indeed both elevated plasma levels of corticosterone and 
increased apoptosis in thymocytes (Concordet and Ferry, 1993; Quadrilatero and 
Hoffman-Goetz, 2005) and intestinal lymphocytes (Hoffman-Goetz and Quadrilatero, 
2003) have been reported in mice following exercise.  
At first glance it may appear that increased apoptosis f IL with acute exercise 
could offer protection against inflammation. However, during acute exercise there is also 





epithelial cells concurrent with IL death.   Indeed, alterations to the epithelial barrier are 
evident in studies demonstrating endotoxemia post exercise.  For example, following 
strenuous exercise Ashton et al. (2003) and Bosenberg et al. (1988) reported increased 
concentrations of LPS in the blood of human volunteers.  However, the results of these 
studies may be questioned given the limitations of the LPS assay. These include the 
difficulty in LPS isolation from other membrane phospholipids and cytoplasmic 
components as well as the hydrophobicity of the endotoxin (Cordwell, 2006).  In 
addition, when examining the effects of exercise in humans it is important to record all 
details of the experimental conditions such as the environmental factors (e.g., 
temperature, humidity), exercise protocol (e.g., exhaustive vs. submaximal work), subject 
characteristics (e.g., age, weight) and whether the subjects were ingesting dietary 
supplements. The works cited here do not contain these potential shortcomings but it is 
important to ensure that when reviewing the literature, particularly with older studies, that 
they do not contain these experimental limitations. Nonetheless, as discussed in section 
1.2.4.2, if bacterial translocation were to occur post exercise it may result in an 
inflammatory response, as the complex immune network of highly activated lymphocytes 
would encounter bacterial antigen. This interaction, a d subsequent immune response, 
would ensue even after the exercise stress is removd.  Thus, theoretically the net result 








1.5. Lactoferrin  
 
The transferrin family of proteins is responsible for the regulation of iron in both 
the blood (serum transferrin) and tissues (Lactoferrin - Lf) (Wally and Buchanan, 2007).  
Iron is potentially detrimental to the host as it can either enhance the formation of tissue 
damaging free radicals or provide an important nutritional source to bacteria (Carrier et 
al., 2006). Lf is produced endogenously (human Lf - hLf) by glandular epithelial cells 
and is found in external (i.e., saliva, tears) and mucosal secretions as well as in secondary 
neutrophil granules (Baker and Baker, 2005; Ward et al., 2005).  A major dietary source 
of Lf is cow (bovine) milk. Bovine lactoferrin (bLf) is an 80 kDa glycoprotein found at 
concentrations of 0.2 mg/mL and 1.5 mg/mL in milk and colostrums, respectively 
(Marshall, 2004).  Upon pepsin digestion lactoferricin (Lfcin) is generated and this 
hydrolysate exhibits similar and, in some cases, enhanced biological properties to that of 
Lf (Gifford et al., 2005). hLf and bLf share 69% sequ nce homology (bLf and hLf 
contain 689 and 691 amino acids, respectively) (Pierce et al., 1991) and both contain 
cationic regions owing to the cellular binding ability of Lf (Legrand et al., 2006).  
Historically, the immunological benefit of Lf was attributed to its ability to bind 
iron and prevent bacterial growth (Teraguchi et al., 1995). Recently, the biological 
functions of Lf have been expanded to also include effects on various immune 
parameters.  For example, dietary feeding of Lf to weanling pigs increased mRNA 
production of the anti-microbial peptides 39-residue proline–arginine-rich peptide and 
protegrin-1 (Wang et al., 2006); these observations suggest a bacteriocidal role of Lf.  Lf 
administration increased IgA and IgG concentrations i  the saliva and intestinal 





and IgA in the presence of Lf (Debbabi et al., 1998). Similar findings were found by 
Shan et al. (2007) who reported that Lf supplementation in pigs increased serum IgG and 
IgA levels following stimulation of lymphocytes with the plant lectin, 
phytohemagglutinin.  
The immunological properties of Lf are likely due to its cell binding ability 
(Legrand et al., 2006) and surface molecules have be n identified that bind and 
internalize Lf (Suzuki et al., 2005; Legrand et al., 2006). Cells found to bind to Lf include 
neutrophils (Deriy et al., 2000; Birgens et al., 1984), mononuclear phagocytes (Britigan 
et al., 1991; Birgens et al., 1984), peripheral blood CD4+ cells (Li et al., 2006), T and B-
cells (Birgens et al., 1984), activated lymphocytes (Mincheva-Nilsson et al., 1997; 
Mazurier et al, 1989) and intestinal epithelial cells (Ashida et al., 2004).  The role of Lf 
once inside the cell is unknown but researchers have suggested that Lf modulates DNA 
expression. In support of this hypothesis is the following evidence: 1) Lf is internalized in 
intestinal cells and is found concentrated around the nucleus (Ashida et al., 2004), 2) Lf 
receptors are found at greater concentrations within e cell on active lymphocytes 
(Mazurier et al., 1989) and, 3) Lf binds with distinct sequence specificity to DNA (He 
and Furmanski, 1995). Although the notion of signaling from receptor to DNA binding 
and transcriptional regulation is still controversial, the prevailing perspective is that the 
immunomodulatory effects of Lf are mediated by inter alization via a specific cellular 





1.5.1. Inflammatory Properties 
 
There are several lines of evidence that show Lf has anti-inflammatory properties. 
First, independent of its iron binding ability, Lf can bind and neutralize several bacterial 
components such as LPS and Lipid A (Appelmelk et al., 1994).  This neutralization 
reduces bacterial activity and decreases the immune response including decreased 
production of pro-inflammatory cytokines (Fischer et al., 2006).  In human CaCo-2 cells, 
Lf, co-cultured with invasive E. coli HB101 (pRI203), significantly attenuated the 
increase in levels of TNF-α and IL-6 (Berlutti et al., 2006). Valenti and colleagues (1999) 
demonstrated that bLf binding to Listeria monocytogenes prevented this bacterium from 
inducing intestinal tissue damage. Thus, interaction of Lf with bacterium or bacterial 
components may prevent or reduce inflammation 
The anti-inflammatory role of bLf is also related to i s ability to promote anti-
inflammatory cytokine production or reduce pro-inflammatory cytokine production. In 
support of Lf as an anti-inflammatory protein is the following evidence: 1) Lf addition in 
culture reduced IL-2 production (important in T cell activation), in TH1 but not TH2 cells 
(Zimecki et al., 1996), 2) Lf administration reduced IFN-γ and increased IL-10 in the 
peripheral blood of patients suffering from systemic lupus (Li et al., 2006), 3) bLf 
addition by gavage attenuated the increase of TNF-α, IL 1 and IL-6 in the ears and joints 
of zymosan treated mice (Hartog et al., 2007), 4) oral administration of  bLf reduced 
plasma levels of TNF-α and increased IL-10 in a rat model of rheumatoid arthritis 
(Hayashida et al., 2004), 5) bLf provided by gavage reduced TNF-α and increased IL-10 





2002a; 2002b), and 6) hLf and bLf incubated with monocytes reduced TNF-α production 
following LPS stimulation (Choe and Lee, 1999).  
However, Lf has also been shown to have pro-inflammtory effects. Evidence for 
the pro-inflammatory effects of bLf include: 1) reduced lung colonization of Co26Lu 
tumour cells following bLf administration in mice by gavage, which was attributed to 
increased IL-18, IFN-γ and IL-1 (TH1 cytokines) as well as enhanced phagocytotic 
activity of splenocytes and augmented NK cell activity (Kuhara et al., 2000; Wang et al., 
2000),  2) increased concentrations of the pro-inflammatory cytokines TNF-α, IFN-γ and 
IL-1 as well as decreased IL-2, were reported in the small intestine of mice receiving bLf 
by gavage (Iigo et al., 2004), 3) increased expression of IL-10 and IFN-α in mouse 
lymphocytes following bLf administration (Takakura et al., 2006), 4) addition of bLf 
increased Type 1 interferon and TNF- α production and reduced viral load up to 100 fold 
in macrophages infected with the vesicular stomatitis virus (Puddu et al., 2007), 5) the 
phagocytic activity of neutrophils in healthy volunteers was increased following co-
culture with bLf (Miyauchi et al., 1998), and 6) macrophages incubated with bLf were 
activated via upregulation of CD40 and increased production of the pro-inflammatory 
cytokine IL-6 (Curran et al., 2006).  
The basis for these mixed effects of bLf (i.e., pro- and anti-inflammatory 
responses) is not fully understood. However; several factors such as the route of 
administration and the immune status of the individual may be critical. For example, 
Sfeir et al. (2004) demonstrated that bLf administered by gavage or by intramuscular 
injection resulted in a mixed TH1/TH2 (e.g., increased IFN-γ, IL-4; IgG2a, IgG1) response 





response. Indeed, Yamauchi et al. (2006) argue that mode of administration may alter bLf 
digestion thus affecting the nature of the peptide fragment available for absorption or 
cellular interaction. In addition, the immune status of the individual can influence the 
direction of the bLf response. For example, during carcinogenesis or viral challenge bLf 
appears to increase TH1 cytokine production whereas during inflammatory conditions bLf 
favours TH2 cytokine production (Fischer et al., 2006). Although the mechanism is not 
understood at this time, Fischer and colleagues speculat  that bLf affects either TH cell 
maturation, differentiation, or development after the initial stimulus. Once the TH cell is 
committed along a path of development (i.e., post stimulus) the addition of bLf may 
enhance the specific pathway of development. Taken together, both the mode of bLf 
administration and immune status appear to influence its mechanism of action and may 
explain its ability to drive two separate (and opposite) responses.  
 
1.5.2. Bovine Lactoferrin, Apoptosis and Proliferation 
 
 
Among the roles of Lf, it may influence various parameters of cell death and cell 
proliferation. Addition of Lf to the diets of animals has been shown to increase apoptosis 
or the expression of apoptotic proteins within epithel al cells. Fujita et al. (2004a; 2004b) 
found that Fas expression is upregulated in the colonic mucosa of AOM treated mice fed 
bLf; expression of Bid, Bax, caspase 8 and caspase 3 (all pro-apoptotic proteins) were 
increased as a result of bLf enriched diets. Lee et al. (2008) observed increases in caspase 
9 and caspase 3 in Jukat T leukemia cells following incubation with hLf. In human 
tongue-derived cancer cells and in human monocytic tumour cells increased apoptotic 





fragmentation, and elevated caspase 3 levels were visualized following LFcin treatment 
(Sakai et al., 2005; Yoo et al., 1997). Therefore, Lf or its derivatives, may be able to 
induce apoptosis or influence apoptotic proteins to fav ur cell death.  
On the other hand, Lf can alter epithelial cell (EC) proliferation. In vitro 
administration of Lf resulted in increased proliferation (as measured by 3[H]-thymidine 
incorporation) in CaCo-2 cells (Buccigrossi et al.,2007) and in rat intestinal epithelial 
cells (Hagiwara et al., 1995).  Similarly, Nichols et al. (1990) demonstrated increased 
3[H]-thymidine incorporation in rat enterocytes following in vitro hLf treatment. These 
studies indicate increased in vitro cellular proliferation in the presence Lf.  The nature of 
this diverse response (apoptosis vs. cell proliferation) may be related to the type of cell 
involved: neoplastic vs. normal cell.  Cell numbers decreased to below original values in 
human colon adenocarcinoma cells following Lf addition (Amouric et al., 1984).  Cell 
viability was reduced by 50% in Jurkat T cells following incubation with hLf (Lee et al., 
2008). Lf may thus decrease proliferation of atypical ells but promote the growth of 





Chapter 2: Study Rationale and Conceptual Framework  
 
 
Inflammatory bowel diseases (IBD), characterized by recurring and relapsing 
bouts of intestinal inflammation, affect millions of people worldwide (estimated 1.5 
million Americans and 2.2 million Europeans) and are diseases of high morbidity 
(Loftus, 2004). A potential detrimental consequence of sustained intestinal inflammation 
is tumour formation and an approximate 10 fold increase in colon cancer incidence is 
observed in patients with ulcerative colitis, a form of IBD (Seril et al., 2003). Even in 
situations of less profound clinical pathology, such as gastrointestinal disturbances 
experienced by athletes, the treatment of intestinal flammation has numerous 
applications and advantages.  
Intestinal lymphocytes (IL) are integral in maintaiing homeostasis as they 
participate in both immune effector and regulator functions. Apoptosis, or programmed 
cell death, is essential in regulating the population of these immune cells, as failure to 
remove activated lymphocytes can result in the onset of inflammatory disease (Levine 
and Fiocchi, 2001). In addition, cytokines play a central role in regulating the immune 
response. The balance between pro-inflammatory (e.g., TNF-α) and anti-inflammatory 
(e.g., IL-10) cytokines is critical in the regulation of immunological homeostasis. 
Therefore, the examination of both apoptosis and inflammatory cytokine levels in 
intestinal lymphocytes offers useful insight into mechanisms of intestinal immune 
regulation. 
Bovine lactoferrin (bLf) is a common dietary protein found in dairy products and 





These immunomodulatory attributes of bLf are, in part, mediated by altering the 
environment in favour of anti-inflammatory cytokines (e.g., decreased pro- and/or 
increased anti-inflammatory cytokine levels). bLf has also been shown to affect apoptosis 
in epithelial cells and carcinoma cells in vitro. Although it has not been determined 
experimentally whether dietary bLf affects apoptosis of intestinal lymphocytes there is 
evidence to suggest a possible mechanism. Therefore, bLf is a potentially attractive agent 
for a variety of inflammatory disorders and, perhaps, carcinogenesis.  Clinically, the 
benefits of bLf induced IL apoptosis and the generation of an anti-inflammation cytokine 
environment would include: alleviation of disease symptoms (in athletes and IBD 
patients), reduced tissue damage and the potential for reduced colon carcinogenesis. 
The purpose of this research was to describe the effects of bLf in mice on: 1) IL 
apoptosis (using surface expression of phosphatidylserine, cell number and protein levels 
of pro-apoptotic caspase 3 and anti-apoptotic Bcl-2) and pro-(TNF-α) and anti-(IL-10) 
inflammatory cytokine levels in a healthy, non-inflamed state; 2) IL apoptosis (using 
surface expression of phosphatidylserine, cell number and protein levels of pro-apoptotic 
caspase 3 and cytochrome c and anti-apoptotic Bcl-2), pro- (TNF-α) and anti- (IL-10) 
inflammatory cytokine levels, and levels of the pro-inflammatory transcription factor 
NFκB under conditions of inflammation induced by a physiological stressor (i.e., 
repeated bouts of acute exercise (AE); 3) IL apoptosis (using surface expression of 
phosphatidylserine, cell number and protein levels of pro-apoptotic caspase 3, 
cytochrome c, and Bax and anti-apoptotic Bcl-2), pro- (TNF-α) and anti- (IL-10) 
inflammatory cytokine levels, and levels of the pro-inflammatory transcription factor 





(e.g., DSS); 4) imparting mucosal protection against DSS and/or AE induced intestinal 
alterations (using histological analysis); and 5) IL apoptosis (by measuring levels of pro-
apoptotic caspase 3 and anti-apoptotic Bcl-2) and the formation of pre-cancerous colonic 
lesions (i.e., aberrant crypts) under conditions of inflammation (i.e., DSS or AE) 
following carcinogen (e.g., AOM) exposure.   
Based on published research it was hypothesized that during inflammation bLf 
would act on IL to induce apoptosis and alter cytokine levels to either increase anti-
inflammatory or reduce pro-inflammatory cytokines. The overall conceptual framework 
for the series of experiments described in the subsequent chapters is presented 
diagrammatically in Figures 2.1-2.3. Figure 2.1 illustrates the normal, non-inflamed state 
of the intestine with a focus on T cells. Figure 2.2 presents inflammation processes in the 
intestine, again with an emphasis on T cells. Figure 2.3 shows how bLf may influence the 
inflammatory process by altering both apoptosis of intestinal lymphocytes (i.e., LPL and 















TH1 Cytokines TH2 Cytokines
LPL Activated lamina propria
lymphocyte
IEL Activated intraepithelial lymphocyte






* Activated dendritic cell


















Figure 2.1:  Schematic diagram showing leukocyte orientation within the colonic 


































Figure 2.2: Schematic diagram showing leukocytes during inflammation. As the 
epithelium is damaged and commensal bacteria translocates into the lamina propria, the 
macrophages and dendritic cells (DC) become activated resulting in subsequent 
activation of lymphocytes. Activation results in production of TH1 cytokines and 







































Figure 2.3: Schematic diagram showing the possible effects of bLf during inflammation.  
bLf may be able to induce apoptosis of activated IEL and LPL. In addition, a possible 
shift from TH1 to TH2 cytokine secretion could occur. The overall result is alleviation 






The addition of bLf during inflammation may thus provide protection by: 1) inducing 
apoptosis of activated lymphocytes and 2) shifting he cytokine milieu to predominantly a 
TH2 environment by either reducing TNF-α or increasing IL-10.  It is expected that the 
bLf induced modifications in both these immunological parameters will result in mucosal 








CHAPTER 3:  Effect of Short Term Dietary Intake of Bovine 






To determine the effect of dietary bovine lactoferrin (bLf) administration on CD4+ and 
CD8+ intestinal lymphocyte (IL) apoptosis and IL cytokine levels of TNF-α and IL-10 in 





Hypothesis 1: bLf administration will decrease the levels of TNF-α and increase the 
levels of IL-10 in mouse IL relative to the levels of TNF-α and IL-10 in mice not given 
bLf supplementation. 
 
Hypothesis 2: bLf administration will increase the percent apoptosis in CD4+ and CD8+ 
mouse IL relative to the percent apoptosis in mice not given bLf supplementation. 
 
3.3. Study Design  
 
This study was designed to provide baseline measurements on the effect of dietary 
bLf on TNF-α and IL-10 levels and the % CD4+ and CD8+ IL apoptosis during a normal 
(non-inflammatory) state. It was also the aim of this study to determine an effective bLf 
dose. Previous studies have determined that during an inflammatory state bLf provided 
by gavage is able to decrease TNF-α and increase IL-10 in the rat colonic epithelium 
(Togawa et al., 2002a; 2002b). However, whether this protective effect occurs in IL of 
healthy mice is unknown. This study also examined varying concentrations of bLf in the 
diet and determined if there were notable changes in IL apoptosis and cytokine 
measurements by dose of bLf. IL were isolated and enumerated and apoptosis of these 
cells determined by measurement of surface phosphatidylserine expression by flow 





protein Bcl-2 and the cytokines TNF-α and IL-10 were quantified in mouse IL by 
Western blot analysis. The study design for this experiment is given in Figure 3.1.  
 
Study duration: Two week acclimation plus 4 d of dietary bLf administration.  
 
Figure 3.1: Experimental set up for study 1 outlining the outcme measures. 
 
One-way analysis of variance (ANOVA) and post-hoc Tukey test was used to 
analyze the study data.  The independent variable is diet condition (no bLf, 0.2% bLf, 
2.0% bLf) and dependent variables included: % CD4+ and % CD8+ IL (as well as percent 
apoptotic IL), apoptotic markers in IL (caspase 3 and Bcl-2) and cytokine proteins (TNF-
α and IL-10).  The software package SPSS (version 15) was used to analyze the data and 
in all cases p< 0.05 was accepted as being significant.  
Female mice (C57BL/6) (n=47) 
Group 1 (n=16) 
Basal diet (bLf: 0%)  
Group 2 (n=16) 
bLf:  0.2% 




phenotypic (%) distribution, 
apoptosis measurement 
Western blotting for apoptotic 
(Caspase 3 and Bcl-2) and cytokine 
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Randomly assigned 





The contents of this chapter were reprinted from with permission from the journal 
Nutrition (23: 812-817, 2007). 
 
 
This is a License Agreement between Paul A Spagnuolo ("You") and Elsevier Limited 
("Elsevier Limited"). The license consists of your order details, the terms and conditions 
provided by Elsevier Limited, and the payment terms and conditions. 
License Number: 1975421347670 
License date: Jun 24, 2008 
Licensed content publisher: Elsevier Limited 
Licensed content publication: Nutrition 
Licensed content title:  Effect of short-term dietary intake of bovine lactoferrin on 
intestinal lymphocyte apoptosis in healthy mice 
Licensed content author: Paul A. Spagnuolo, Ranjana P. Bird and Laurie Hoffman-Goetz 
Licensed content date: November-December 2007 
Volume number: 23 
Issue number:11-12 
Pages:6 
Type of Use: Thesis / Dissertation 
Portion: Full article 
Format: Print 
You are the author of this Elsevier article: Yes 
Are you translating?: No 
Purchase order number 
Expected publication date: Oct 2008 
Elsevier VAT number: GB 494 6272 12 
Permissions price: 0.00 USD 







3.4. Overview  
 
 
The objective of this study was to describe the effcts of short term dietary exposure of 
bovine lactoferrin (Lf) on intestinal lymphocyte apoptosis and expression of tumour 
necrosis factor (TNF)-α in healthy mice.  Female C57BL/6 mice were randomly assigned 
to 3 treatment groups; 0% Lf (n=16), 0.2% Lf (n=16) and 2.0% Lf (n=15). Bovine Lf was 
administered orally, as part of the diet, for 4 consecutive days.  Intestinal lymphocytes 
(IL) were isolated and analyzed for % CD4, % CD8, % apoptotic CD4, and % apoptotic 
CD8 cells using flow cytometry. Pro- (caspase 3) and ti- (Bcl-2) apoptotic protein 
expression and TNF-α expression in IL were determined by Western blotting. There was 
a significant increase in the % CD4 (p=0.02) and % apoptotic CD4 (p=0.02) IL in bovine 
Lf fed compared with control mice.  The % CD8, % apoptotic CD8 and the expression of 
caspase 3 and Bcl-2 in IL did not differ significantly by diet group.  In contrast, the 
expression of TNF-α was significantly lower in Lf fed relative to control mice (p=0.01).   
Short term dietary Lf decreased TNF-α expression in IL and increased apoptosis of CD4 








Bovine lactoferrin (Lf), an iron binding glycoprotein found in they whey fraction 
of mammalian milk and colostrums, has immune modulatory properties. Lf and 
lactoferricin (Lfcin), a result of pepsin digestion f Lf,  increase apoptosis (programmed 
cell death) of colonic tumours in rats (Fujita et al., 2004a; 2004b), leukemia (Jurkat), 
breast cancer (MCF-7), colon cancer (Colo-35) and human cell lines (Mader et al., 2005); 
Lf is also associated with an increase in the population of NK cells in mice and humans 
(Kuhara et al., 2000; Shau et al., 1992), an increase in the population of CD8 T cells in 
mice (Kuhara et al., 2000; Wang et al., 2000), and  decrease in blood concentrations of 
the TH1 cytokines, TNF-α and IFN-γ, during inflammation in rats (Hayashida et al., 2004; 
Togawa et al., 2002a; 2002b). CD4 T lymphocytes, crucial to immune regulation through 
the production of cytokines, are also affected by Lf.  For example, after Lf administration 
to rodents, CD4 T cells increase in peripheral blood and decrease in the spleen 
(Wakabayashi et al., 2006), and increase in mucosal lymphoid tissue (Wang et al., 2000)   
Most experimental studies on the immune modulating effects of exogenous Lf 
have focused on pathological conditions including carcinogenesis (Fujita et al., 2004a; 
2002b; Kuhara et al., 2002; Wang et al., 2000; Sekine et al., 1997a; 1997b) and 
inflammation (Togawa et al., 2002a; 2002b; Wakabayashi et al., 2006). Few studies 
describe how (or if) Lf acts on lymphocytes in non-diseased states (Wakabayashi et al., 
2006; Takakura et al., 2006; Debabbi et al., 1998; Sfeir et al., 2004). Moreover, 
experimental studies (Kuhara et al., 2000; Wang et al., 2000; Hayashida et al., 2004; 
Togawa et al., 2002a; 2002b; Wakabayashi et al., 2006; Takakura et al., 2006; Debabbi et 





physiological. Indeed, there is virtually no research on Lf administration through 
physiological routes (i.e., oral feeding) in non-disease states. This absence is striking 
given that Sfeir et al. (2004) reported mucosal immune responsiveness varies according 
to the route of Lf administration.  
The purpose of this pilot study was to describe the eff cts in healthy animals of 
short term dietary exposure to bovine Lf on intestinal lymphocyte apoptosis (Annexin V 
and caspase 3 expression) and the expression of tumur necrosis factor (TNF)-α. Because 
Lf induces apoptosis under pathological conditions a d in tumour cell lines in vitro, our 
hypothesis was that dietary bovine Lf would also increase apoptosis in IL obtained from 
healthy animals. 
 
3.6. Materials and Methods 
 
 
Animals and Diets:  Female C57BL/6 mice (n=47) (Harlan Sprague Dawley, 
Indianapolis, IN, USA), 3-4 weeks of age, were housed individually at 21±1oC on a 
12/12h reversed light/dark cycle, with  ad libitum access to a maintenance diet 
(Laboratory Rodent Chow, PMI feeds Richmond, IN, USA) and tap water for 2 weeks. 
After this acclimation period, mice were randomly assigned based on weight, to 3 diet 
groups: control [0% bovine Lf] (n=16), low dose [0.2% bovine Lf] (n=16), or high dose 
[2.0% bovine Lf] (n=15).  Diets were based on a semi-purified AIN 76A standard diet 
and formulated to contain either: 0%, 0.2% or 2.0% bovine Lf (Erie Foods International 
Inc, Erie IL), while maintaining similar overall protein concentrations (20% total protein 
in all groups) (Table 3.1). Diets were individually prepared and pelleted to resemble the 





or timing of feeding) compared to the maintenance diet.  Bovine Lf was 16% iron 
saturated and greater than 90% pure. Mice were given ad libitum access to the Lf 
containing diets for 4 consecutive days prior to sacrifice.  All protocols with live animals 
conformed to the established ethical guidelines of the Canadian Council on Animal Care 
and were approved by the University Animal Ethics Committee.  
 
 
Table 3.1: Composition of the semi-purified AIN 76A diets 
 
 
Component Control (%) 0.2% Lf (%) 2.0% Lf (%)
Sucrose 49.9 49.9 49.9
Casein 20.0 19.8 18.0
Bovine Lf 0.0 0.2 2.0
Corn Stach 15.0 15.0 15.0
Cellulose 5.0 5.0 5.0
Corn Oil 5.0 5.0 5.0
Mineral Mix 3.5 3.5 3.5
Vitamin Mix 1.0 1.0 1.0
Choline 0.2 0.2 0.2
L-cysteine 0.3 0.3 0.3
TBHQ 0.1 0.1 0.1








Intestinal Lymphocyte Preparation: Intestinal lymphocytes (IL) were isolated 
according to Lefrancois (1993) and modified by Hoffman-Goetz and Quadrilatero (2003). 
The intestinal compartment was immediately removed, Peyer’s patches and visible fat 
dissected out, intestinal lymphocytes (IL) isolated over a column of 0.3 g of nylon wool, 
washed, and layered over a density gradient medium (Lympholyte-M; Cedarlane 
Laboratories, Hornby, Ont.) to remove epithelial cel s and debris. IL were collected and 
counted manually by microscopy after staining with Turk’s solution (Hoffman-Goetz and 
Spagnuolo, 2007b). IL included both intraepithelial and lamina propria lymphocytes. 
 
IL Apoptosis and Phenotypes:  Apoptosis was assessed by FITC-Annexin V+ staining 
which detects the expression of phosphatidylserine on cell surface membranes. 
Externalization of phosphatidylserine is an early apoptotic event and occurs as a result of 
the loss of plasma membrane lipid asymmetry (Vermes et al., 2002). Propidium iodide 
(PI) is a non-specific DNA dye that becomes incorporated in non-viable cells but is 
excluded from living cells with intact plasma membranes (Lecoeur et al., 2001). PI was 
used to assess late apoptotic or dead cells. Briefly, 1 x 105 IL were incubated with 100µL 
Annexin V binding buffer (Pharmingen, Mississauga, ON) and 2.5 µL Annexin V-FITC 
monoclonal antibody and 2.5µL of PI (Sigma Chemical) for 15 min at room temperatu e 
in the dark. 400µL Annexin V binding buffer was adde  to each sample before analysis 
by flow cytometry (Epics XL Flow Cytometer, Beckman-Coulter, Hialeah, FL) for 
apoptotic and necrotic cells.   
For T cell phenotypes, 1 x 105 IL were incubated for 45 min at 4ºC in the dark 





CD45, clone: 30F11), PE-conjugated CD4 (anti-CD4, clone: GK1.5), or PE-conjugated 
CD8α (anti-CD8a, clone: 53-6.7) (Pharmingen). Details about preparation of cell 
suspensions for determination of lymphocyte phenotypes are reported elsewhere 
(Hoffman-Goetz and Quadrilatero, 2003; Davidson and Hoffman-Goetz, 2006).  The 
initial acquisition gate was created based on the forward and side scatter properties of a 
population shown to collect >90% CD45+ cells (leukocytes). 
 
Western Blot Analysis of Caspase 3, Bcl-2 and TNF-α:  Lysis buffer [300 mM NaCl, 
50 mM Tris-Cl (pH 7.6), 0.5% Triton X-100] and 0.1 mM phenylmethylsulfonyl fluoride 
(PMSF) were added to IL on ice for 45 min. Lysates were centrifuged, the supernatant 
collected, and protein was determined by the BCA assay. Forty micrograms of protein 
and molecular weight markers (Full Range Rainbow and Biotin Markers, Amersham 
Biosciences, Buckinghamshire, U.K.) were separated by electrophoresis on a 12% SDS 
PAGE gel and transferred onto a PVDF membrane (Sigma Chemical).  Following 
transfer, membranes were stained with Ponceau S (Sigma Chemical) to confirm quality 
of transfer and equal loading. Membranes were blocked overnight in 10% milk-TBST 
(Tris-Buffered Saline Tween-20) at 4oC and incubated with primary antibody for 1 h. The 
concentration of antibodies to Bcl-2 (clone: C-2; mouse anti-human monoclonal IgG1, 
MW=28kDa), caspase 3 (clone: H-227; rabbit anti-human clone IgG, MW=35kDa) and 
TNF-α (clone: N-19; goat anti-human polyclonal IgG, MW=17kDa) were 1:200 (in 10% 
milk-TBST) (Santa Cruz Biotechnology, Santa Cruz, CA, USA). This was followed by 
incubation for 1 h with secondary antibody: horseradish peroxidase-conjugated anti-





1:2000 in 10% milk-TBST. Protein was determined using ECL Western blotting 
detection reagents (Amersham Biosciences, Buckinghams ire, UK) and the ChemiGenius 
2 Bio-imaging System (Cambridge, UK). Samples from the three treatment groups were 
run together on the gels. 
 
Statistical Analysis:  All data were analyzed with a one-way analysis of variance by 
group using SPSS (Version 15; Chicago, IL, USA). Post hoc analysis was performed with 
Tukey HSD test to determine difference between the thr e diet groups.  For Tukey’s post 
hoc analysis, p<0.05 was accepted as being significantly different from chance alone. All 






 There was no significant change in body weights over the 4 days of the 
experiment  (average start weights: 0% Lf: 17.20 ± 0.40g; 0.2% Lf: 17.58 ± 0.46g; 2.0% 
Lf: 17.25 ± 0.27g; average end weights: 0% Lf: 17.20 ± 0.64g; 0.2% Lf: 17.80 ± 0.45g; 
2.0% Lf: 17.48 ± 0.37g), or in food intake (0% Lf: 10.45 ± 0.45g; 0.2% Lf: 10.86 ± 




















PI + (%) 
“Dead” 
0% Lf 16 24.73 + 1.42 16.57 + 1.32 17.75 + 1.36 
0.2% Lf 16 31.63 + 1.94* 22.07 + 1.89
* 23.07 + 1.89 
2.0% Lf 15 31.7 + 1.77* 24.35 + 1.66
* 25.34 + 1.66* 
 























Figure 3.2: Percent T cell phenotypes and apoptosis in IL of mice given bovine Lf in the 
diet.  A: % CD8 IL and % CD8/Ann+ IL; B: % CD4 IL and % CD4/Ann+ IL. All values 
are means ± SEM. 0% = 0% Lf (n=16), 0.2% = low dose (0.2% Lf) (n=16); 2.0% = high 

















































































 There was no significant effect of short term dietary bovine Lf exposure on total 
IL counts in mice (0% Lf: 4.32x107 ± 0.29 cells; 0.2% Lf: 3.46x107 ± 0.35 cells; 2.0% Lf: 
3.90 x 107 ± 0.30 cells). In contrast, the % Annexin V+ (early apoptotic) and % Annexin 
V+/PI+ (late apoptotic) IL were significantly higher in the Lf fed relative to control mice 
(F2,44=5.47, P=0.008 and F2,44=5.91, P=0.005, respectively) (Table 3.2). The % PI
+
(necrotic) IL was also significantly higher in the 2.0% Lf fed mice relative to the group 
not supplemented with Lf (F2,44=5.57, P=0.007) (Table 3.2). 
 Figure 3.2 shows the flow cytometry results for the IL T cell subsets CD8+ and 
CD4+ and for the expression of apoptosis in these subsets using the Annexin V marker. 
No significant change was observed in the % of CD8+ IL or in the % CD8+/Annexin V+ 
as a function of diet group (Figure 3.2A). In contras , the % CD4+ (F2,44=4.38, P=0.02) 
and the % CD4+/Annexin V+ (F2,44=4.45, P=0.02) were both significantly higher in the Lf 
groups relative to the control (Figure 3.2B). 
Figure 3.3 presents the concentrations of caspase 3, Bcl-2 and TNF-α, as 
determined from Western blot analysis, in response to Lf or control diets in mouse IL. 
Short term dietary Lf did not significantly alter the expression of caspase 3 or Bcl-2 in 
mouse IL. However, the expression of TNF-α (Figure 3.3C) was significantly affected by 
diet condition (F2,23=5.26, P=0.01) with the two Lf groups having lower concentrations 
than the control fed group. Figure 3.4 shows representative Western blots for caspase 3, 





































Figure 3.3:  Concentration of apoptotic proteins in IL of mice given bovine Lf in the diet.  
(A) Caspase 3, (B) Bcl-2 and (C) TNF-α.  All values are means ± SEM. AU= arbitrary 
densitometric units; 0% = 0% Lf (n=16); 0.2% = low dose (0.2% Lf) (n=16); 2.0% = high 

















































































































































Figure 3.4:  Representative Western blots of apoptotic proteins in IL of mice given 
bovine Lf in the diet. Lane 1 is 0% Lf, Lane 2 is 0.2% Lf, Lane 3 is 2.0% Lf, and Lane 4 
is the molecular weight (biotin) standards. 
 
 
3.8. Discussion  
To our knowledge, this is the first study to describe the effects of short term 
exposure of Lf administered in the diet on intestinal lymphocytes from healthy animals. 
A novel finding was that four days of bovine Lf feeding in healthy mice was associated 
with increased apoptosis of CD4 (but not CD8) IL. Our research also confirms and 
extends previous observations that Lf modifies CD4 lymphocytes in different situations.  
A second important observation was that dietary Lf was associated with decreased 
expression of TNF-α in IL from healthy animals.  
We investigated whether Lf triggered IL apoptosis by influencing the expression 
of the pro-apoptosis (caspase 3) and anti-apoptosis (Bcl-2) intracellular proteins. There 





groups. Although others have shown that Lf increases th  expression of pro-apoptotic 
proteins, these effects have been documented only in pathological states (e.g., cancer) or 
when Lf is administered through non-physiological routes (e.g., gavage) (Fujita et al., 
2004a; 2004b; Mader et al., 2005; Chandra Mohan, 2006).  In this present study (during a 
normal physiological state), the small increases in IL apoptosis without a corresponding 
increase in caspase 3 expression may reflect a number of possible factors including 1) 
apoptosis occurring through caspase 3 independent pathways and 2) the timing of caspase 
3 expression in relation to other apoptotic markers. Although activation of caspase 3 is 
central to apoptosis, caspase-independent cell death also occurs, with pathways involving 
cathepsin and calpain proteases and mitochondrial derived apoptosis inducing factor 
(AIF) (Jaattela and Tschopp, 2003; Chwieralsk et al,. 2006). Whether Lf induces IL 
apoptosis through caspase-independent pathways has not been determined. Moreover, 
given the kinetics of the sequence in apoptosis, (i.e., phosphatidylserine externalization 
occurs early in the apoptotic pathway prior to caspase 3 activation (Huppertz et al., 
1999), we cannot rule out the expression of caspase 3 in IL if samples were obtained at 
other time points.  Similar factors may be involved in the apparent lack of effect on Bcl-2 
expression (e.g., activation of apoptosis through other pathways, involvement of other 
proteins upstream from Bcl-2, kinetics of protein expression). Indeed, an important 
limitation of this study is that protein expression in IL was determined at only one time 
point (i.e., after 4 days of Lf exposure) and future experiments will be necessary to 
determine whether longer (or shorter) exposures to Lf affect the expression of apoptotic 





 Concurrent with an increase in the percent of apoptotic CD4 IL there was also an 
increase in the percent of this T cell subpopulation. This finding suggests that Lf not only 
stimulates greater apoptosis of IL but also their rplacement. There is evidence that 
administration of Lf increases the mobilization of CD4 T lymphocytes from various 
tissue sites.  Wakabayashi et al. (2006), after a single dose of Lf (2.5 g/kg body weight) 
given by gavage, found increased blood CD4 cells and decreased splenic CD4 cells in 
Balb/c mice as well as a small increase in CCR9, a chemokine receptor involved in the 
recruitment of intestinal lymphocytes. CCR9 and other cell adhesion molecules (e.g., 
α4β7) are known for their specific role in intestinal homing of primed IL after exposure to 
oral antigen as well as for controlled intestinal migration of naïve CD8+αβ T cells 
(Mowat et al., 2003; Kunisawa and Kiyono, 2005; Sato nd Iwasaki, 2005).  Therefore, 
the increase in the % of CD4 IL observed in the present study may be due to increased 
mobilization to the intestine from other lymphoid tissues (e.g., spleen) to replace 
apoptotic cells. Further studies will be needed to determine whether CD4 lymphocytes 
home to the gut in response to Lf feeding in healthy mice.   
An important result of this study was that the exprssion of TNF-α was lower in 
IL of healthy mice fed Lf compared to the control.  TNF-α is produced by a variety of 
immune cells, including CD4+ cells (Mosmann and Sad, 1996), and affects a variety of 
physiological processes such as cell proliferation, differentiation and apoptosis 
(Dinarello, 2000). This cytokine also contributes to tissue injury and decreased levels are 
associated with the resolution of inflammation and less inflammatory damage in the 
intestine (Togawa et al., 2002a; 2002b; Baert et al., 1999). Other investigators have 





subcutaneous injection of Lf decreased LPS induced TNF-α production in a rat model of 
rheumatoid arthritis. Togawa et al. (2002a) observed an approximate 4 fold decrease in 
TNF-α expression in the colon of male rats after 3 days of Lf administration by gavage.  
Our findings agree with these earlier reports of Lf reducing TNF-α production and show 
this effect after only 4 days of oral feeding. The m chanism by which short term feeding 
of Lf reduces the expression of TNF-α in IL cannot be directly determined from our 
results. However, since CD4 cells produce TNF-α (Mossman and Sad, 1996) and given 
the increase in the percent of apoptotic CD4 IL in this study, it is tantalizing to suggest 
that simple loss of TNF-α producing CD4 cells may account for the observed reduction in 
TNF-α expression. Although this remains speculative, in support of this hypothesis, 
others have shown similar effects. For example, the co-polymer glatiramer acetate 
decreases the population of TNF-α producing CD4 T cells in patients with multiple 
sclerosis (Kantengwa et al., 2007).  In addition, Li et al. (2007b) reported glucocorticoid 
treatment of IFN-γ stimulated murine microglial cells resulted in reduced TNF-α 
secretion and partially suppressed anti-CD3 induced proliferation of CD4 T cells. Taken 
together, the mechanism of decreased TNF-α, as a result of short-term oral Lf feeding, 
may be a consequence of increased apoptosis of TNF-α producing CD4 IL.  
Previous research has shown increases in intestinal CD8 lymphocytes as a result 
of Lf administration (Kuhara et al., 2000; Wang et al., 2000). In contrast, we did not find 
a significant impact of short term Lf administration n the percent or apoptosis of CD8 IL 
in healthy mice. Possible explanations for this discrepancy include dose and mode of Lf 
administration. These earlier studies provided Lf by gavage and at much higher 





resistance to Lf-associated apoptosis of CD8 IL mayrepresent another mechanism of host 
protection as these cells have prominent roles in tumour surveillance and defense against 
bacterial pathogens. We have shown elsewhere a dichotomous response of mouse IL T 
cell subpopulations to physiological stress (Davidson and Hoffman-Goetz, 2006; 
Hoffman-Goetz and Spagnuolo, 2007a): CD4 IL were more sensitive to repeated exercise 
stress induced apoptosis than CD8 IL, possibly due to differential of expression of 
antioxidant and heat shock proteins. In addition, Murosaki et al. (1997) reported that in 
mice following water immersion stress, intraepithelial intestinal CD8 cells were more 
resistant to apoptosis compared to CD4 cells. This highlights the possibility of a 
differential response of IL to external stimuli and may explain why short term oral 
feeding of Lf influences apoptosis of only one subset. 
  In this study two different concentrations of Lf had significant effects on IL 
apoptosis and cytokine production but there was no observable linear dose dependency 
(i.e., no stepwise increase in % CD4 or % CD4+/Ann+ IL or decrease in TNF-α 
expression with increasing Lf concentrations). It is not clear from our data why there was 
no dose response for Lf on the IL immune parameters. However, Lf receptors are found 
on numerous immune cells including neutrophils (Deriy t al., 2000) and lymphocytes 
(Mazurier et al,. 1989). Therefore, the absence of a dose response may be due to the 
number and availability of Lf receptors on IL; once these receptors are saturated, any 







In summary, Lf given by diet for four days was associated with a small but 
significant increase in the percent and apoptosis of CD4, but not CD8, IL and decreased 
the expression of TNF-α in IL of healthy mice. Additional studies will be needed to 
determine whether the reduction in TNF-α expression in IL occurs specifically in CD4 
lymphocytes and what the physiological consequences ar  of these small changes in IL 
apoptosis.   
 
3.10. Additional Findings 
 
The concentration of IL-10 in intestinal lymphocytes was also quantified by 
Western blotting, similar to the methods outlined in section 3.6, using an antibody 
specific for IL-10 (clone: M-18; goat anti-mouse IgG, MW=15kDa, Santa Cruz, 
California). There was no significant effect (F2,20 = 0.571, p=0.574) of bLf on IL-10 
levels in the IL of healthy mice (0% Lf: 1.2 ± 0.1 AU, 0.2% Lf: 1.1 ± 0.08 AU, 2.0% Lf: 
1.1 ± 0.1).  
These results suggest that bLf does not affect levels of IL-10 in the IL of healthy 
mice. Although there are no published studies on the effects of bLf given in the diet on 
IL-10 concentrations, others (Togawa et al., 2002a; 002b; Hayashida et al., 2004; 
Takakura et al., 2006) have demonstrated that IL-10 is increased in plasma or colonic 
tissue following bLf treatment.  Reasons for the differences between the IL-10 results 
presented here and those of the Togawa et al. (2002a; 2002b), Hayashida et al., (2004) 
and Takakura et al. (2006) are not known, however; considerable variation in how bLf 





For example, Togawa et al. (2002a; 2002b) and Takakura et al. (2006) provided bLf via 
gastric intubation, and Hayashida et al. (2004) orally dministered bLf. Evidence to 
support this notion are the observations by Sfeir et al. (2004) who reported that the 
cytokine response varied based on the route of bLf administration. Sfeir and colleagues 
demonstrated that dietary administration increased IL-4 (anti-inflammatory) levels 
whereas gastric intubation resulted in IFN-γ (pro-inflammatory) production. Although no 
change in IL-10 levels were observed in this study the decrease in TNF-α levels in mouse 
IL following dietary bLf feeding supports the hypothesis that bLf favours a TH1/TH2 





CHAPTER 4: Lactoferrin Effect on Lymphocyte Cytokin es and 




To determine the effects of dietary bovine lactoferrin (bLf) on intestinal lymphocyte (IL) 
levels of TNF-α and IL-10 and on CD4+ and CD8+ IL apoptosis in female C57BL/6 mice 





Hypothesis 1: bLf administration will influence (increase or decrase) the number and/or 
percent of apoptotic intestinal CD4+ and CD8+ lymphocytes in mice subjected to repeated 
bouts of acute exercise relative to the percent of apoptotic intestinal CD4+ and CD8+ 
lymphocytes in mice not receiving bLf supplementation. 
 
Hypothesis 2: bLf administration will decrease TNF-α and increase IL-10 levels in IL of 
mice subjected to repeated bouts of acute exercise relative to the levels of TNF-α and IL-
10 in mice not receiving bLf supplementation. 
 
 
4.3. Study Design 
 
This study was designed to determine if dietary bLf influenced the inflammatory 
cytokines, TNF-α and IL-10, and the percentage of apoptotic CD4+ and CD8+ intestinal 
lymphocytes during physiological stress induced by repeated bouts of acute exercise.  
The findings of the first experiment (Chapter 3) determined that 2.0% bLf in the diet was 
associated with reduced TNF-α levels and increased apoptosis of CD4+ IL. Given the 
observations that athletes experience gastrointestial disturbances following strenuous 
exercise (Peters et al., 2001b), possibly due to increased intestinal inflammation, it was 
aim of this study to determine if dietary bLf increased anti-inflammatory responses 
following exercise challenge in mice. An exercise protocol of three repeated bouts of 





and intestinal lymphocyte apoptosis in mice (Hoffman-Goetz and Spagnuolo, 2007a; 
Quadrilatero and Hoffman-Goetz, 2005; Hoffman-Goetz and Quadrilatero, 2003). Mice 
were sacrificed immediately following cessation of the final exercise bout (IMM) or 24 h 
after cessation of the final bout (24 h POST) and these were compared to control animals 
not subjected to exercise (SED). The experimental groups are outlined in Table 4.1 and 
the study design for experiment 2 is outlined in Figure 4.1. 
 
Table 4.1: Summary of study 2 treatment groups with panel A showing the 3x2 factorial 























Diet SED IMM 24 h POST 
No 1 3 5 Lactoferrin 
Yes 2 4 6 
Group Treatment 
1 No bLf/ SED 
2 bLf/SED 
3 No bLf/ IMM 
4 bLf/IMM 
5 No bLf/ 24 h POST 





Study duration: Two week acclimation plus 12 d of dietary bLf administration.  
 
 





Western blotting for apoptotic proteins 
(caspase 3, Bcl-2) and cytokines (IL-10, 
TNF-α), and the transcription factor NFκB
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Figure 4.1: Schematic outline of the study design for experiment 2. 
 
A two way ANOVA (3x2 factorial design) and post-hoc Tukey tests were used to 
analyze the study data.  In this study the independent variables are diet condition (0% bLf 
or 2.0% bLf) and exercise treatment (SED, IMM or 24h POST) (Table 4.1A).  
Dependent variables included: % CD4+ and % CD8+ IL (including apoptotic 
determination), apoptotic markers in intestinal lymphocytes (caspase 3 and Bcl-2), 
cytokine levels (TNF-α, IL-10), NFκB, plasma concentrations of 8-iso prostaglandin F2α, 





The contents of this chapter were reprinted with permission from Medicine and 
Science in Sports Exercise (40:1013-1021, 2008) and the copyright owner Lippincott 













Strenuous exercise increases apoptosis of intestinal lymphocytes (IL). Bovine lactoferrin 
(bLf), a protein found in milk products, affects lymphocyte apoptosis and the expression 
of TH1 and TH2 cytokines. The purpose of this experiment was to determine if bLf affects 
apoptosis and TH1 (TNF-α) and TH2 (IL-10) cytokine expression in IL of mice given 
strenuous exercise. Female C57BL/6 mice (n=89), given 3 bouts of treadmill exercise, 
were sacrificed immediately, or 24 h after the lastbout, or prior to initiation of exercise; 
within exercise conditions mice were fed a control (0% bLf) or bLf supplemented (2% 
bLf) diet for 12 days until sacrifice. IL were enumerated and apoptosis and cytokine 
expression were determined by Western blotting; markers of stress (corticosterone; iso-
prostanes) were measured in plasma by radioimmunoassay and direct immunoassay. 
Exercise increased IL loss (p<0.05) and the expression of caspase 3 (p<0.001), HSP 70 
(p<0.01) and IL-10 (p< 0.05) in mouse IL; bLf did not alter these responses. However, 
bLf reduced TNF-α expression in mouse IL (p<0.05), possibly through decreased NFκB 
expression (p<0.05) in the supplemented group. Dietary bLf does not affect IL apoptosis 
following exercise but may confer intestinal protection through changes in cytokine 








Intestinal lymphocytes (IL) comprised of lamina proria and intraepithelial 
lymphocytes, are important in the protection of the gut mucosal barrier against infection 
and tumour growth (Abreu-Martin and Targan, 1996). Apoptosis of IL affects 
gastrointestinal equilibrium not just during normal physiological states but also during 
times of antigen activation and inflammation (Bu et al., 2001). For example, breakdown 
of the mucosal barrier results in chronic exposure of IL to commensal bacteria, with 
resultant excessive activation of IL and, potentially, ongoing inflammation (Sartor, 1997).  
Apoptosis of these activated T cells can provide protection against mucosal damage 
(Lugering et al., 2006) whereas inappropriate IL apoptosis during quiescent states could 
leave the GI tract vulnerable to infection or tumour growth. 
Aerobic exercise increases IL loss and apoptosis following a single bout 
(Hoffman-Goetz and Quadrilatero, 2003) and after repeated bouts (Hoffman-Goetz and 
Spagnuolo, 2007a) of exhaustive treadmill running i mice.  Oxidative stress (from 
increased whole body and cellular respiration) is one mechanism whereby lymphocyte 
apoptosis could occur since administration of the antioxidant N-acetyl-cysteine decreases 
the extent of mouse IL loss following exercise (Quadril tero and Hoffman-Goetz, 2005).  
Oxidant stress could also occur from ischemia-reperfusion injury due to changes in 
splanchnic blood flow with exercise; indeed, ischemia-reperfusion injury is associated 
with damage of the mucosal epithelium, bacterial trnslocation, and inflammation 
(Cerqueira et al., 2005). Glucocorticoids (GC) are another potential mechanism 
contributing to exercise-induced IL apoptosis and cell loss.  GC concentrations in blood 





exercise-induced apoptosis are the following observations: 1) in vitro exposure of mouse 
lymphocytes to corticosterone increased cell death (Hoffman-Goetz and Zajchowski, 
1999) and 2) repeated treadmill exercise, with associated elevated GC, was linked with 
greater expression of protein markers of apoptosis in mouse IL (Hoffman-Goetz and 
Spagnuolo, 2007a).  
Strenuous exercise alters the production and balance of pro- and anti-
inflammatory cytokines, leading to perpetuation or resolution, of intestinal inflammation. 
For example, TNF-α, a pro-inflammatory TH1 cytokine responsible for inducing tissue 
damage, is increased in circulation following exercise at or greater than 75% VO2max  in 
humans (Ostrowski et al., 1999). On the other hand, ti-inflammatory (TH2) cytokines, 
such as IL-10, also have a putative role in the resolution of inflammation.  IL-10 
knockout mice spontaneously develop intestinal colitis (Kuhn et al., 1993) and alleviation 
of this condition occurs upon IL-10 administration (Lindsay et al., 2004).  Therefore, the 
balance between pro- and anti-inflammatory cytokines is vital for intestinal homeostasis. 
The impact of exercise on the maintenance of the balance between TH1 and TH2 
cytokines in the gastrointestinal tract has not been well characterized.  In humans, 
increases in plasma IL-10 and TNF-α following intense exercise have been reported 
(Ostrowski et al., 1999); increased IL-10 expression n IL after repeated bouts of 
treadmill exercise in mice has recently been described (Hoffman-Goetz et al., 2008).  
Bovine lactoferrin (bLf) is an 80 kDa iron binding protein found in milk products 
(Lonnerdal and Iyer, 1995).  It interacts with many immune cells and receptors for Lf 
have been found on activated lymphocytes (Mazurier et al., 1989). Among the reported 





2002a; 2002b) and induction of apoptosis (Mader et al., 2007; Spagnuolo et al., 2007).  
Togawa et al. (2002a; 2002b) found that bLf reduced TNF-α and increased IL-10 levels 
during experimentally-induced intestinal inflammation in rats. Decreased NFκB activity 
leading to decreased TNF-α production was also evident following bLf administration 
(Haversen et al., 2002).  It is not known if bLf supplementation affects TH1 or TH2 
cytokine expression in lymphocytes in response to exercise. However, given altered 
cytokine expression during exercise, the interaction between exercise and bLf may be 
beneficial by reducing pro-inflammatory and increasing anti-inflammatory cytokines.  
How Lf influences apoptosis is unclear since Lf administration increases cell 
death (Spagnuolo et al., 2007) and cell viability (Shoji et al., 2007). Opposing actions of 
Lf during oxidative stress have also been reported with decreased oxidative damage in 
intestinal epithelial cells following H2O2 treatment (Shoji et al., 2007) and increased 
mitochondrial ROS production resulting in cell death (Lupetti et al., 2002). Thus, how 
bLf affects IL apoptosis following strenuous exercise (associated with oxidant stress) is 
not obvious. The purpose of this study was to determine the effects of dietary Lf 
administration in mice on 1) TNF-α and IL-10 expression in IL and 2) cell loss and 
apoptosis of IL in conjunction with repeated bouts of aerobic exercise. We hypothesized 
that dietary Lf given prior to strenuous exercise would result in a shift to a TH2 cytokine 
response in IL and further that bLf would affect exercise-induced IL apoptosis (either 





4.6. Materials and Methods 
 
Animals and Diets:  Female C57BL/6 mice (n=89) (Harlan Sprague Dawley, 
Indianapolis, IN, USA), 3-4 weeks of age, were indivi ually housed on a 12/12h reversed 
light/dark cycle at 21±1oC. Mice had ad libitum access to a maintenance diet (Laboratory 
Rodent Chow, PMI feeds Richmond, IN, USA) and tap water for 2 weeks. Following 
acclimation, mice were randomly assigned by weight to 2 dietary conditions: bovine 
lactoferrin (bLf; n=44) or control diet (no bLf; n=45).  Diets were formulated based on a 
semi-purified AIN 76A standard diet to contain eithr: 0% or 2.0% bovine Lf (Erie Foods 
International Inc, Erie IL), while maintaining similar overall protein concentrations (20% 
total protein in both groups). Concentrations of dietary bLf were based on our previous 
work indicating that 2.0% dietary lactoferrin resulted in apoptotic and cytokine responses 
in mouse IL (Spagnuolo et al., 2007). bLf was 16% iron saturated and greater than 90% 
pure. Mice were given ad libitum access to the diets for 12 consecutive days prior to 
sacrifice.  All protocols with live animals were approved by the University Animal 
Research Committee and conformed to the ethical princi les of the Canadian Council on 
Animal Care and the American College of Sports Medicine.   
 
Exercise Protocol: Within diet conditions, mice were randomized to one of three 
exercise groups: three bouts of intensive treadmill running (each bout separated by a 24 h 
rest interval) with sacrifice immediately upon completion of the final exercise session 
(IMM, n=26), or with sacrifice 24h after completion of the final exercise session (24 h 
POST, n=31), or to a no exercise sedentary control condition (SED, n=32). Thus, there 





bLf/IMM (n=12); no bLf/24 h POST (n=15); and bLf/24 h POST (n=16).  The treadmill 
protocol, described in detail elsewhere (Hoffman-Goetz and Spagnuolo, 2007a), 
consisted of a 10 min warm-up, 90 min continuous exercise (30 min at 22 m. in-1, 
2°slope; 30 min at 25 m. in-1, 2°slope; 30 min at 28 m. in-1, 2°slope) and 5 min 
deceleration. Mice were motivated to run (Omni-Max metabolic treadmill, Omni Tech 
Electronics, Columbus, OH) during the dark cycle by occasional gentle prodding using a 
soft nylon brush. 
 
Intestinal Lymphocyte Preparation:  IL were isolated as described by Hoffman-Goetz 
and Quadrilatero (2003). Briefly, the intestinal compartments were immediately removed 
and Peyer’s patches and visible fat dissected out.  IL were prepared as single suspensions 
by isolation over a column containing 0.3 g of pre-washed nylon wool, washed and 
layered over a density gradient medium (Lympholyte-M; Cedarlane Laboratories, 
Hornby, Ont.) to exclude epithelial cells and remove cellular debris. A sample of IL, 
consisting of both intraepithelial and lamina propria lymphocytes, was stained with 
Turk’s solution and enumerated manually by microscopy.   
 
Flow Cytometry:   Flow cytometry was used to determine IL phenotype distribution and 
extent of apoptosis. In order to discern IL populations an initial acquisition gate was 
created based on the forward and side scatter properties of a population shown to collect 
>90% CD45+ cells (leukocytes) using a CD45 (common leukocyte antigen, clone: 30F11) 
FITC-conjugated monoclonal antibody (mAb; Miltenyi Biotec, Auburn, CA).  Apoptosis 





expression of phosphatidylserine, which is an early marker of apoptosis, whereas PI is a 
non-specific DNA dye that indicates late apoptotic r necrotic cells. 1.0 x 105 cells were 
incubated with 2.5 µL of both Annexin V (Pharmingen) and PI (Sigma Chemical) in 100 
µl of Annexin binding buffer (Pharmingen) for 15 min at room temperature in the dark, 
followed by addition of binding buffer (400µl) and analysis by flow cytometry. 
Individual IL phenotypes were determined by suspending 5 x105 cells in 100µl of PBS 
and with the addition of 2.5µl of PE-conjugated mAbs (PharMingen, San Diego, CA, 
USA) for CD4 (anti-CD4, clone: GK1.5) and CD8α (anti-CD8α, clone: 53-6.7) in the 
dark at 4ºC for 45 min. Cells were washed and centrifuged (5 min, 450 x g),  the pellet 
resuspended and analyzed for phenotype on a two color fl w cytometer (Epics XL Flow 
Cytometer, Beckman-Coulter, Hialeah, FL) with an excitation wavelength of 488nm and 
emission filters of 525nm (green fluorescence) and 575nm (red fluorescence). 
 
Corticosterone and 8-iso Prostaglandin F2α:  Mice were sacrificed by sodium 
pentobarbital (0.06-0.08 ml) overdose. Blood was immediately collected by cardiac 
puncture into a 1 ml syringe containing 0.08ml of heparin. Following centrifugation (6 
min, 1500g) plasma was collected and frozen at -20°C for corticosterone and 8-iso 
prostaglandin F2α   (8-iso-PGF2α) analysis.  
Plasma corticosterone was quantified using a commercially available double 
antibody 125I radioimmunoassay kit (ICN Biomedicals, Inc., Costa Mesa, CA) according 
to the manufacturer’s protocol. Plasma samples were diluted 1:200 with steroid dilutant 
and radioactivity was measured with a Gamma 5500 counter (Beckman Coulter, Hialeah, 





kit (Assay Designs, Ann Arbor, Michigan, USA).   Samples were hydrolyzed (25 µl 10N 
NaOH: 100 µl sample) at 45°C for 2 h and neutralized to pH 6-8 with 12N HCl.  Samples 
were centrifuged (5 min, 14000g), and incubated with 8-iso-PGF2α antibody for 24 h at 
4°C. Absorbance was determined at room temperature at 405 nm.  
 
Western Blot Analysis of Caspase 3, Bcl-2, NFκB, HSP 70, IL-10 and TNF-α:  
Cytoplasmic protein samples were separated by electrophoresis on a 12% SDS PAGE gel 
and transferred onto a PVDF membrane (Sigma Chemical) (Quadrilatero and Hoffman-
Goetz, 2005). For quantification of NFκB, nuclear fractions were isolated; following 
cytoplasmic fractionation the pellet was resuspended in phosphate buffered saline, 
incubated 1 h with high salt lysis buffer, samples c ntrifuged (15 min, 15000g), and the 
supernatant recovered as the nuclear fraction.  Membranes containing the separated 
proteins (cytoplasmic or nuclear) were incubated for 1 h with primary antibody (1:200 in 
10% milk-TBST): Bcl-2 (clone: C-2; mouse anti-human monoclonal IgG1, MW=28kDa), 
caspase 3 (clone: H-227; rabbit anti-human clone IgG, MW=35kDa),  TNF-α (clone: N-
19; goat anti-human polyclonal IgG, MW=17kDa), NFκB (clone: C-20; rabbit anti-
human polyclonal IgG, MW=65kDa), IL-10 (clone: M-18; goat anti-mouse IgG, 
MW=15kDa) or HSP 70 (clone: C92F3A-5; mouse anti-mouse monoclonal IgG1, 
MW=70kDa) (Santa Cruz Biotechnology, Santa Cruz, CAUSA). This was followed by 
incubation for 1 h with secondary antibody: horseradish peroxidase-conjugated anti-
mouse (Bcl-2, HSP 70), anti-rabbit (caspase 3, NFκB) or anti-goat (TNF-α, IL-10) IgG at 
a concentration of 1:2000 in 10% milk-TBST. Protein was determined using ECL or ECL 





and the ChemiGenius 2 Bio-imaging System (Cambridge, UK).  Samples from each 
treatment group were run together along with a biotinylated protein ladder to identify the 
molecular weight of the immunoblotted protein (Cell Signaling Technology, Beverly, 
MA, USA). For IL-10 and TNF-α blots, recombinant IL-10 and TNF-α standards (mouse 
IL-10, CL9310R, mouse TNF-α, CL9300TR; Cedarlane Laboratories) were run on each 
gel. 
 
Statistical Analysis:  All data were analyzed as a 2x3 analysis of variance design with 
diet (two levels: no bLf, bLf) and exercise (three l vels: SED, IMM, 24 h POST) as the 
independent factors using SPSS (Version 15; Chicago, IL, USA). Post hoc analysis was 
performed with Tukey HSD test to determine differenc s between exercise groups and 
for interactions between diet and exercise groups.  P<0.05 was accepted as being 





Effect of Exercise and bLf on Food Intake and Body Weights of Mice:  There were 
no significant main or interaction effects of diet or exercise treatments on total food 
intake over the course of the 12 d experiment (results are presented for the diet x exercise 
groups): no bLf/SED 33.1 ± 1.0g; bLf/SED 34.0 ± 0.7 g; no bLf/IMM 31.7 ± 0.8 g; 
bLf/IMM 33.5 ± 1.0 g; no bLf/24h POST 32.5 ± 0.8 g;bLf/24h POST 33.6 ± 0.1 g. 
Similarly, there were no significant main or interaction effects of diet or exercise 





± 0.3 g; no bLf/IMM 19.8 ± 0.3 g; bLf/IMM 19.8 ± 0.5 g; no bLf/24 h POST 20.0 ± 0.5 g 
and bLf/24 h POST 20.8 ± 0.6 g.  
 
Effect of Exercise and Lactoferrin on Plasma Isoprostanes and Corticosterone in 
Mice:  Figure 4.2 shows the plasma concentrations of 8-iso-PGF2α (Panel A) in mice.  
There was a significant main effect of exercise on plasma concentrations of 8-iso-PGF2α 
(F2,63 = 6.94, p<0.01). This was due to increased concentrations of plasma 8-iso-PGF2α in 
the immediate (IMM) (p<0.05) and 24 h POST group (p<0.01) compared to the SED 
mice.  There was no effect of dietary bLf on plasma 8-iso-PGF2α concentrations.  Not 
unexpectedly, exercise significantly increased plasma corticosterone levels in mice (F2,73 
= 12.49, p<0.0001) (Panel B). This was due to the higher levels in the IMM group 
relative to the SED animals (p<0.0001).   There wasa smaller main effect of diet on 
plasma corticosterone in mice (F1,73 = 6.07, p<0.05); plasma corticosterone was 
decreased in the bLf (398.6 ± 17.2 ng/ml) compared to the no bLf (473.3 ± 23.6 ng/ml) 
fed group.  There was no significant diet x exercise interaction effect for 8-iso-PGF2α or 










Figure 4.2: Plasma concentrations in mice of common markers of exercise induced 
stress. Panel A: 8-iso prostaglandin F2α (pg/ml); *p<0.05, #p<0.01 vs. SED; Panel B: 
Corticosterone (ng/ml); **p<0.0001 vs. SED and 24 h POST. All values are means ± 1 
SEM.  SED = no treadmill exercise; IMM = three bouts of treadmill exercise each 
separated by 24 h rest and sacrifice immediately after the third bout; 24 h POST= three 









Effect of Exercise and Lactoferrin on IL Counts, Apoptosis and Phenotypes in Mice:  
A shown in Figure 4.3, there was a significant main effect of exercise on total IL numbers 
in mice (F2,83 = 3.09, p=0.05). This effect was due to a decrease in IL counts at 24 h 
POST exercise relative to the SED group (p<0.05). There was a non-significant trend 
(p=0.06) for higher IL counts in mice fed bLf (5.3 ± 0.3 x 107 cells) compared with the no 
bLf group (4.5 ± 0.3 x 107 cells).  No interaction effect was observed for IL counts 
between diet and exercise. IL loss following exercise has been attributed to increased 
apoptosis as measured by Annexin V expression (Quadrilatero and Hoffman-Goetz, 
2005). We found a small effect of exercise on the % Annexin V+/PI+ in IL, a difference 
which approached significance (P=0.07; SED: 18.7 ± 1.6%, IMM: 22.5 ± 2.6%, 24 h 
POST 16.9 ± 1.0 %). Neither diet nor diet x exercise significantly affected the % Annexin 















Figure 4.3:  Intestinal lymphocyte (IL) counts in mice given repeated treadmill exercise. 
*p<0.05 vs. SED. Values are means ± SEM. SED = no exercise; IMM = 3 repeated bouts 
of exhaustive exercise and immediate sacrifice; 24 h POST = 3 repeated bouts of 









Figure 4.4: Intestinal lymphocyte (IL) phenotype distribution in mice following repeated 
bouts of strenuous exercise. Panel A: Percent CD4; Panel B: Percent CD8α; *p<0.05 vs. 
24 h POST. Values are means ± SEM. SED = no exercise; IMM = 3 repeated bouts of 
exhaustive exercise and immediate sacrifice; 24 h POST = 3 repeated bouts of exhaustive 
exercise and sacrifice 24 h after the third bout. 
 
 
Figure 4.4 gives the phenotypic distribution for the IL T cell subsets CD4 and 
CD8α. There were no significant main effects of exercise or diet, nor was there an 
interaction effect between these factors, in the percent of CD4 IL.  In contrast, there was 
a significant main effect of exercise (F2,83 = 3.91, p<0.05) on the percentage of CD8α IL 







p<0.05).  There was no significant interaction or main effect of diet on the percentage of 
CD8α mouse IL. 
 
Effect of Exercise and Lactoferrin on Bcl-2, Caspase 3, NFκB and HSP 70 in Mouse 
IL:   Exercise significantly affected the expression of the anti-apoptotic protein Bcl-2 in 
mouse IL (F1,82 = 3.85, p<0.01) with decreased concentrations in the IMM compared to 
the SED group (IMM: 1.54 ± 0.09 vs. SED: 2.02 ± 0.17; p<0.01). There was a main 
effect of bLf on Bcl-2 concentrations in mouse IL (F1,82 = 7.35, p<0.01) with the 
supplemented group having lower levels (bLf: 1.58 ± 0.16 AU) compared with the 
control group (no bLf: 1.95 ± 0.07 AU). There was a ignificant interaction (F2,82 = 4.52, 
p<0.01) between diet and exercise on the expression of Bcl-2 in mouse IL (Figure 4.5A). 
SED mice given the control diet (no bLf) had higher Bcl-2 expression relative to the 
other treatment groups (p<0.05) which did not differ rom each other.  Figure 4.5B shows 
the exercise effect on the expression of the pro-apoptotic protein caspase 3 in mouse IL 
(F2,71 = 8.09, p<0.001). Repeated exercise stress increased caspase 3 expression IMM 
after compared to the SED and 24 h POST group (p<0.05).  There was no diet x exercise 
or diet effect on the expression of caspase 3.  
There was no effect of exercise on the expression of NFκB. In contrast, bLf 
affected NFκB concentration in mouse IL (F1,43 = 5.74, p<0.05) with the bLf group 
having lower levels of NFκB (Figure 4.5C).  A significant interaction occurred in the 
expression of NFκB in mouse IL (F2, 43 = 4.57, p<0.05). The expression of NFκB in IL 
was decreased in the immediate exercise group fed bLf (0.80 ± 0.14) relative to the 
immediate exercise group fed the control diet (1.50 ± 0.16, p<0.05). Figure 4.5D shows 





expression in mouse IL was higher in the IMM exercise vs. the SED condition (p<0.05) 
which then returned to levels not different from SED (i.e., SED vs. 24 h POST). There 
was no diet or interaction effect on the expression of HSP 70. 
 
Effect of Exercise and Lactoferrin on IL-10 and TNF-α Expression in Mouse IL:  
Figure 4.6A describes the concentration of the TH2 cytokine, IL-10, in mouse IL as a 
function of exercise (F1,27 = 3.96, p<0.05), an effect due to the differences b tween the 
IMM and 24 h POST exercise groups (p<0.05). There was no exercise x diet or diet 
effects on IL-10 expression in mouse IL.  The TH1 cytokine, TNF-α, was significantly 
affected by dietary bLf (F1,61 = 3.85, p<0.05, Figure 4.6B), with the bLf fed group having 
lower TNF-α expression  compared to the control (no bLf) group. TNF-α expression in 











Figure 4.5: Concentrations of apoptotic and stress proteins in mouse IL. Panel A: Anti-
apoptotic Bcl-2 in arbitrary densitometric units [AU]); *p<0.05 vs. all other treatment 
groups. Panel B: Pro-apoptotic protein caspase 3 [AU]; *p<0.05 vs. SED and 24 h POST; 
Panel C: NFκB [AU]; *p<0.05 vs. no bLf; Panel D: HSP 70 [AU], *p<0.05 vs. SED and 






Figure 4.6: Effect of exercise and diet conditions on concentrations of the cytokines, IL-
10 and TNF-α, in mouse IL. Panel A: Concentration of IL-10 [AU] as a function of 
exercise (*p<0.05 IMM vs. 24 h POST). Panel B: Concentration of TNF-α [AU] as a 









One main objective of this study was to determine if dietary Lf affected cell loss 
and apoptosis of IL in response to acute exercise in mice. A second related objective was 
to determine whether bLf given during exercise altered the expression of the cytokines 
IL-10 and TNF-α in IL, since these cytokines have regulatory roles in intestinal 
inflammation. We observed that dietary bLf did not ameliorate (nor did it exacerbate) the 
loss of T lymphocytes from mouse intestine under conditions of repeated exercise stress; 
moreover, bLf did not affect the increase in the pro-apoptotic protein caspase 3 or the 
expression of the heat shock protein HSP 70 in response to exercise. However, bLf 
feeding resulted in lower levels of the pro-inflammatory cytokine, TNF-α, in mouse IL.    
Exhaustive exercise stress was associated with IL loss 24 hours after cessation of 
exercise, an observation which has been reported for single (Hoffman-Goetz and 
Quadrilatero, 2003) and repeated exercise (Hoffman-Goetz and Spagnuolo, 2007a) 
challenge.   Cell loss has been related to oxidative stress induced apoptosis since 
provision of antioxidants reduced the exercise-related apoptosis of IL (Quadrilatero and 
Hoffman-Goetz, 2005). Others have shown decreased mitochondrial membrane potential 
(MMP) and increased apoptosis of human monocytes, nutrophils and lymphocytes 
following repeated bouts of exhaustive (85% VO2max) exercise (Tuan et al., 2007).  
bLf administration for 12 days in the diet did not al er mouse IL apoptosis and 
cell loss associated with aerobic exercise. The absnce of a bLf effect under conditions of 
oxidant stress may reflect the magnitude of ROS production by exercise since ROS 
generated by bLf would likely be negligible compared to the generation of free radicals 





(measured by 8-isoprostanes) for up to 24 h after cessation of exercise. Elevated blood 
iso-prostanes have been reported for up to 6 days post race in ultramarathoners 
(Mastaloudis et al., 2004).  The limited research on ROS generation by bLf suggests a 
mitochondrial pathway: addition of bovine lactoferricin (bLfcin- a pepsin derivative of 
bLf) resulted in MMP disruption with consequent casp e activation (Mader et al., 2007) 
and the bactericidal ability of human Lf to Candida albicans was due to increased 
mitochondrial ROS production (Lupetti et al., 2002). Both caspase activation and 
mitochondrial ROS production with bLfcin and Lf were reversed by antioxidant 
administration. Moreover, there are multiple pathways whereby exercise could induce IL 
loss and apoptosis apart from mitochondrial derived ROS arising from increased cellular 
respiration. These would include increased secretion of glucocorticoid (GC) hormones 
and ischemia/reperfusion injury. Even within mitochndria, ROS can be generated by 
several enzyme systems: mitochondrial electron transport chain, xanthine oxidase, 
NADPH oxidase, lipoxygenase, cyclooxygenase, and peroxisomes (Fruehauf and 
Meyskens, 2007). Given multiple mechanisms of ROS generation during exercise, the 
contribution of bLf induced ROS would be minimal and likely not add to observed 
increases in IL apoptosis with exercise.  
Lactoferrin has also been associated with protection against ROS generation.  The 
iron binding property of bLf is credited to its capacity to decrease metal (iron) catalyzed 
hydroxyl radical formation. Indeed this property of Lf has been linked to decreased 
hydroxyl radical formation and decreased intracellular oxidative damage in neutrophils, 
macrophages and intestinal epithelial cells (Shoji et al., 2007). Although bLf can reduce 





production through other mitochondrial pathways (such as MMP or cytochrome c 
oxidase) which would be more typical of aerobic exercise. Therefore, the multiple 
pathways of apoptosis and ROS production initiated by exercise would be larger than any 
bLf attributed reduction in metal catalyzed hydroxyl radical generation and thus not 
prevent IL loss.  
Repeated bouts of exhaustive exercise resulted in greater loss of IL likely due to 
apoptosis of CD4, but not CD8α, T cells; apoptosis as the mechanism leading to IL l ss is 
suggested by marginally higher % Annexin V+/PI+ and significantly higher caspase 3 
expression. Nevertheless, because the % Annexin V+/PI+ IL were not non-significantly 
different across exercise groups (p=0.07), it is not possible to unequivocally conclude that 
IL loss was due to apoptosis. Other factors (for example, hemodynamic effects) may have 
contributed to IL loss with exercise.  Dietary Lf did not alter the overall apoptotic index 
or the distribution in individual phenotypes of mouse IL following the repeated exercise 
challenge. There are, however, conflicting data about how bLf affects intestinal 
lymphocyte subsets. Wang et al. (2000) found increased CD4 and CD8 expression in 
mouse intestine following three consecutive days of bLf administration by gavage. CD4, 
but not CD8α, mouse IL were increased in response to four days of dietary bLf feeding 
(Spagnuolo et al., 2007). No change in any IL phenotype was observed following 3 doses 
of bLf by gavage (Takakura et al., 2006). Discrepancies among studies may reflect 
differences in duration, dose and mode of bLf administration; moreover, none combined 
lactoferrin with exercise. In the present study bLf was given by diet whereas others 





Additionally, these studies used shorter durations a d smaller cumulative doses of bLf 
than reported here.  
Dietary Lf did not affect the expression of the pro-apoptotic protein, caspase 3, or 
the anti-apoptotic protein, Bcl-2, in mouse IL in response to exercise. IL loss following 
exercise has been attributed to apoptotic mechanisms including increased caspase 3 and 
reduced Bcl-2 expression (Hoffman-Goetz and Quadriltero, 2003; Hoffman-Goetz and 
Spagnuolo, 2007a). Although there was no significant effect of bLf on expression of 
caspase 3 in mouse IL, overall Bcl-2 levels were lower in the bLf fed mice suggestive of 
a possible role of bLf in altering MMP. However, an important limitation is that no other 
mitochondrial pro- or anti-apoptotic proteins (e.g., Bax, Bid) were quantified and there 
are many proteins which regulate MMP. Nonetheless, bLf was insufficient to alter Bcl-
2/Bax ratios in human tongue squamous carcinoma cells (Chandra Mohan et al., 2006) 
and the observed Bcl-2 decrease with bLf supplementatio  may be minimal in the overall 
regulation of the MMP.  
Immediately following exercise, there was an increased expression of HSP 70 in 
mouse IL. Elevated HSP 70 after exercise has been dmonstrated in rat blood leukocytes 
(Antunes-Neto et al., 2006) and the current findings extend these observations to a 
repeated exercise model in mice IL (Hoffman-Goetz and Spagnuolo, 2007a). Given that 
the increase in HSP 70 expression under conditions of heat and other physiological 
stressors serves to protect cells from damage (van Eden et al., 2005), the finding of 
increased levels with repeated exercise challenge was expected.  Concentrations of 
plasma 8-iso-PGF2α were increased after exercise. 8-iso-PGF2α is produced from 





(Patrono et al., 1997) and elevated plasma levels ar  a common indicator of exercise 
induced oxidative stress in humans (Steensberg et al., 2002) and mice (Hoffman-Goetz 
and Quadrilatero, 2003). Lf did not affect either stre s marker which we attribute to the 
magnitude of the exercise induced oxidant stress reponse and the various methods of 
exercise induced ROS production. Given the inability of Lf, at the concentrations 
provided in the diet, to significantly influence exercise induced IL apoptosis, it was not 
surprising that Lf did not influence the expression of stress proteins or protect against 
oxidant stress generation.  
Dietary bLf was associated with reduced expression of TNF-α in mouse IL. 
Although the mechanism of decreased concentrations of TNF-α in mouse IL as a result of 
dietary Lf administration is unknown, it may be linked to the observed decrease in levels 
of NFκB a transcription factor responsible for the expression of pro-inflammatory 
cytokines (e.g., TNF-α) (Bours et al., 2000). Exercise did not affect the levels of NFκB in 
mouse IL but concentrations were lower in the Lf group.  A potential benefit of decreased 
NFκB in mouse IL is the subsequent decreased production of pro-inflammatory 
cytokines. Togawa et al. (2002b) showed that in rat colon following 
trinitrobenzenesulfonic acid (TNBS) induced colitis bLf decreased concentrations of 
TNF-α and phosphorylation of Iκ, indicative of decreased levels of activated NFκB. Lf 
administration decreased the extent of LPS induced bin ing of NFκB to the TNF-α 
promoter (Haversen et al., 2002). These results suggest that bLf may protect against gut 
inflammation by reducing the production of TNF-α through modulation of NFκB. 
Nevertheless, there is also evidence that bLf has little effect on inflammatory cytokine 





patches (Griffiths et al., 2004). The reason for the differences between our findings and 
those of Griffiths and colleagues (Griffiths et al., 2004) may be due to duration of 
exposure to Lf (12 vs. 28 days of exposure), age of the mice (~8 weeks vs. 4 weeks at 
sacrifice), immunological mucosal ‘maturity’ (adult vs. weaning mice), or mouse strain 
(C57BL/6 vs. Balb/c) with different immunological profiles.  
Two cytokines involved in the pathogenesis of intestinal inflammation are TNF-α 
and IL-10. TNF-α is elevated in patients with inflammatory bowel diseases and symptom 
amelioration occurs with anti-TNF-α treatment whereas IL-10, a potent anti-
inflammatory cytokine, inhibits immune cells from producing TH1 cytokines (Papadakis 
and Targan, 2000).  Thus, the balance between these pro- and anti-inflammatory 
cytokines (TH1/TH2) is crucial in maintaining homeostasis within the intestine.  Our 
results show that bLf administration does not signif cantly increase the concentration of 
IL-10 but is associated with reduced concentrations f TNF-α, which could bias the 
balance towards an anti-inflammatory response. Others ave shown bLf to favour a TH2 
response during stress. Togawa et al. (2002a, 2002b) reported decreased TNF- α and 
increased IL-10 following DSS and TNBS induced inflammation in the colon of rats fed 
bLf by gavage. Similarly, bLf suppressed TNF-α and increased IL-10 concentrations of 
LPS stimulated peripheral blood lymphocytes (Hayashida et al., 2004).  In cultured IEL 
bLf for 3 days prior to stimulation with anti-CD3 antibodies increased production of IL-
10 and decreased production of IFN-γ, a TH1 cytokine (Takakura et al., 2006). Thus, bLf 
may shift the balance from TH1 to TH2 responses under periods of stress. Although we did 
not find that bLf increased IL expression of IL-10, the decrease in TNF-α levels partially 





bowel. Further studies will be needed to determine wh ther the expression of other anti-
inflammatory TH2 cytokines, such as IL-4 and IL-7 which are produced by intraepithelial 
intestinal lymphocytes, are influenced by dietary bLf and under conditions of exercise 
stress.  
Repeated treadmill exercise increased plasma corticosterone concentrations in 
mice, a response which was not unexpected since GC levels increase after exercise of 
long duration (Li et al., 2007a).  What was unexpected was that bLf was associated with 
lower levels of plasma corticosterone in mice. Whereas classical stress induced ACTH-
GC responses have been well described, GC synthesis is al o influenced by the pro-
inflammatory cytokines, IL-1β and TNF-α (John and Buckingham, 2003).  Lactoferrin 
reduces the secretion of TNF-α and IL-1β in a variety of cells including THP-1 cells 
(Haversen et al., 2002) and lymphocytes (Crouch et al., 1992). Thus, it is possible that the 
lower levels of TNF-α seen in the current study also contributed to the lower plasma 
corticosterone levels in bLf fed mice. Nevertheless, the actual physiological significance 
of this effect remains to be determined since bLf did not reduce GC levels in response to 
exercise. 
 
4.9. Conclusion  
 
Repeated bouts of treadmill exercise in mice resultd in increased oxidative stress, 
as measured by 8-iso prostaglandin F2α and concentrations of corticosterone, which 
contributed to IL loss probably via apoptosis. Although dietary bLf reduced plasma 
corticosterone levels and Bcl-2 expression in IL, there was no effect of this dietary 





stress effects of exercise on increased caspase 3 and HSP 70 were not moderated by 
dietary bLf. The inability of bLf to affect the loss of IL or reduce caspase 3 expression in 
IL may be due to the magnitude of the stress response induced by exercise.  Nevertheless, 
bLf may provide some limited protection against oxidant stress-induced inflammation in 
the bowel by decreasing IL expression of TNF-α, possibly through a mechanism 
involving decreased NFκB, to favour a TH2 response. Further studies will be needed to 
determine if higher concentrations of bLf in the dit and for longer time periods affect 








CHAPTER 5: Dietary Lactoferrin Does Not Prevent Dextran Sulfate 





To determine the effects of dietary bovine lactoferrin (bLf) on intestinal lymphocyte (IL) 
levels of TNF-α and IL-10 and on CD4+ and CD8+ IL apoptosis in female C57BL/6 mice 





Hypothesis 1: bLf administration will influence (increase or decrase) the number and/or 
percent of apoptotic intestinal CD4+ and CD8+ lymphocytes in mice subjected to DSS 
treatment relative to the percent of apoptotic intestinal CD4+ and CD8+ lymphocytes of 
mice not receiving bLf supplementation. 
 
Hypothesis 2: bLf administration will decrease levels of TNF-α and increase levels of 
IL-10 in the IL of mice subjected to DSS treatment relative to the IL levels of TNF-α and 
IL-10 in mice not receiving bLf supplementation. 
 
 
5.3. Study Design 
 
This study was designed to determine the possible physiological benefit of dietary 
bLf on levels of the cytokines, TNF-α and IL-10, and on the % of CD4+ and CD8+ 
intestinal lymphocyte apoptosis during DSS induced intestinal inflammation. Since DSS 
is the most commonly method used in the study of intestinal inflammation, it was 
important to use this model in the study of dietary bLf effects on inflammation. During 
DSS induced inflammation, Togawa et al. (2002a) provided bLf by gavage and 
demonstrated a decrease in the extent of colonic tissue damage as well as a reduction in 
the concentration of TNF-α and NFκB in the colonic tissue of rats.  The previous study 
(Chapter 4) determined that inclusion of bLf at 2.0% in the diet for 12 d was effective at 





reasonable argument that these effects on TNF-α and NFκB would also occur within the 
IL following dietary bLf and DSS administration to mice. The study design for 
experiment 3 is outlined in Figure 5.1.  
 
Study duration: Two week acclimation plus 12 d of dietary bLf administration.  
 






Western Blotting for apoptotic (Caspase 3, 
Bcl-2), inflammatory cytokines (IL-10, 
TNF-α,) and the transcription factor NFκB
1 cm section


















A two way ANOVA (2x2 factorial design) was used to analyze the study data.  In 
this study the independent variables are diet condition (0% bLf or 2.0% bLf) and DSS 
treatment (no DSS or DSS). Dependent variables include: % CD4+ and % CD8+ IL 
(including apoptotic determination), apoptotic markers in intestinal lymphocytes (caspase 
3, Bax and Bcl-2), cytokine proteins (TNF-α, IL-10) and the pro-inflammatory 
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Dextran sulfate sodium (DSS) induced intestinal inflammation is characterized by 
pronounced mucosal and epithelial cell damage. Bovine lactoferrin (bLf), a common 
dietary protein, influences inflammatory cytokines and intestinal lymphocyte (IL) 
apoptosis. The objectives of this study were to determine if 1) DSS induces IL necrotic or 
apoptotic death, 2) dietary bLf affects DSS induced IL eath and, 3) if bLf alters cytokine 
profiles during DSS induced inflammation. Female C57BL/6 mice were randomized to 
2% or 0% bLf diets for 12 d and within diets to 5% or 0% DSS in the drinking water for 
4 d after which intestinal histology, IL number, % IL apoptosis/necrosis, IL phenotypes, 
protein levels of pro- inflammatory cytokine (TNF-α) and transcription factor (NFκB), 
apoptotic (caspase 3, Bax) proteins, anti-inflammatory cytokine (IL-10) and anti-
apoptotic (Bcl-2) protein levels in IL were evaluated. DSS treatment resulted in shortened 
intestinal length, decreased body weight and widespread mucosal damage as well as 
increased IL death as determined by a decreased percentage of viable (PI-/ANN-, 
p<0.005) and increased percentage of necrotic/late apoptotic (PI+/ANN+, p<0.05) and 
necrotic (PI+/ANN-, p<0.05) IL.  DSS exposure increased caspase 3 (p<0.05) and 
decreased Bcl-2 (p<0.01) protein levels in mouse IL.  Dietary bLf did not influence these 
cell death outcome measures. However, bLf reduced protein levels of the pro-
inflammatory transcription factor, NFκB, in IL (p<0.05) and was associated with a 34%, 
albeit non-significant, reduction in TNF-α relative to non-bLf fed mice. DSS treatment 
increased apoptosis and necrosis of mouse IL and elevat d pro-apoptotic and reduced 





apoptosis of IL but may provide limited protection in the intestine by affecting the pro-





 Inflammatory bowel diseases (IBD) are characterized by pronounced destruction 
of the gastrointestinal mucosa and the epithelial cell barrier (Brandtzaeg et al., 1997).  
Although the etiology of IBD is unknown, alterations in TH1 and TH2 cytokine balance 
coupled with prolonged or excessive immune cell activ tion to dietary or bacterial 
antigens are believed to contribute to IBD pathogenesis (Podolsky, 2002).  Inflamed 
tissue of patients with active IBD contains large quantities of activated immune cells 
including neutrophils, macrophages and lymphocytes as well as increased concentrations 
of pro-inflammatory cytokines (Brandtzaeg et al., 1997; MacDermott, 1996) 
Oral administration of dextran sulfate sodium (DSS) is a common method of 
inducing intestinal colitis in animal models. The mechanism by which DSS induces 
inflammation likely involves multiple biological pathways including direct cytotoxic 
effects on epithelial cells (Cooper et al., 1993) and indirect damage due to changes in 
resident bacteria (Okayasu et al., 1990), upregulation of lymphocyte adhesion molecules 
on intestinal epithelial cells (Ni et al., 1996) and activation of gut macrophages and T 
cells (Okayasu et al., 1990; Takizawa et al., 1995a; 1995b).  DSS induced mucosal injury 
is characterized by nitrosative damage and, similar to human IBD, increased tissue 
concentrations of neutrophils, macrophages and activated T cells (Cooper et al., 1993; 





Concentrations of inflammatory cytokines (IL-1, IL-6, TNF-α) are increased in 
patients with active IBD.  For example, Isaacs et al. (1992) showed elevated mRNA 
expression of IL-1 and IL-6 in colonic mucosal biopsies of patients with IBD; increased 
intestinal mRNA of TNF-α was also found in children with active IBD (MacDonald et 
al., 1990).  The sources of most cytokines in inflamed tissue are activated macrophages 
and lymphocytes (MacDermott, 1996).  Similar to human IBD, DSS induced intestinal 
inflammation in mice results in higher concentrations of pro-inflammatory cytokines 
within the colonic mucosa (Takizawa et al., 1995a, 1995b; Egger et al., 2000).  
Moreover, the DNA-binding activity of NFκB is increased with DSS treatment (Herfarth 
et al., 2000).  NFκB is a transcription factor found inactive in the cytoplasm, which upon 
activation (e.g., stress signals, pathogens and cytokines such as TNF-α) is relieved of its 
cytoplasmic inhibitor (IκB) and translocates to the nucleus where it binds to DNA and 
activates various pro-inflammatory genes (Li et al., 2002). NFκB is elevated in mice 
given DSS; addition of oligonucleotides (‘NFκB decoys’) that suppress transcription of 
NFκB reduces the extent of DSS induced inflammatory damage (De Vry et al., 2007). 
Thus, decreases in NFκB could potentially lead to decreased pro-inflammatory (TH1) 
cytokine synthesis and less damage to the mucosal barrier. 
Cell death can be characterized by two processes distinguished by different 
cellular morphologies and immunological consequences. Apoptosis, involving cellular 
shrinking, chromatic condensation, nuclear fragmentation and budding of the plasma 
membrane, is a genetically coded form of cell suicide with resultant apoptotic bodies 
engulfed by phagocytes (Vermes et al., 2002). Cell death by apoptosis normally does not 





In contrast, necrotic cell death involves cellular swelling, membrane disruption and 
release of intracellular contents and involves recruitment of inflammatory cells 
(Hoffman-Goetz et al., 2005).   In DSS induced intestinal inflammation both apoptotic 
and necrotic damage have been shown to occur for epithelial cells (Renes et al., 2002); 
whether DSS induces either or both mechanisms of cell death in other cell populations 
resident in the gut, such as intestinal lymphocytes (IL), is not known.  
Lactoferrin (Lf) is an 80 kDa iron binding glycoprotein found in neutrophilic 
granules and various mucosal secretions including milk and colostrums as well as 
commercially available dairy and whey protein containing products. During periods of 
physiological stress dietary Lf may alter cytokine levels with apparent bias to a TH2 (anti-
inflammatory) cytokine profile.  For example, dietary dministration of bovine lactoferrin 
(bLf) reduced TNF-α and NFκB expression in mouse IL following oxidant stress ari ing 
from repeated bouts of acute exercise (Spagnuolo and Hoffman-Goetz, 2008a). Similarly, 
Togawa et al. (2002a) showed reduced TNF-α and NFκB during DSS induced colitis in 
the colon of rats fed bLf by gavage. Oral administration of human Lf (hLf) to mice 
reduced the number of TNF-α producing CD4+ T lymphocytes in the colon following 
DSS treatment (Haversen et al., 2002).  Whether dietary bLf alters cytokine profile 
following DSS treatment in mouse IL is not known. Moreover, bLf has also been shown 
to influence intestinal cell turnover with reports of increased apoptosis (Spagnuolo et al., 
2007) and increased cell viability (Shoji et al., 2007). However, the influence of dietary 
bLf on IL turnover (apoptosis, necrosis, viability) during periods of DSS induced 





The purpose of this study was to determine the effect of bLf supplementation in 
mice given DSS on IL apoptotic and necrotic death and cytokine profile. We 
hypothesized that DSS induces IL death by both apoptotic and necrotic pathways and that 
dietary bLf given prior to DSS treatment affects cell death either by enhancing or 
reducing IL apoptosis and necrosis. We also addressed whether bLf given during DSS 
induced inflammation in mice decreases TH1 (TNF-α) or increases TH2 (IL-10) cytokine 
protein levels in IL. 
 
5.6. Materials and Methods 
 
 
Animals and Diets: Sixty three, 3-4 week old, female C57BL/6 mice, obtained from 
Harlan Sprague Dawley (Indianapolis, IN, USA), were individually housed on a 12/12h 
reversed light/dark cycle at 21±1oC. Mice had ad libitum access to tap water and 
maintenance diet (Laboratory Rodent Chow, PMI feeds Richmond, IN, USA) for 2 weeks 
prior to the start of the study. Following acclimation, mice were randomly assigned by 
weight to two dietary conditions: bovine lactoferrin (bLf; n=31) or control diet (no bLf; 
n=32).  Diets were prepared to contain either 0% or 2.0% bLf (Erie Foods International 
Inc, Erie IL) while maintaining similar overall protein concentrations (20% total protein 
in both groups) and were formulated based on a semi-purif ed AIN 76A standard diet.  
Concentrations of bLf were based on previous studies showing that 2.0% bLf was 
sufficient to influence apoptosis as well as cytokine production (Spagnuolo et al., 2007; 
Spagnuolo and Hoffman-Goetz, 2008a).  bLf was 16% iron saturated and greater than 





with live animals were approved by the University Animal Ethics Committee according 
to the principles of the Canadian Council on Animal C re. 
 
DSS Protocol:  Within diet conditions, mice were randomized to one of two treatment 
conditions: 0% DSS (n=31) or 5.0% DSS (n=32) in drinking water. There were a total of 
4 groups:  no bLf/no DSS (n=16); no bLf/DSS (n=16); bLf/no DSS (n=15) and bLf/DSS 
(n=16). DSS (MP Biomedicals, Solon, OH; mol wt=36-50 kDa) was solubilized in tap 
water at room temperature; mice had ad libitum access to DSS containing drinking water 
for 4 days prior to sacrifice.   
 
Intestinal Lymphocyte Preparation: Mice were sacrificed by sodium pentobarbital 
(0.06-0.08 ml) overdose, the intestinal compartment, which includes both the small and 
large intestine, was removed and Peyer’s patches and visible fat dissected out. IL were 
isolated as previously described (Spagnuolo and Hoffman-Goetz, 2008a). Briefly, IL 
were prepared as single cell suspensions by isolation over a column containing 0.3 g of 
pre-washed nylon wool, washed and layered over a density gradient medium 
(Lympholyte-M; Cedarlane Laboratories, Hornby, Ont.) to exclude epithelial cells and 
remove cellular debris. A sample of IL, which contai s both intraepithelial and lamina 
propria lymphocytes, was stained with Turk’s solution and counted manually by 
microscopy.   
 
Flow Cytometry: Flow cytometry was used to determine IL apoptosis/necrosis and 





mice per treatment condition was included in the flow cytometry analysis. To distinguish 
between IL populations, an initial acquisition gate was created based on the forward and 
side scatter properties of a population shown to colle t >90% CD45+ cells using a CD45 
(common leukocyte antigen, clone: 30F11) FITC-conjugated monoclonal antibody (mAb; 
Miltenyi Biotec, Auburn, CA).  Apoptosis and necrosis were determined using FITC-
conjugated Annexin V and PI staining, respectively.  Annexin V detects externalization 
of cell membrane associated phosphatidylserine, an arly marker of apoptosis whereas PI 
binds to DNA following cell membrane disruption and is indicative of necrotic cells 
(Vermes et al. 2002). Briefly, 1.0 x 105 cells were incubated with 2.5 µL of both Annexin 
V-FITC (Pharmingen) and PI (Sigma Chemical) in 100 µl of Annexin binding buffer 
(Pharmingen) for 15 min at room temperature in the dark, followed by addition of 
binding buffer (400µl) and analysis by flow cytometry.  Individual IL phenotypes were 
determined by suspending 5 x105 cells in 100µl PBS and incubated with 2.5µl of PE-
conjugated mAbs (PharMingen, San Diego, CA, USA) for CD4 (anti-CD4, clone: 
GK1.5) and CD8α (anti-CD8α, clone: 53-6.7) in the dark at 4ºC for 45 min. Cells were 
washed and centrifuged (5 min, 450g) and the pellet resuspended in 50µl Annexin V 
binding buffer and incubated with 2.5µl of Annexin V-FITC for 15 min at room 
temperature in the dark. Following incubation, 400 µl of binding buffer was added and 
analyzed for phenotype and apoptosis on a flow cytome er (FACSVantage SE).  
 
Western Blot Analysis of Caspase 3, Bcl-2, Bax, NFκB, IL-10 and TNF-α:  
Cytoplasmic and nuclear mouse IL protein samples were prepared and separated by 





Chemical). Following transfer, membranes were stained with Ponceau S (Sigma 
Chemical) to confirm quality of transfer and equal loading. Membranes containing the 
separated proteins (cytoplasmic or nuclear) were incubated for 1 h with primary antibody 
(1:200 in 10% milk-TBST): Bcl-2 (clone: C-2; mouse anti-human monoclonal IgG1, mol 
wt =28kDa), caspase 3 (clone: H-227; rabbit anti-human clone IgG, mol wt =35kDa),  
TNF-α (clone: N-19; goat anti-human polyclonal IgG, mol wt =17kDa), NFκB (clone: C-
20; rabbit anti-human polyclonal IgG, mol wt=65kDa), IL-10 (clone: M-18; goat anti-
mouse IgG, mol wt =15kDa) or Bax (clone: 5B7; mouse anti-mouse monoclonal IgG1, 
mol wt =23kDa) (Santa Cruz Biotechnology, Santa Cruz, CA, USA). This was followed 
by 1 h incubation with secondary antibody: horseradish peroxidase-conjugated anti-
mouse (Bcl-2, Bax), anti-rabbit (caspase 3, NFκB) or anti-goat (TNF-α, IL-10) IgG at a 
concentration of 1:2000 in 10% milk-TBST. Protein was determined using ECL or ECL 
Plus Western blotting detection reagents (Amersham Biosciences, Buckinghamshire, UK) 
and the ChemiGenius 2 Bio-imaging System (Cambridge, UK). Each gel contained 
samples from all 4 treatment groups along with a biotinylated protein ladder to identify 
the molecular weight of the immunoblotted protein (Cell Signaling Technology, Beverly, 
MA, USA). For IL-10 and TNF-α blots, recombinant IL-10 and TNF-α standards (mouse 
IL-10, CL9310R, mouse TNF-α, CL9300TR; Cedarlane Laboratories) were run on each 
gel. 
 
Histology:  Approximately 1 cm sections of distal colon were excised, cleaned of fecal 
matter, and rinsed with PBS. Samples were fixed in 10% formalin and embedded in 





(H&E) and viewed under light microscopy at 40X magnification. Samples were masked 
as to group allocation during visualization. 
 
Statistical Analysis: Data were analyzed as a 2x2 analysis of variance design with diet 
(two levels: no bLf, bLf) and DSS (two levels: no DSS and DSS) as the independent 
factors using SPSS (Version 15; Chicago, IL, USA).  P<0.05 was accepted as being 
significantly different from chance alone.  Significant interaction effects were further 
examined by t test analysis within the treatment conditions. All values are expressed as 





Effect of DSS and bLf on Mouse Body Weight and Food Intake:  Mice did not differ 
by treatment condition (diet x DSS) in their average body weights at the start of the 
experiment: no bLf/no DSS 18.8 ± 0.5g; no bLf/DSS 18.9 ± 0.5g; bLf/no DSS 18.1 ± 
0.5g; bLf/DSS 19.6 ± 0.5g.  In contrast, there was a ignificant effect of DSS, but not 
diet, on the weight of animals at sacrifice (F1,59 = 12.45, p<0.001; Table 5.1). Mice given 
DSS had significantly lower body weights than those not given DSS (p<0.05). 
Cumulative food intake did not differ among the trea ment groups over the 12 days of 
feeding: no bLf/no DSS 40.9 ± 1.4g; no bLf/DSS 40.0 ± 1.3g; bLf/no DSS 42.5 ± 0.9g; 





Table 5.1: Dextran sulfate sodium and bovine lactoferrin effects on mouse intestinal 
































Figure 5.2:  Hematoxylin and Eosin stained tissue sections of m use colon viewed by 
light microscopy under 40x. A: no bLf/ no DSS, B:  bLf/ no DSS, C:  no bLf/DSS, D:  











19.93 ± 0.25 42.92 ± 0.38 4.29 ± 0.77 
DSS 
 
18.45 ± 0.32**  41.47 ± 0.41## 4.41 ± 0.78 
no bLf 
 
19.05 ± 0.32 41.73 ± 0.48 3.71 ± 0.35 
bLf 
 





Effect of bLf and DSS on Mouse Intestinal Morphology and Disease Indicators: 
There was a significant effect of DSS on the length of the intestinal compartment (both 
the small and large intestine) (F1,59 = 6.61, p<0.01; Table 5.1) with reduced length in DSS 
treated mice.  As a result of DSS treatment 30 of 32 mice had visual rectal bleeding and 
all animals had visual blood within the intestine. No rectal bleeding was observed in mice 
not given DSS and bLf did not decrease any bleeding. H&E stained colon sections 
(Figure 5.2) indicated structural damage arising from DSS treatment. Figure 5.2C and 
5.2D illustrate mucosal damage and crypt disruption following DSS treatment compared 
to the controls not given DSS (Figure 5.2A and 5.2B). Further, in mice given DSS, 
ablation of crypts was observed whereas intact crypts characterized mice not challenged 
with DSS. 
 
Effect of DSS and bLf on Mouse IL Counts, Cell Death and Phenotypes:  There was 
a significant diet effect on IL counts (F1,59 = 5.49, p<0.05; Table 5.1).  This was due to 
higher cell numbers in mice fed bLf compared with controls. There was no significant 
main effect of DSS nor was there an interaction betwe n diet and DSS on mouse IL 
counts.  
Figure 5.3 shows the apoptosis and necrosis flow cytometry results for mouse IL.  
There were significant effects of DSS on the percentage of PI+/ANN- (necrotic) (F1,27 = 
7.65, p<0.05; Figure 5.3A), PI+/ANN+ (late apoptotic) (F1,27 = 4.35, p<0.05; Figure 5.3B) 
and PI-/ANN- (viable) (F1,27 = 11.34, p<0.005; Figure 5.3C) mouse IL. Diet condition did 
































Figure 5.3:  % PI and Annexin V+ mouse IL by DSS treatment condition. *p<0.05, 



























































Figure 5.4 shows the flow cytometric results for CD4+ IL and for expression of the 
apoptotic marker Annexin V within this subset. There was a significant interaction effect 
between DSS treatment and diet in the % CD4+ IL (F1,23 = 4.46, p<0.05; Figure 5.4A). 
This interaction effect was due to a decrease in the percentage of CD4+ IL in the bLf/DSS 
vs. the no bLf/DSS groups (t9 = 2.41, p<0.05, Figure 5.4A) and a decrease in the bLf/no 
DSS vs. the no bLf/no DSS groups (t11 = 2.92, p<0.01, Figure 5.4A).   
There was a similar interaction effect between DSS and diet on the percentage of 
mouse CD4+/ANN+ IL (apoptotic CD4) (F1,23 = 5.03, p<0.05; Figure 5.4B).  This 
interaction reflected a decrease in the percentage of CD4+/ANN+ IL in the bLf/DSS vs. 
the no bLf/DSS groups (t9 = 1.79, p<0.05, Figure 5.4B). Subsequently, there was also a 
significant main effect of DSS on the percentage of CD4+/ANN- (viable CD4) (F1,23 = 
14.04, p<0.001; Figure 5.4C), as these cells decreased following DSS treatment.  
Figure 5.5 illustrates flow cytometric results for CD8α+ IL and for expression of the 
apoptotic marker Annexin V within this subset.  There were no main or interaction 
effects of diet and DSS on the percentage of CD8α+ IL. There was, however, a trend 
toward an increase in the percentage of CD8α+ IL as a result of DSS treatment (no DSS: 
53.77 ± 1.85%, DSS: 60.86 ± 3.75%, p=0.085). There was a significant main effect of 
DSS on CD8α+/ANN+ IL (apoptotic CD8α) (F1,23 = 11.67, p<0.01; Figure 5.5A): mice 
given DSS had a lower percentage of CD8α+/ANN+ IL as compared to those not 
receiving DSS. There was also a significant main effect of DSS on the percentage of non-
apoptotic CD8α+ IL (i.e., CD8α+/ANN-) (F1,24 = 4.96,  p<0.05; Figure 5.5B) with  a 
































Figure 5.4:  (A) %CD4 IL, *p<0.05, ##p<0.01,  (B) %CD4+/Annexin V+, *p<0.05, and 
(C) %CD4+/Annexin V-, ** p<0.001, of mice by DSS and bovine lactoferrin treatment 
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Figure 5.5:  %CD8+/Annexin V+ (A), and %CD8+/Annexin V- (B) of mouse IL by DSS 








































































Figure 5.6:  Concentration of apoptotic and inflammatory proteins in mouse IL by DSS 
and bovine lactoferrin treatment. (A) NFκB, *p<0.05, (B) anti-inflammatory IL-10, 
*p<0.05, (C) pro-apoptotic caspase 3, *p<0.05, (D) anti-apoptotic Bcl-2, ##p<0.01.  Values 





















































































































Effect of DSS and bLf on NFκB, IL-10, TNF-α:  Western blotting results for NFκB, 
IL-10 and TNF-α concentrations in mouse IL are shown in Figure 5.6. There was a 
significant effect of diet on NFκB protein levels in mouse IL (F1,43 = 5.37, p<0.05; Figure 
5.6A), an effect due to lower NFκB levels in mice fed bLf supplemented diets. There was 
no significant effect of DSS or interaction between diet and DSS on NFκB levels in 
mouse IL.  Protein levels of TNF-α, a pro-inflammatory cytokine, in mouse IL was not 
affected by diet or DSS. Nevertheless, we observed a 34% decrease in TNF-α levels in IL 
of mice fed bLf compared to no bLf controls (no bLf: 1.3 ± 0.18, bLf:  0.91 ± 0.090). 
Protein levels of IL-10, an anti-inflammatory cytokine, in mouse IL was significantly 
affected as an interaction of diet x DSS exposure (F1,33 = 6.78, p<0.05; Figure 5.6B).  
This interaction reflected increased IL-10 concentrations in the no bLf/DSS (t17 = -1.95, 
p<0.05) and bLf/no DSS (t15 = -1.95, p<0.05) groups compared with the no bLf/no DSS 
control group and a decrease in IL-10 in the bLf/DSS group (t16 = 1.79, p<0.05) 
compared to the bLf/no DSS group.  
 
Effect of DSS and bLf on Bax, Bcl-2, and Caspase 3: Figure 5.6C shows the effects of 
DSS on the concentrations of the pro-apoptotic protein caspase 3 in mouse IL (F1,37 = 
6.37, p<0.05), an effect due to higher caspase 3 expression in DSS challenged animals 
relative to no DSS controls. bLf, either alone or interacting with DSS, did not 
significantly influence protein levels of caspase 3 in mouse IL.  As shown in Figure 5.6D, 
there was a significant effect of DSS on the concentration of the anti-apoptotic protein 
Bcl-2 (F1,54 = 7.60, p<0.01), with decreased concentrations following DSS treatment.  











The objectives of this study were threefold: 1) to characterize the effects of DSS, 
an inducer of inflammatory damage in gut mucosa and epithelium, on mouse IL death, 2) 
to determine if bLf affected mouse IL death during DSS challenge and 3) to determine if 
bLf affected protein levels of mouse pro- and anti-i flammatory cytokines (TNF-α and 
IL-10) and pro- and anti-apoptotic proteins (caspase 3, Bax, Bcl-2) in IL during DSS 
exposure.  A novel finding of this study was that mice subjected to 5% DSS for 4 days 
had increased death of IL as measured by the expression of Annexin V and PI as well as 
increased pro-apoptotic caspase 3 and decreased anti-apop otic Bcl-2 protein levels in IL. 
Our study is also the first to report that bLf reduced the IL concentration of NFκB, an 
important transcription factor in the synthesis of pro-inflammatory cytokines such as 
TNF-α.  
Administration of 5% DSS in drinking water for 4 consecutive days resulted in 
marked structural intestinal damage, intestinal andrectal bleeding, shortened intestinal 
length and reduced body weights in mice. These findings suggest active inflammation in 
the bowel and agree with those structural (reduced olon length, crypt destruction, 
epithelial cell ulceration) and disease indicators (rectal bleeding, lower final body weight) 
induced by DSS in mice reported by others (Cooper et al., 1993; Okayasu et al., 1990; 
Egger et al., 2000; Naito et al., 2003). In this present study, dietary bLf did not affect 





contrast with those of Haversen et al. (2003) showing that mice given 2 mg of human 
lactoferrin (hLf) twice daily for 7 d during 5% DSS treatment had less colonic length 
shortening, mucosal damage and fecal occult blood.  The reasons for this discrepancy 
between our findings and those of Haversen and colleagues are not known but may 
reflect differences in: the type of Lf (bovine vs. human), the total concentration of Lf to 
which the mice were exposed (800mg vs. 28mg), the duration of Lf exposure (12 d vs. 7 
d), or mode of administration (diet vs. sublingual). 
IL isolated from animals given DSS exhibited high degrees of necrotic cell death. 
The percentage of late apoptotic/necrotic (ANN+/PI+) IL and necrotic (PI+/ANN-) IL 
increased whereas viable (ANN-/PI-) IL decreased following DSS treatment.  DSS 
induced necrotic death of IL has not been previously reported. However, erosion of the 
intestinal mucosa has been suggested to occur as a esult of necrosis (Renes et al., 2002).  
Dieleman et al. (1994) demonstrated that DSS reduced th  viability and growth of a 
colonic epithelial cell line as measured by PI staining and [3H] thymidine incorporation. 
Thus, given the anatomic proximity of IL to the intes inal epithelium, it seems likely that 
DSS acts in a direct cytotoxic manner on IL similar to epithelial cells.   
Dietary bLf did not affect DSS induced IL death, which may be related to the 
mechanism of action and magnitude of inflammatory damage of DSS. First, if DSS is 
directly cytotoxic to IL a primary mechanism by whic  bLf could be protective would be 
by interaction and neutralization of DSS. There is, however, no evidence in the literature 
to support a neutralization role for bLf on DSS.  Second, the inflammatory response in 
the bowel induced by DSS is extensive: any potential benefit provided by bLf (at least in 





for the large pathophysiological changes resulting from DSS exposure.  Although bLf 
primes toward an anti-inflammatory cytokine profile (Spagnuolo and Hoffman-Goetz, 
2008a; Togawa et al. 2000a, 2002b) and decreases the ex ent of oxidative stress (Shoji et 
al., 2007), this benefit may not be able to overcome the array of DSS induced disease 
sequelae including disruption in membrane barrier function and potential exposure of 
commensal bacteria, immune activation, infiltration f neutrophils, macrophages and 
lymphocytes, increased nitrosative and oxidative str s  and increased pro-inflammatory 
cytokine production (Cooper et al., 1993; Okayasu et al., 1990; Takizawa et al., 1995a; 
1995b; Egger et al., 2000; Naito et al., 2001).   
Death of IL by DSS was largely necrotic; nevertheless, DSS induced apoptosis 
cannot be completely dismissed given the increased expression of PI+/ANN+, the 
increased protein levels of caspase 3, and the decreased levels Bcl-2 in mouse IL.  
Indeed, apoptotic cells that are not recognized by phagocytes undergo secondary (or 
apoptotic) necrosis, subsequent to apoptosis, a process characterized by the appearance of 
the PI+/ANN+ phenotype (Vermes et al., 2002; van Cruchten and Van Den Broeck, 2002). 
Given the dynamic kinetic process of apoptosis and the cross-sectional nature of the 
study, we were unable to fully differentiate between apoptotic and necrotic IL death 
induced by DSS. Increases in both measurement parameters indicate that both processes 
were likely occurring in IL and is consistent with Renes et al. (2002), who observed 
apoptosis and necrosis within the colonic epithelium of DSS treated rats. Future studies, 
such as sampling at different time points and morphlogical analysis of IL, will be 





Dietary bLf administration did not affect the concetration of apoptotic related 
proteins, a finding which is consistent with its inability to influence IL death during DSS 
induced inflammation. Although bLfcin has been shown to affect apoptotic related 
parameters such as mitochondrial membrane permeability (Mader et al., 2005; 2007) and 
apoptotic proteins such as Bcl-2 (Spagnuolo and Hoffman-Goetz, 2008a), the inability of 
bLf to affect either caspase 3 or Bcl-2 in the present study likely reflects the extent and 
severity of the DSS induced inflammatory response.  
  Administration of dietary bLf in mice for 12 days resulted in an increase in the 
total number of IL, similar to other reports (Spagnuolo and Hoffman-Goetz, 2008a; Wang 
et al., 2000). However, DSS treatment did not influence overall IL numbers despite an 
increase in IL death. We suggest that this can be explained by the increase in the 
percentage of CD8+ IL with DSS treatment. Increases in CD3+ T cells (Melgar et al., 
2006), T and B lymphocytes (subsets not identified) (Cooper et al., 1993) and activated T 
lymphocytes (Takizawa et al., 1995a; 1995b) in the colonic mucosa of mice following 
DSS treatment have been reported. In this study, the observed percent increase in CD8 
cells, with no change in IL number, may reflect mobilization of this subpopulation from 
other lymphoid compartments in response to the DSS induced intestinal inflammation.  In 
support of this hypothesis are the following observations: 1) there is a decreased number 
of CD8α+ T cells in the spleen coupled with an approximate three fold increase in 
peripheral blood lymphocytes following DSS treatment in mice (Da Silva et al., 2006), 2) 
there is an increased  number of  ‘mature phenotype’ thymocytes following DSS 
treatment in mice, a phenomenon attributed to preparation for mobilization to other 





adhesion molecules in mouse intestinal epithelial cells following incubation with DSS 
(Ni et al., 1996). Taken together, the percent increase in CD8α T cells in mouse intestine 
may reflect lymphocyte recruitment from other pools in the periphery and may contribute 
to the maintenance of total IL numbers following DSS treatment. Alternatively, the 
percent increase in CD8α cells may only reflect a loss of another lymphocyte population 
(e.g., B cells). However; given the consistent total IL numbers between DSS and non 
DSS treated mice this interpretation seems less likely (i.e., a cell population must replace 
the dying cells).  
During inflammation cytokines play central roles in dictating the extent, duration 
and direction of the immune response.  Our results suggest a shift towards an anti-
inflammatory response with increased IL-10 (independent of DSS exposure environment) 
and a trend of decreased TNF-α following bLf administration.  bLf given through te diet 
alters the ratio of TNF-α/IL-10 in mouse IL to favour anti-inflammatory responses 
following a known physiological stressor (repeated bouts of exhaustive exercise with 
associated oxidant stress) (Spagnuolo and Hoffman-Goetz, 2008a).  Togawa et al. 
(2002a; 2002b) reported that bLf administered by gava e increased IL-10 and decreased 
TNF-α following DSS and TNBS treatment in rat colon, resp ctively. Thus, a potential 
benefit of bLf supplementation may involve a shift in the TH1 and TH2 cytokine balance 
to favour anti-inflammatory responses. 
Treatment of mice with DSS was associated with increased IL-10 concentrations 
in IL (no bLf/no DSS vs. no bLf/DSS), a finding whic  may seem paradoxical given the 
TH1 suppressing, anti-inflammatory role of this cytokine. However, increased IL-10 





inflammation. In support of this hypothesis are thefindings of Egger et al. (2000) who 
demonstrated increased mRNA of several pro-inflammatory cytokines (e.g., TNF-α, IFN-
γ, IL-1) as well as increased IL-10 mRNA in the colonic mucosa of DSS treated mice. 
Increased IL-10 mRNA was also found in mucosal biopsies of patients with active Celiac 
Disease (Forsberg et al., 2007).  Haversen et al. (2003) reported increases in IL-10 
producing cells in the colonic mucosa of mice subjected to DSS, which were decreased 
following oral hLf administration; this reduction was related to a hLf associated down-
regulation of DSS induced inflammation. We report a decrease in IL-10 following dietary 
bLf administration in mouse IL within DSS treatment (bLf/no DSS vs. bLf/DSS), which 
may reflect a lessening of the inflammatory stress.  Therefore, increased IL-10 production 
may be a physiological compensatory mechanism in response to DSS and the addition of 
bLf may attenuate the need for this compensation. 
Dietary bLf was associated with decreased protein levels of the pro-inflammatory 
transcription factor NFκB in mouse IL. Reduced NFκB may subsequently result in less 
pro-inflammatory cytokine production by immune cells.   In support of this are the 
following observations: first, following LPS stimulation, binding of NFκB to the TNF-α 
promoter in monocytes was inhibited by Lf (21). Second, Togawa et al. (2002b) 
demonstrated reduced phosphorylation of IκB indicating decreased NFκB activation in 
rat colon following gavage administration of bLf in rats with TNBS induced colitis; third, 
dietary bLf reduced both NFκB and TNF-α expression in mouse IL following oxidant 
stress accompanying acute, repeated exercise  (Spagnuolo and Hoffman-Goetz, 2008a). 
These findings suggest that bLf may reduce the extent of inflammation by altering the 







In summary, 5% DSS treatment for 4 days in female C57BL/6 mice was 
associated with marked inflammatory damage within te intestinal compartment.  DSS 
resulted in necrotic death of IL as well as increased protein levels of the apoptotic protein 
caspase 3 and decreased expression of the anti-apopotic Bcl-2 protein. DSS treatment 
also induced a non-significant increase in the percent of CD8α IL indicative of an 
activated immune response. Finally, dietary bLf did not provide any observable benefit in 
disease activity measurements nor did it influence DSS induced IL death. Nevertheless, 
bLf may offer some limited intestinal protection bydecreasing the levels of the pro-
inflammatory transcription factor NFκB. However, the physiological impact of lower 
NFκB levels in IL on the actual synthesis of pro-inflammatory cytokines (IL-1, IL-6, 






Chapter 6: Effect of Dextran Sulfate Sodium and Acute Exercise on 
Mouse Intestinal Inflammation and Lymphocyte 





To determine the effects of dietary bovine lactoferrin (bLf) on small and large intestinal 
histology and on cytochrome c levels in mouse intestinal lymphocytes in female 





Hypothesis 1: bLf administration will increase cytochrome c levels in mouse IL 
following repeated bouts of strenuous exercise and DSS challenge relative to the IL 
levels of cytochrome c in mice not receiving bLf supplementation. 
 
Hypothesis 2: Mice receiving repeated bouts of strenuous exercis will exhibit similar 
intestinal histology relative to mice receiving DSS treatment. 
 
Hypothesis 3: bLf administration will provide protection, as determined by histological 
scores, against both DSS and AE induced intestinal damage relative to the histological 
scores of mice not receiving bLf supplementation.  
 
 
6.3. Study Design 
 
This study was designed to provide direct evidence about the possible benefits of 
dietary bLf on small and large intestinal morphology following DSS and AE challenge.  
In addition, it was the aim of this study to determine the histological effects of AE and if 
any alterations were similar to that induced by DSS. Previous experiments (Chapter 4 and 
5) demonstrated that bLf had small, albeit, significant effects on decreasing the levels in 
mouse IL of the pro-inflammatory cytokine TNF-α, the pro-inflammatory transcription 
factor NFκB, and the anti-apoptotic protein Bcl-2. It was theaim in this experiment to 
determine if these bLf induced modifications were associated with direct mucosal 





c, located in the mitochondria, was measured within e IL by Western blotting.  Since 
the previous studies determined that dietary bLf given to mice was able to decrease the 
expression of the anti-apoptotic protein Bcl-2 (involved in regulation of mitochondrial 
outer membrane permeability), it was hypothesized that here would also be an increase 
in cytochrome c expression in mouse IL. The study design for experiment 4 is outlined in 
Figure 6.1. 
 
Study duration: Two week acclimation plus 12 d of dietary bLf administration.  
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A two way ANOVA and post-hoc Tukey tests were used to analyze the study 
data.  In the DSS study, a two way ANOVA (2x2 factorial design) was used to analyze 
the data. In this study the independent variables ar  diet condition (0% bLf or 2.0% bLf) 
and DSS treatment (no DSS or DSS). In the AE study, a two way ANOVA (2x3 factorial 
design) and post-hoc Tukey tests was used to analyze the data. In this experiment, the 
independent variables were diet condition (0% bLf or 2.0% bLf) and exercise treatment 
(SED, IMM, 24 h POST).   For both experimental studies, the dependent variable was the 
cell death marker cytochrome c. Small and large intestinal histology was graded 
according to the inflammatory and crypt score outlined in Table 6.1 and verified by two 
independent veterinary pathologists. 
 
Table 6.1: Details of the inflammatory and crypt scoring system used to grade small and 
large intestinal histology. 
 
Grade Inflammatory Score 
(Melgar et al., 2005) 
Crypt Score 
(Cooper et al., 1993) 
0 normal, intact crypt 
1 slight inflammation loss of basal one-third of crypt 
2 moderate inflammation and/or 
edema 
loss of basal two-thirds 
3 heavy inflammation and/or 
ulceration and/or edema. 
loss of entire crypt with no alteration to 
the epithelium 












Dextran sulfate sodium (DSS) is commonly used to induce intestinal inflammation in 
animal models.  Acute exercise (AE) is associated with oxidative stress and ischemia-
reperfusion injury that may result in intestinal tissue damage. Bovine lactoferrin (bLf), an 
anti-inflammatory protein, may provide protection during DSS or AE inducing intestinal 
tissue damage. The purpose of this study was to investigate the influence of DSS and AE 
challenge in mice on: 1) tissue inflammatory changes within small and large intestine, 2) 
extent of cell death as measured by cytochrome c protein levels in intestinal lymphocytes 
(IL) and, 3) the effects of dietary bLf on these parameters. Tissue inflammation was 
determined by histology and cytochrome c levels in murine IL by Western blotting. 
Cytochrome c levels were elevated following bLf (p<0.01) and DSS (p<0.05) treatment 
whereas exercise had no significant effect. DSS, but not AE, resulted in histological 
alterations indicative of inflammation, with no attenuation by bLf, in the small and large 
intestine. The novel findings of this study were that both DSS and bLf induce cell death 
as suggested by increased cytochrome c expression in mouse IL.  Further, the results 
show that DSS, but not AE, elicits intestinal inflammation and that bLf does not protect 








Athletes commonly suffer from gastrointestinal disturbances such as abdominal 
pain and bleeding following strenuous exercise (Peters et al., 2001b; Bi and 
Triadafilopoulos, 2003). These gastrointestinal problems may be related to the induction 
of intestinal inflammation as a result of exhaustive exercise. A mechanism by which 
acute strenuous exercise could trigger intestinal iflammation is through oxidative stress 
and/or ischemia-reperfusion injury. Marshal (1998) suggested that acute exercise results 
in bacterial translocation following ischemia/reperfusion injury to the intestine post 
exercise. Choi et al. (2006) reported that 22 of 24 long distance runners had upper GI 
mucosal lesions post exercise. Bloody diarrhea was reportedly due to colonic lesions 
caused by ischemia following long distance running (Heer et al., 1987). Jeukendrup and 
colleagues (2000) reported mild endotoxemia due to gut ischemia-associated leakage of 
endotoxins in 68% of athletes completing a long-distance triathlon event. Further support 
for intense exercise as a model of inducing intestinal inflammatory damage comes from:  
1) the high levels of bacterial lipopolysaccharide n human plasma following maximal 
aerobic exercise suggestive of increased intestinal permeability (Ashton et al., 2003),  2) 
the increase in the pro-inflammatory cytokine TNF-α in human plasma (Ostrowski et al., 
1999) and mouse intestinal lymphocytes (Hoffman-Goetz et al., 2008) following acute 
exercise, 3) the mild increases in cellular infiltrates in the mouse small intestine following 
repeated bouts of acute exercise (Rosa et al., 2008), and 4) the increase in oxidative stress 
(measured by plasma levels of lipid metabolites) in mice following single (Hoffman-
Goetz and Quadrilatero, 2003) and repeated bouts of strenuous exercise (Spagnuolo and 





Sampling gastrointestinal tissue from athletes (or other human populations) is 
problematic for ethical reasons. Rodents have been us d to examine the effects of intense 
exercise on various immunological and physiological parameters within the 
gastrointestinal tract. Among the methodological advantages of using an animal model of 
exercise-induced intestinal inflammation is the ability to directly analyze tissue 
alterations. However, to determine whether exercise actually induces intestinal 
inflammation it is important to compare the physiological alterations to a model known to 
elicit such effects. The “gold standard” for induction of experimental intestinal 
inflammation is dextran sulfate sodium (DSS), a sulfated polysaccharide, which is 
administered in the drinking water (Strober et al., 2002). Exposure of mice to DSS results 
in pathological alterations to the intestine including crypt destruction, intestinal 
shortening and bleeding, epithelial erosion and recruitment of immune cells (Okayasu et 
al., 1990; Cooper et al., 1993). DSS-induced intestinal inflammation is, in part, believed 
to occur by eliciting direct mucosal injury (Strober t al., 2002).  Several studies 
(Okayasu et al., 1990; Cooper et al., 1993; Egger et al., 2000; Melgar et al., 2005; Renes 
et al,. 2002; Takizawa et al., 1995a; 1995b; Vetuschi et al., 2002) examined the effects of 
DSS on the intestinal epithelium and demonstrated epith lial cell death following 
treatment. There is, however, only limited research on whether these effects of DSS occur 
similarly in intestinal lymphocytes (IL) (Spagnuolo and Hoffman-Goetz, 2008b).  
Given the potential of gastrointestinal disturbances (at least in part) related to 
oxidative stress that accompanies exercise, it is not surprising that athletes adjust their 
diets to improve antioxidant defenses. Froiland et al. (2004) reported 89% of Division 1 





whey protein, a natural by-product of cheese manufact ring.  Whey protein 
administration also reduced the extent of oxidative damage as shown by decreased lipid 
peroxidation markers and decreased ratios of GSH/GSSG in untrained animals following 
a bout of exhaustive exercise (Elia et al., 2006).  An important constituent of whey 
proteins is lactoferrin (Lf). Indeed, bovine lactoferrin (bLf) has demonstrated anti-
inflammatory effects including increased apoptosis (Mader et al., 2007) and cytokine 
alterations (Togawa et al., 2002a; 2002b). In addition, dietary bLf reduces TNF-α levels 
in mouse IL through reductions in NFκB expression following acute exercise and DSS 
challenge (Spagnuolo and Hoffman-Goetz, 2008a, Spagnuolo and Hoffman-Goetz, 
2008b). However, a direct role of dietary bLf in protecting the intestinal epithelium in 
response to repeated bouts of AE or DSS damage in th  bowel has not been tested.  
Apoptosis and necrosis are two terms used to describe cell death. Apoptosis 
involves a series of events resulting in DNA degradation, cellular shrinking and the 
formation of apoptotic bodies that are removed by loca  phagocytes to prevent the 
induction of inflammation. Necrosis occurs following direct cellular injury resulting in 
swelling, membrane rupture and the release of cellular contents and inflammation 
(Hoffman-Goetz et al., 2005).  We reported that mice exposed to DSS had significant IL 
death characteristic of both apoptosis and necrosis (Spagnuolo and Hoffman-Goetz, 
2008b). To investigate that DSS causes IL death and that AE induces a similar response 
to that of DSS, the cell death associated protein cytochrome c was quantified. 
Cytochrome c, located on the mitochondrial inner membrane and involved with electron 
transport, corresponds with both apoptosis and necrosis (Garrido et al., 2006; Jemmerson 





cytoplasm, the formation of an apoptosome complex consisting of caspase 9, ATP and 
APAF 1, and activation of caspase 3, the primary executor of apoptotic cell death (van 
Loo et al., 2002). Cytochrome c release from the mitochondria has also been associated 
with necrotic cell death. Jemmerson et al. (2002) demonstrated that cellular injury 
resulted in the presence of cytochrome c attributed to irect insult to the mitochondria.  
Thus, an increase in cytochrome c is a reasonable marker of cell death, either by 
apoptotic or necrotic mechanisms.  
The purpose of this study was twofold. The first aim was to compare DSS and AE 
as modalities of inducing direct (histological) damage within mouse small and large 
intestine, both independently and in combination with dietary bLf. A second aim was to 
determine cytochrome c levels in mouse IL following DSS or AE exposure alone or in 
combination with dietary bLf.  We hypothesized that if intestinal damage arises from AE 
than this protocol would induce intestinal alterations similar to those caused by DSS. We 
also hypothesized if DSS or AE exposure resulted in apoptotic or necrotic cell death, then 
cytochrome c levels would be increased in mouse IL.   
 
6.6. Materials and Methods 
 
Animals. A total of 152  female C57BL/6 mice, 3-4 weeks old, were obtained from 
Harlan Sprague Dawley (Indianapolis, IN, USA) and iividually housed at 21±1 ºC on a 
12/12h reversed light/dark cycle. The purchase of anim ls, the husbandry and the 
experiments conformed to the European Convention for the Protection of Vertebrate 





Council on Animal Care. All protocols with live animals were approved by the 
University Animal Ethics Committee.   
 
Diet.  Mice had ad libitum access to tap water and maintenance diet (Laboratory R dent 
Chow, PMI feeds Richmond, IN, USA) for 2 weeks prior t  the start of the studies. 
Following acclimation, mice were randomly assigned by weight into treatment conditions 
for Studies I and II (see below). Diets were formulated to contain 20% total protein which 
included either 0% or 2.0% bLf (Erie Foods International Inc, Erie IL); bLf 
concentrations were determined based on previous studie  which showed 2.0% was 
sufficient to influence apoptosis and cytokine production (Spagnuolo et al., 2007). No 
bLf mice had 0% bLf in the diet; bLf mice had 2.0% bLf in the diet. Mice had free access 
to the diets for 12 d prior to sacrifice.   
 
Study I: DSS Exposure.  Mice (n=63) were randomized into 4 treatment conditions:  no 
bLf/no DSS (n=16); no bLf/DSS (n=16); bLf/no DSS (n=15) and bLf/DSS (n=16). DSS 
(MP Biomedicals, Solon, OH; mol wt=36-50 kDa), conce tration of 5% w/v, was 
solubilized in tap water at room temperature and mice had ad libitum access to DSS 
containing drinking water for 4 d prior to sacrifice.   
 
Study II: Acute Exercise (AE) Exposure.  Mice (n=89) were randomized to one of six 
treatment groups: no bLf/SED (n=16); bLf/SED (n=16); no bLf/IMM (n=14); bLf/IMM 
(n=12); no bLf/24 h POST (n=15); and bLf/24 h POST (n=16). SED were sedentary 





by a 24 h rest interval and with sacrifice upon completion of the third exercise bout; 24 h 
POST were animals given repeated  treadmill running a d sacrificed 24 h after the final 
exercise session (Spagnuolo et al., 2008a).  The treadmill protocol described elsewhere 
(Hoffman-Goetz and Quadrilatero, 2003) consisted of a 10 min warm-up, 90 min 
continuous exercise (30 min at 22 m.min-1, 2°slope; 30 min at 25 m. in-1, 2°slope; 30 
min at 28 m.min-1, 2°slope) and 5 min deceleration. Mice were run during the dark cycle 
(Omni-Max metabolic treadmill, Omni Tech Electronics, Columbus, OH) and were 
motivated to run by occasional gentle prodding using a soft nylon brush. 
 
Intestinal Lymphocyte (IL) Preparation. IL were isolated according to Hoffman-Goetz 
and Quadrilatero (2003), modified from Lefrancois (1993). Following sacrifice, intestinal 
compartments (small and large intestines) were immediat ly removed, Peyer’s patches 
and visible fat dissected out, and IL prepared as single cell suspensions by isolation over 
a column containing 0.3 g of pre-washed nylon wool, washing and layering over a 
density gradient medium (Lympholyte-M; Cedarlane Laboratories, Hornby, Ont.) to 
exclude epithelial cells and remove cellular debris. A ample of IL, which contained both 
intraepithelial and lamina propria lymphocytes, was stained with Turk’s solution and 
counted manually by light microscopy.   
 
Western Blot Analysis of Cytochrome C.  Cytoplasmic protein samples were prepared 
from whole IL samples, separated by electrophoresis on a 12% SDS PAGE gel, and 
transferred onto a PVDF membrane (Sigma Chemical, St. Louis, MO, USA). Quality of 





Chemical). Membranes containing the separated proteins were incubated in primary 
antibody for 1 h (1:200 in 10% milk-TBST): cytochrome c (Clone: 6H2; mouse-anti-rat 
IgG1, mol wt=11 kDa) (Santa Cruz Biotechnology, Santa Cruz, CA, USA), followed by 1 
h incubation with secondary antibody (1:2000): horseradish peroxidase-conjugated anti-
mouse in 10% milk-TBST. Protein was determined using ECL Western blotting detection 
reagents (Amersham Biosciences, Buckinghamshire, UK) and the ChemiGenius 2 Bio-
imaging System (Cambridge, UK). Each gel contained samples from all treatment groups 
as well as a biotinylated protein ladder to identify the molecular weight of the 
immunoblotted protein.  
 
Histology.  Within each experimental group, 1 cm sections of distal colon/large intestine 
(n=4) and terminal ileum/small intestine (n=4) were xcised, cleaned of fecal matter and 
rinsed with PBS. Samples were fixed in formalin, emb dded in paraffin, sectioned and 
stained with hematoxylin (Harris) and eosin (H & E) and viewed under light microscopy 
at 40X magnification. Inflammatory scores were asses ed based on the grading system of 
Melgar et al. (2005): (0) normal, (1) slight inflammation, (2) moderate inflammation 
and/or edema and (3) heavy inflammation and/or ulceration and/or edema. Crypt scores 
were evaluated based on Cooper et al. (1993): (0) intact crypt, (1) loss of basal one-third 
of crypt, (2) loss of basal two-thirds, (3) loss of entire crypt with no alteration to the 
epithelium and (4) loss of entire crypt and epithelum. Samples were masked as to group 
allocation during visualization. Tissue samples were scored independently by two 






8-iso Prostaglandin F2α.  Following sacrifice (Study II) cardiac blood was immediately 
collected into a 1ml syringe containing 0.08ml of heparin, centrifuged (6 min, 1500g), 
plasma collected, and stored at -20˚C. Plasma concentrations of 8-iso prostaglandin F2α 
(8-iso-PGF2α) were determined by direct enzyme immunoassay (EIA) using a 
commercially available kit (Assay Designs, Ann Arbor, Michigan, USA). Briefly, at 
room temperature samples were hydrolyzed (25µL part 10N NaOH: 100µL sample) for 2 
h and neutralized with 12N HCL to pH 6-8. Following centrifugation (5 min, 14000g), 
the supernatant was collected and incubated with 8-so-PGF2α antibody at 4˚C for 24 h. 
Absorbance was determined at room temperature at 405 nm. 
 
Statistical Analysis.  For Study I (DSS study) there were two independent factors: diet 
(two levels: no bLf, bLf) and DSS (two levels: no DSS and DSS. For Study II (AE study) 
there were two independent factors: diet (two levels: no bLf, bLf) and exercise (three 
levels: SED, IMM, 24 h POST).  Data were analyzed using SPSS (Version 15; Chicago, 
IL, USA) and p<0.05 was accepted as being different from chance alone. Values are 





Study I: DSS and bLf on Cytochrome c Levels in Mouse IL: Figure 6.2A shows that 
there was a significant main effect of DSS on cytochr me c levels in mouse IL (F1,45 = 
6.92, p<0.05). This effect was due to increased levels of cytochrome c in DSS treated 
compared to non DSS mice. There was also an effect o  diet (bLf exposure) on mouse IL 





cytochrome c levels compared with the no bLf controls (Figure 6.2B). There was no 
significant interaction between lactoferrin and DSS exposure. 
 
Study I: DSS and bLf on Mouse Intestinal Histology: There were significant changes 
in small and large intestine histology due to DSS treatment. Table 6.2 summarizes the 
inflammatory and crypt scores as markers of tissue changes. Large intestine samples 
displayed pathological inflammation evidenced by complete crypt obliteration and 
epithelial erosion following DSS treatment (Figure 6.3 shows a representative tissue 
section).  Additionally, there were large amounts of mononuclear (lymphocytes, 
macrophages) and polymorphonuclear (neutrophils) cellular infiltrates. There was no 
evidence of attenuation of DSS induced inflammatory damage in animals fed bLf (Figure 
6.3D).  
DSS induced alterations, albeit more subtle, within the small intestine. 
Inflammatory scores were slightly increased (Table 6.2) and, as shown in Figure 6.4, 
DSS altered crypt structure and resulted in mild increases in cellular infiltrates. As 
observed in the large intestine, provision of bLf in the diet did not reduce DSS induced 







Table 6.2: Inflammatory and Crypt Scores 









Acute Exercise Study 
no bLf/SED (n=4) 0 0 0 0 
bLf/SED (n=4) 0 0 0 0 
no bLf/IMM (n=4) 0 0 0 0 
bLf/IMM (n=4) 0 0 0 0 
no bLf/24h POST (n=4) 0 0 0 0 
bLf/24h POST (n=4) 0 0 0 0 
DSS Study 
no bLf/no DSS (n=4) 0 0 0 0 
bLf/no DSS (n=4) 0 0 0 0 
no bLf/DSS (n=4) 1.3 ± 0.8 3.5 ± 0.3 0 2.3 ± 0.3 
bLf/DSS (n=4) 1.0 ± 0.5 3.3 ± 0.3 0 2.5 ±0.3 
 
1 Inflammatory and 2 Crypt Scores were based on the scoring systems outlined by Melgar 















Figure 6.2:  Protein levels of cytochrome c, expressed in arbitrary densitometric units, in 
mouse IL as a function of [A] DSS condition (*p<0.05) and [B] diet (bLf) treatment 













Figure 6.3:  Representative hematoxylin and eosin (H & E) stained sections of mouse 
large intestine viewed by light microscopy under 40x magnification.  All tissue sections 
are from mice given DSS and bLf treatments.  A: DSS for no bLf/ no DSS, B:  bLf/ no 



















































































Study II:  AE and bLf on Cytochrome c Levels in Mouse IL: Neither exercise nor diet 
influenced the expression of cytochrome c in mouse IL (SED: 0.78 ± 0.1 AU, IMM: 0.57 
± 0.06 AU, 24h POST: 0.68 ± 0.1 AU; bLf: 0.64 ± 0.06, no bLf: 0.73 ± 0.1).  There were 
no interactions between acute exercise and diet on mouse IL cytochrome c levels. 
 
Study II:  AE and bLf on Mouse Intestinal Morphology: As shown in Table 6.1 and in 
representative histology (Figure 6.5), there was no evidence of pathological changes in 
either the small or large intestine as measured by crypt disruption or histology scores due 
to acute exercise exposure. Dietary bLf had no effect on the inflammatory indicators 
either alone or in combination with AE (data for AE x bLf are shown in Table 6.2). 
 
Study II:  AE and bLf on 8-iso-Prostaglandin F2α.  There was a significant main effect 
of exercise on plasma concentrations of 8-iso-PGF2α (F2,63 = 6.94, p<0.01) (SED: 318.1 ± 
97.6 pg/ml, IMM: 856.4 ± 23.8 pg/ml, 24 h POST: 1024.3 ± 146.8 pg/ml). This was due 
to elevated levels in both the IMM (p<0.05) and 24 h POST (p<0.01) group relative to 
the SED control. Neither a significant diet effect nor interaction effect were observed.  
There was, however, a non-significant 20% reduction in plasma levels of 8-iso-PGF2α in 
mice fed bLf compared to those on bLf free diets (no bLf: 831.9 ± 125.0 pg/ml, bLf: 


















Figure 6.4:  Representative hematoxylin and eosin (H & E) stained tissue sections of 
mouse small intestine viewed by light microscopy under 40x magnification. All tissue 
sections are from mice given DSS and bLf treatments. A: no bLf/ no DSS, B:  bLf/ no 
DSS, C:  no bLf/DSS, D:  bLf/DSS. Arrows indicate crypt disruption and areas of 








Figure 6.5:  Representative hematoxylin and eosin (H & E) stained tissue sections f 
mouse large intestine viewed by light microscopy under 40x magnification. All tissue 
sections are from mice given repeated bouts of acute exercise. A: SED, B: IMM, C: 24 h 
POST. Only the no bLf treatment groups are shown. 













The primary objective of this research was to examine the effects of AE on mouse 
small and large intestinal inflammation as evidenced by histological changes and if these 
alterations were similar to those caused by DSS. We also determined if bLf attenuates 
any of these potential alterations.  A second aim was to determine if DSS or AE, coupled 
with bLf, influenced the levels of the cell death associated protein cytochrome c, as a 
marker for lymphocyte mitochondrial disruption. A novel finding was that both DSS and 
bLf treatments increased the expression of cytochrome c in mouse IL. DSS treatment 
resulted in gross histological changes within the mouse small and large intestines and 
these effects were not observed in animals subjected to repeated bouts of treadmill 
exercise.  
Administration of 5% DSS for 4 consecutive days in the drinking water was 
associated with marked structural alterations and increases in inflammatory and crypt 
scores within the large intestine. We observed an increased presence of inflammatory 
cells as well as mucosal ulcerations and edema following DSS treatment. These 
pathophysiological changes in the colon have been rported by others. For example, 
Takizawa et al. (1995a; 1995b) showed increased inflammatory cells coupled with the 
development of mucosal erosions 4 days following 3% DSS in the colon of rats. Body 
weights of female C57BL/6 mice were reduced at day 4 and evidence of infiltration of 
inflammatory cells occurred as early as day 3, with crypt loss, edema and focal 
ulcerations present at day 5 following 3% DSS treatment (Melgar et al., 2005). Our study 





the mouse small intestine but to a lesser degree. Ohtsuka and Sanderson (2003) observed 
increases in neutrophils, confirmed by increased myeloperoxidase activity, in the small 
intestine of DSS treated mice.   Administration of DSS increased intestinal disease 
indicators in mice with shortening of intestinal length, visual rectal bleeding, and 
decreased body weight (Spagnuolo and Hoffman-Goetz, 2008b). We found no evidence 
of an attenuation of DSS-induced structural alterations in mice receiving bLf.  This lack 
of bLf effect was not entirely unexpected as the potentially protective anti-inflammatory 
benefits (i.e., cytokine alteration) may not have be n sufficient to counter the numerous 
pathways through which DSS induces disease (disrupton of intestinal barrier, 
recruitment of immune cells, changes in microflora, cytokine alterations). These results 
provide evidence of small and large intestinal alter tions, indicative of inflammatory 
tissue damage, in mice subjected to DSS treatment and, further, of no effect of 2.0% 
dietary bLf supplementation on these tissue alterations.  
Repeated bouts of intense exercise in mice were associ ted with increased 
oxidative stress as evidenced by the elevated plasma concentrations in 8-iso 
prostaglandin F2α. This lipid metabolite is a marker of exercise induced oxidative stress 
(Hoffman-Goetz and Quadrilatero, 2003; Mastaloudis et al., 2004; Steensberg et al., 
2002). Although oxidative stress was induced by the AE protocol used in this study, there 
were no gross histological alterations indicative of inflammation within the small and 
large intestine. This finding is in contrast to that of Rosa et al. (2008) who reported that 
following 4 d of exhaustive treadmill running morphological alterations within the 
terminal ileum of mice were observed; these alterations included reduced muscular layer 





outcomes between the two studies are not known but may reflect a less strenuous exercise 
regimen reported here compared to that of Rosa and colleagues. That the AE in the 
current study was less strenuous is suggested by: 1) fewer number of exercise bouts (3 vs. 
4), 2) differences in the durations of each bout (90 min. continuous exercise vs. durations 
based on times to exhaustion), and 3) lower intensiy of the physical work (68%, 74% 
and 80% VO2 peak at 22 m
.min-1, 25 m.min-1, and 28 m.min-1 in the present study 
[Quadrilatero and Hoffman-Goetz, 2005] vs. 85% of maximal running velocity).  These 
results suggest that aerobic exercise, at the intensity, duration and frequency used in this 
study, does not cause alterations indicative of intestinal inflammation.  
DSS treatment resulted in increased cytochrome c levels in mouse IL and implies 
that DSS exposure results in cell death of lymphocytes within the intestine. This result is 
consistent with previous findings that DSS increases c ll death, characteristic of 
apoptosis and necrosis, as evidenced by the increases in the % of PI+/ANN- (necrotic), % 
of PI+/ANN+ (late apoptotic), and protein levels of the pro-apptotic caspase 3 in mouse 
IL (Spagnuolo and Hoffman-Goetz, 2008b).  Apoptotic and necrotic death of mouse 
intestinal epithelial cells (IEC) by DSS has been demonstrated (Renes et al., 2002; 
Vetuschi et al., 2002) and given the anatomic proximity of IL to IEC, it is not surprising 
that similar mechanisms of death in IL also occur. Thus, the published evidence indicates 
that DSS treatment results in IL death and this current study extends the observation to 
demonstrate that cytochrome c levels (and presumably mitochondrial dysfunction) 
increase in mouse IL with DSS exposure.  
Conversely, three bouts of intense treadmill exercis , each separated by a 24 h 





this exercise protocol does not impart similar inflammatory alterations to that of DSS. 
This exercise modality, however; does result in greater Annexin V expression and fewer 
IL numbers indicative of apoptotic cell death (Spagnuolo and Hoffman-Goetz, 2008a, 
Hoffman-Goetz and Spagnuolo 2007a). Expression of ph s hatidylserine (as indicated by 
Annexin V) on the outer leaflet of the cell membrane is an early marker of apoptosis 
which precedes both the release of cytochrome c and the decrease in mitochondrial 
transmembrane potential (Denecker et al., 2000). Thus, a finding of no increase in 
cytochrome c levels in mouse IL following AE does not exclude apoptotic pathways 
independent of mitochondrial disruption (e.g., lysosomal, ER and TNF receptor 
mediated) (Jaatela and Tschopp, 2003; Hoffman-Goetz et al., 2005) or the kinetics of 
cytochrome c release relative to phosphatidylserine expression on IL with AE challenge. 
It is also possible that cytochrome c was complexed within the apoptosome and not 
readily detected by Western blot analysis.   
Dietary bLf was associated with elevated expression of cytochrome c in mouse IL 
indicative of increased cell death. We have shown that bLf increases apoptotic indicators 
in mouse IL including decreased concentrations of Bcl-2 (Spagnuolo and Hoffman-
Goetz, 2008a) and increased levels of Annexin V (Spagnuolo et al., 2007).  Others (Sakai 
et al., 2005; Yoo et al, 1997) suggest bLf or its metabolites favour cell death. Mader et al. 
(2005; 2007) demonstrated that bLfcin induces apoptosis of Jurkat T cells through 
alterations in cell membrane integrity and increased mitochondrial permeability which 
was associated with increased cytochrome c release.   Thus, the findings suggest that bLf 





mitochondrial membrane permeability. The physiological relevance of bLf as a potential 





In summary, three bouts of intense treadmill exercis  in mice did not result in 
inflammatory damage in small or large intestine as indicated by tissue histology. AE was 
also not associated with differential expression of cytochrome c in mouse IL. In contrast, 
4 days of exposure to 5% DSS in the drinking water of mice produced gross histological 
alterations within the large intestine and minor changes within the small intestine.  
Cytochrome c levels in IL were higher following DSS treatment and support our previous 
observations that DSS treatment results in IL death. Finally, although bLf did not 
attenuate the DSS-induced histological alterations i  mouse intestine, there is a 
possibility that this protein can promote IL death since cytochrome c levels were elevated 
following dietary exposure.  The clinical relevance of dietary bLf in modulating cell 
death of lymphocytes in the intestine during normal and pathophysiological states 
remains to be determined. Nonetheless, given that lactoferrin did not protect against 
intestinal pathology following exposure to DSS, dietary bLf should probably not be 






Chapter 7: Dietary Bovine Lactoferrin Does Not Prevent Aberrant 
Crypt Formation in Mice After Dextran Sulfate Sodium 





To determine the effects of dietary bovine lactoferrin (bLf) on aberrant crypt formation 
and on levels of the apoptotic proteins caspase 3 and Bcl-2 in intestinal lymphocytes of 
female C57BL/6 mice injected with the carcinogen azoxymethane (AOM) and following 





Hypothesis 1:  bLf administration will decrease the number of aberrant crypts in AOM 
injected mice subjected to DSS or AE relative to the number of aberrant crypts in mice 
not receiving bLf supplementation.  
 
Hypothesis 2: bLf administration will increase levels of caspase 3 and decrease levels of 
Bcl-2 in mice given DSS or AE in conjunction with te carcinogen AOM relative to the 
levels of caspase 3 and Bcl-2 in mice not receiving bLf supplementation.  
 
 
7.3. Study Design 
 
 
Inflammation has been demonstrated to be a promoter of colon carcinogenesis 
(Tanaka et al., 2000; Onose et al., 2003). Given th ability of dietary bLf to influence 
both apoptotic and cytokine measures following DSS and AE challenge (Chapters 4, 5, 
6), it was the aim of this study to determine if this anti-inflammatory benefit was 
associated with direct mucosal protection against colon carcinogenesis. This study was 
thus designed to determine the possible protective benefit of dietary bLf on the formation 
of pre-cancerous lesions (i.e., aberrant crypts) in the colon following both inflammatory 
insult and tumour initiation events (i.e., AOM injection).  The study design for 





Study duration: Two week acclimation, two week injection period, two week rest period, 
plus 12 d of dietary bLf administration.  
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Western Blotting for Caspase 3 and Bcl-2  
 
Figure 7.1: Schematic outline of the study design for experiment 5. 
 
A two way ANOVA (2x3 factorial design) and post-hoc Tukey tests were used to 
analyze the study data.  In this study the independent variables were diet condition (0% 
bLf or 2.0% bLf) and treatment condition (control, DSS, AE).  Dependent variables 
include number of aberrant crypts, spleen weight, intestinal length, and animal weight 
prior to sacrifice.  Pre-planned comparisons were run on IL apoptotic protein levels of 
caspase 3 and Bcl-2 as well as on IL counts, given th  direction of effects on those 








Colonic inflammation increases aberrant crypt (AC) formation, pre-neoplastic lesions 
which may progress into tumours.  We have shown that bovine lactoferrin (bLf) has 
small anti-inflammatory properties following dextran sulfate sodium (DSS) or acute 
exercise (AE) challenge in mice. The purpose of this study was to examine the effects of 
bLf in azoxymethane (AOM) injected mice given DSS or AE on AC formation and 
intestinal lymphocyte (IL) death. Female (n=53) C57BL/6 mice injected with AOM were 
randomized into two dietary conditions (no bLf, bLf) followed by allocation to three 
treatment conditions (Control, AE or DSS). AC were determined by light microscopy in 
colon samples and IL isolated, enumerated and apoptotic protein levels determined by 
Western blotting. DSS, but not AE, increased AC formation (p<0.001) and bLf had no 
effect on AC numbers. bLf did not affect the loss of IL which occurred in DSS (p<0.01) 
and AE (p<0.05) mice nor did it prevent the increase in IL caspase 3 levels following 
DSS or AE (p<0.05). The results suggest that dietary bLf, at the dose and exposure 
duration used in this study, does not protect the mucosa from AC formation or influence 










Colon carcinogenesis is a complex process characterized as three distinct stages: 
initiation, promotion and progression (Trosko, 2006).  Experimentally, initiation can be 
induced by injection with colon specific carcinogens, such as 1,2-dimethylhydrazine 
(DMH) or azoxymethane (AOM). The earliest detectable measure of colon 
carcinogenesis is the formation of aberrant crypts (AC) (Bird, 1987). AC differ from 
normal crypts by exhibiting altered width and height, increased thickness of epithelial 
lining, and irregular luminal openings (Bird, 1995). The enumeration of AC has been 
used as a biomarker of early colonic tumour development (Mori et al., 2005). 
Inflammation is believed to be a promoter of tumourigenesis. Animal studies 
show that following initiation by a carcinogen, inflammation promotes the formation of 
AC and tumour development. Onose et al. (2003) described increased tumour incidence 
in rats given DMH (initiation) followed by an inflammatory agent, dextran sulfate 
sodium (DSS) (promotion), compared to non-DSS rats.  Increased AC in rat colon 
following AOM and DSS treatment was observed compared to animals given AOM 
without DSS (Tanaka et al., 2003). To further emphasize inflammation as a promoter of 
carcinogenesis, anti-inflammatory agents were able to r duce AC and tumour growth. For 
example, fewer aberrant crypt foci (ACF), which are clusters of AC, were observed 
following AOM and DSS treatment in mice given three different peroxisome proliferator-






  Intestinal inflammation can be induced in rodents by adding DSS in the drinking 
water. This causes death of intestinal lymphocytes (IL) (Spagnuolo and Hoffman-Goetz, 
2008b), activation of immune cells within the colon (Takizawa et al., 1995a; 1995b), 
increased concentrations of pro-inflammatory cytokines (i.e., TNF-α) (Egger et al., 2000) 
and increased free radicals (Naito et al., 2003). Another modality which may produce 
inflammation in the bowel is intense exercise.  Acute exhaustive exercise (AE) results in 
some physiological changes similar to DSS-induced inflammation; these include 
increased oxidative stress (Hoffman-Goetz and Spagnuolo, 2007b), increased pro-
inflammatory cytokine levels in the intestine (Hoffman-Goetz et al., 2008), IL death 
(Spagnuolo and Hoffman-Goetz, 2008a) and increased inflammatory cells within the 
intestine (Rosa et al., 2008).  Whereas DSS promotes AC and tumour formation, it is not 
known whether intense AE promotes colon carcinogenesis. 
IL function as effector and regulatory cells and contr l over their apoptosis and 
proliferation is critical for homeostasis.  We have shown earlier that mouse IL undergo 
cell death following DSS (Spagnuolo and Hoffman-Goetz, 2008b) and AE challenge 
(Spagnuolo and Hoffman-Goetz, 2008a) that is characte ized by an increased percentage 
of apoptotic IL, increased levels of the pro-apoptotic protein caspase 3 and decreased 
expression of the anti-apoptotic protein Bcl-2. Both DSS and AE may contribute to 
increased cell death in the intestine, but the impact on IL when administered as a tumour 
“promoter” (i.e., following carcinogen injection) has not been characterized.  
Bovine lactoferrin (bLf), an 80 kDa dietary protein with anti-inflammatory 
properties, is found in mammalian milk, colostrums and dairy products. Dietary 





necrosis factor-α (TNF-α) in mouse intestine (Spagnuolo et al., 2007). Dietary bLf also 
has a small but significant effect on apoptotic protein expression (e.g., decreased Bcl-2) 
and a larger effect on pro-inflammatory markers (e.g., reduced TNF-α and NFκB) in 
mouse IL following DSS (Spagnuolo and Hoffman-Goetz, 2008a) and AE (Spagnuolo 
and Hoffman-Goetz, 2008b) challenge.  There is also evidence of a potential anti-
carcinogenic role of bLf, as Sekine et al. (1997a) reported fewer numbers of AC in rat 
colon following AOM injection and 4 weeks of bLf supplementation. The role of bLf in 
influencing inflammatory and carcinogenic events when both are applied independently 
(i.e., DSS alone; AOM alone) is clear from the literature. However the effects of bLf on 
AC formation when promotional events (DSS or AE) are used in conjunction with 
tumour initiation (AOM) have not been evaluated experimentally.  
The purpose of this study was to examine the effect of bLf on the formation of 
AC and IL apoptotic protein levels in mice following both tumour initiation (AOM 
injection) and promotion (DSS and AE) events. We hypothesized that DSS and AE 
would increase the number of AC and alter IL apoptotic proteins to favour cell death 
(increase caspase 3 and decrease Bcl-2); we further hypothesized that dietary bLf 
administration in mice would reduce AC numbers and influence (reduce or increased) IL 
death and apoptotic protein levels.   
 
7.6. Materials and Methods 
 
Animals: Female C57BL/6 mice (n=53) 3-4 weeks old (Harlan Sprague Dawley, 
Indianapolis, IN, USA) were individually housed at 21±1 ºC and on a 12-12h reversed 





access to tap water and maintenance diet (Laboratory Rodent Chow, PMI feeds 
Richmond, IN, USA).  Following acclimation, mice had free access to specialized diets 
for 12 d prior to sacrifice.   
 
Diets: Semi-purified AIN 76A standard diets were prepared 2 weeks prior to the start of 
the experiment and were formulated to contain 20% total protein including either 0% or 
2.0% bLf (Erie Foods International Inc, Erie IL). Concentrations were based on previous 
studies showing that 2.0% bLf was sufficient to influence apoptosis as well as cytokine 
production (Spagnuolo et al., 2007; Spagnuolo and Hoffman-Goetz, 2008a; Spagnuolo 
and Hoffman-Goetz, 2008b).  All protocols with live animals were approved by the 
University Animal Ethics Committee according to theprinciples of the Canadian Council 
on Animal Care. 
 
Azoxymethane Injections: Mice were injected subcutaneously with AOM at 10mg/kg 
body weight, once a week for 2 weeks, followed by a 2 week rest period. Mice were then 
given free access to the specialized prepared diets with or without bLf (12 d); the 
induction period was 4 weeks in duration and this protocol was based on Sekine et al. 
(1997a).    
 
DSS and Acute Exercise Protocol:  Within diet conditions, mice were randomized to 
one of three treatment conditions: three sessions of acute treadmill running (each bout 
separated by a 24 h rest interval) with sacrifice 24 h after completion of the final exercise 





control (CTL) (n=18).  Thus, there were a total of 6 groups: no bLf/CTL (n=9); bLf/CTL 
(n=8); no bLf/AE (n=9); bLf/AE (n=9); no bLf/DSS (n=9); bLf/DSS (n=9).  DSS (MP 
Biomedicals, Solon, OH; mol wt=36-50 kDa) was solubilized in tap water at room 
temperature and mice had a libitum access to DSS containing drinking water for 4 d 
prior to sacrifice.  The treadmill protocol consisted of 10 min warm-up, 90 min 
continuous exercise (30 min at 22 m.min-1, 2°slope; 30 min at 25 m. in-1, 2°slope; 30 
min at 28 m.min-1, 2°slope) and 5 min deceleration. The work intensity is approximately 
68%, 74% and 80% of VO2 peak at 22 m
.min-1, 25 m.min-1 and 28 m.min-1 (Quadrilatero 
and Hoffman-Goetz, 2005). Mice ran during the dark cycle (Omni-Max metabolic 
treadmill, Omni Tech Electronics, Columbus, OH) and were motivated by occasional 
gentle prodding using a soft nylon brush. 
 
Aberrant Crypt Determination:  Mice were sacrificed by sodium pentobarbital (0.06-
0.08 ml) overdose, the colon immediately removed, cleaned from fecal matter and visible 
fat, opened longitudinally, fixed in formalin and stained with 0.2% methylene blue (Bird, 
1987). Samples were masked to the microscopist during AC enumeration (Nikon Eclipse 
50i digital imaging system).  
 
Intestinal Lymphocyte Preparation: IL from mouse small intestine were isolated as 
previously described by Spagnuolo et al. (2007). Briefly, following sacrifice, the small 
intestine was immediately removed, Peyer’s patches and visible fat dissected out, IL 
prepared as single cell suspensions by isolation over a column containing 0.3 g of pre-





M; Cedarlane Laboratories, Hornby, Ont.). IL, contai ing both intraepithelial and lamina 
propria lymphocytes were enumerated manually by light microscopy following staining 
with Turk’s solution.  
 
Western Blot Analysis of Caspase 3 and Bcl-2:  Cytoplasmic protein samples were 
prepared and separated by electrophoresis on a 12% SDS PAGE gel and transferred onto 
a PVDF membrane (Sigma Chemical).  Following transfer, membranes were stained with 
Ponceau S to confirm the quality of transfer and equal protein loading. Membranes 
containing the separated proteins were incubated for 1 h with primary antibody (1:200 in 
10% milk-TBST): Bcl-2 (clone: C-2; mouse anti-human monoclonal IgG1, mol 
wt=28kDa) or caspase 3 (clone: H-227; rabbit anti-human clone IgG, mol wt=35kDa) 
(Santa Cruz Biotechnology, Santa Cruz, CA, USA), followed by  incubation for 1 h with 
secondary antibody: horseradish peroxidase-conjugated nti-mouse (Bcl-2) or anti-rabbit 
(caspase 3) IgG at a concentration of 1:2000 in 10%milk-TBST. Protein was determined 
using ECL Western blotting detection reagents (Amersham Biosciences, 
Buckinghamshire, UK) and the ChemiGenius 2 Bio-imaging System (Cambridge, UK). 
Each gel contained samples from all 6 treatment groups along with a biotinylated protein 
ladder to identify the molecular weight of the immunoblotted protein. 
 
Statistical Analysis: Cell counts and IL protein levels of caspase 3 andBcl-2 were 
analyzed by pre-planned comparisons because earlier studies showed that these variables 
were altered by AE or DSS. The remaining outcome measures (inflammatory indicators, 





(ANOVA) with diet (two levels: no bLf, bLf) and treatment condition (three levels: CTL, 
AE, DSS) as the independent factors using SPSS (Version 15; Chicago, IL, USA).  Post 
hoc analysis was performed using Turkey’s HSD test and p<0.05 was accepted as being 






Inflammatory Indicators, Food Intake and IL Counts:    Animal weights at the start of 
the experiment (no bLf/CTL 21.0 ± 0.02g; bLf/CTL 20.9 ± 0.5g; no bLf/AE 21.6 ± 0.4g; 
bLf/AE 20.9 ± 0.4g; no bLf/DSS 20.5 ± 0.3g; bLf/DSS 20.8 ± 0.6g) did not differ 
significantly across groups. In contrast, there was a significant treatment effect prior to 
sacrifice (F2,45 = 17.04, p<0.0001) due to the reduced body weights of mice given DSS 
compared to CTL and AE mice (Table 7.1). There was no effect of diet nor was there an 
interaction between diet and treatment on mouse weight at sacrifice. Intestinal length was 
reduced (F2,45 = 8.75, p<0.001) and spleen weight was increased (F2,42 = 10.36, p<0.0001) 
in mice given DSS relative to CTL and AE mice (Table 7.1). Dietary bLf had no effect 
on the length of the intestinal compartment (small and large intestine) or spleen weights 
of mice.  Neither diet nor interaction effects were observed on food intake but there was a 
significant main effect of DSS, AE or CTL treatment (F2,47 = 5.71, p<0.01). This was due 
to the reduced food intake in the DSS compared to the AE mice and not between the DSS 
vs. CTL or the AE vs. CTL mice (CTL 43.0 ± 2.8 g; AE 50.9 ± 1.96 g; DSS 39.4 ± 2.5 g, 
Tukey’s test, p<0.01). IL counts were also significantly affected by treatment (Figure 





numbers compared to CTL animals. There was no significa t effect of diet (bLf: 4.0 ± 
0.43 x107 cells vs. no bLf: 3.8 ± 0.43 x 107 cells) nor was there any interaction effect. 
 
Apoptotic Protein Levels in IL:   Figure 7.3 Panel A shows the effect of treatment 
condition on Bcl-2 levels in mouse IL. There was a ignificant decrease in Bcl-2 protein 
levels (t15 = 2.43, p<0.05) in the DSS group relative to the CTL; no significant difference 
was observed between the CTL and AE groups. The effect of treatment condition on the 
levels of caspase 3 in mouse IL is shown in Figure 7.3 Panel B.   There were significant 
increases in IL levels of caspase 3 in the DSS (t15 = 2.40, p<0.05) and AE (t14 = -2.01, 
p<0.05) groups relative to CTL.  There were no significant effects of bLf on Bcl-2 (bLf: 
2.1 ± 0.34 [AU] vs. no bLf: 2.2 ± 0.35 [AU]) or caspase 3 (bLf: 0.84 ± 0.05 [AU] vs. no 
bLf: 0.85 ± 0.028 [AU]) levels in IL; there were no significant interaction effects between 





Table 7.1: Acute exercise (AE) and dextran sulfate sodium (DSS) effect on indictors of 




Animal End Body 
Weight (g) 
Small and Large 





Control 22.1 ± 0.4 45.0 ± 0.6 0.08 ± 0.005 No 
AE 22.7 ± 0.3 44.6 ± 0.5 0.08 ± 0.002 No 
DSS 19.1 ± 0.6** 41.6 ± 0.8* 0.11 ± 0.010# Yes 
AE = Acute exercise, DSS = dextran sulfate sodium. Tukey’s post hoc analysis: ** 
























Figure 7.2: Mouse IL count as a function of treatment (CTL, AE, DSS ) condition. All 
values are expressed as means ± SEM. *p <0.05, #p<0.01 vs. control. See text for details 























Figure 7.3: Concentrations of apoptotic proteins in mouse IL expr ssed as arbitrary 
densitometric units (AU). [A] anti-apoptotic Bcl-2 and [B] pro-apoptotic caspase 3. All 






















Figure 7.4: Number of aberrant crypts (AC) per mouse colon as a function of treatment 
(DSS, AE or CTL) condition. All values are expressed as means ± SEM.  *p<0.005 vs. 
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Aberrant Crypts:   Figure 7.3 shows the number of AC in the CTL, AE and DSS 
treatment conditions. There was a significant main effect of treatment (F2,31 = 9.21, 
p<0.001) with mice given DSS having a greater  number of AC (p<0.005) relative to AE 
and CTL mice.  There was no effect of bLf on AC numbers (F1,31 = 0.37, p=0.55) (bLf: 
43.9 ± 5.8 vs. no bLf: 42.7 ± 5.6) nor was there any i teraction between diet and 





The objectives of this study were to examine the eff cts of dietary bLf in mice 
following AOM injection in conjunction with either DSS or AE treatment on: 1) AC 
formation and 2) apoptotic protein levels in IL. Since we had previously demonstrated 
that bLf influences apoptotic and cytokine parameters in the IL of healthy mice and in 
mice exposed to agents (DSS) or protocols (AE) which may promote intestinal 
inflammation, we were interested in whether the anti-inflammatory properties translated 
into direct mucosal protection in a model of colon carcinogenesis (AOM + DSS or AOM 
+ AE). The results of this study indicate that DSS, but not AE, increased the number of 
AC in mouse colon and that, contrary to our hypothesis, bLf did not prevent this increase 
nor did it reduce total AC numbers as a function of treatment. Dietary bLf did not affect 
IL loss or levels of pro-apoptotic protein, caspase 3, which accompanied DSS and AE 
challenge in mice. 
Mice given DSS in drinking water and injected with AOM had increased numbers 
of AC, a finding consistent with other investigations (Tanaka et al., 2003; Onose et al., 





inflammation. Similar to the findings of others (Cooper et al., 1993; Melgar et al., 2005), 
we observed that DSS increased spleen weight and intesti al bleeding, decreased body 
weight at sacrifice, and reduced intestinal length of mice. Dietary bLf did not mitigate 
these disease indicators nor did bLf attenuate the DSS-induced increases in AC 
formation. Our results indicate that dietary bLf does not protect the intestinal mucosa 
from AC formation following tumour initiation (AOM injection) and promotion (DSS 
treatment) events. This finding was not entirely unexpected: at similar doses (2.0% for 12 
d) and during only DSS treatment, dietary bLf reduced the expression in mouse IL of 
TNF-α and NFκB but did not protect the intestine from DSS-induced damage (Spagnuolo 
and Hoffman-Goetz, 2008b). Therefore, the inability of bLf to reduce AC formation may 
reflect the intensity of inflammation following DSS exposure. In contrast, Togawa et al. 
(2002a) reported that bLf administration reduced levels of pro-inflammatory cytokines 
(TNF-α, IL-1β) and provided intestinal mucosal protection following DSS treatment.  
Although the reasons for the difference between our results and those of Togawa et al. 
(2002a) are not known, factors such as dose of bLf (~800-1000mg vs. 1400mg), mode of 
administration (dietary exposure vs. gastric intubaion), rodent model (female C57BL/6 
mice vs. male Sprague-Dawley rats) and concentration and duration of exposure to DSS 
in the drinking water (5% DSS for 4d vs. 2.5% for 7d) may be involved. More 
importantly, the current study included tumour initiat on events (AOM injection) as well 
as inflammation (DSS treatment) whereas Togawa et al. (2002a) used a protocol which 
did not involve tumour initiation.  Indeed, the increased physiological stress provided by 
both tumour initiation and promotion may account for the inability of bLf to protect the 





(Buccigrossi et al., 2007) with higher doses resulting in greater bLf effects. In addition, 
greater concentrations of DSS exposure produced larger inflammatory stress as evident 
by elevated pro-inflammatory cytokine production and increased intestinal damage 
(Egger et al., 2000). Together these findings imply that the greater the magnitude of the 
inflammation producing exposure, the higher the bLfdose that will be required. Future 
studies will be needed to determine if a dose respon e relationship occurs between bLf 
and DSS exposure in mice given a colonic carcinogen such as AOM.  
Administration of dietary bLf did not reduce AC formation following AE 
challenge (no bLf/AE vs. bLf/AE). Similar to DSS treatment, the potential benefits 
provided by bLf may be insufficient to compensate for the multiple alterations associated 
with acute intense exercise (e.g., ischemia/reperfusion injury, increased pro-inflammatory 
cytokines, and increased free radicals). Although bLf administration favours the 
expression of anti-inflammatory cytokines following AE challenge, there was no 
decrease in plasma lipid metabolites or influence on IL loss (Spagnuolo and Hoffman-
Goetz, 2008a). Thus, bLf administration may not be associated with direct mucosal 
protection at least at the concentration and exposure d ration provided in this study. 
Nevertheless, we observed a non-significant 38% decrease in AC numbers in CTL mice 
given bLf compared with no bLf mice (no bLf/CTL: 40.1 ± 10.8 and bLf/CTL: 25.0 ± 
3.2). Our finding is in contrast to Sekine and colleagues (1997a) who found that 2.0% bLf 
reduced AC formation in rats treated with AOM. A key difference between these studies 
is that one involved both tumour initiation and promotion events and the other involved 
only initiation events. The additional stress applied by the promotional event may have 





bLf exposure (28 d vs. 12 d), the animal model used (male F344 rats vs. female C57BL/6 
mice) and the dose of carcinogen (15 vs. 10 mg AOM/kg body weight).  
An important and novel finding was that mice given r peated AE stress did not 
have increased numbers of AC. Intense exercise stress is associated with several 
physiological events which could potentially increas  AC formation such as increased 
muscle damage (Aoi et al., 2004), increased pro-inflammatory cytokines (Pedersen et al., 
1998), ischemia-reperfusion injury (Moses, 2005), and greater oxidative stress 
(Quadrilatero and Hoffman-Goetz, 2005).  That there were no increases in AC numbers 
in mouse colon suggests that AE, at least in the int nsity, duration and frequency 
administered in this study, does not lead to alterations in the bowel which promote AC 
formation.  The exercise protocol used in this study di  result in IL loss and increased IL 
levels of pro-apoptotic caspase 3, and was identical to previous studies showing increased 
plasma levels of corticosterone and lipid metabolites as well as increased HSP 70, SOD1, 
caspase 3 and decreased Bcl-2 in mouse IL (Hoffman-Goetz and Spagnuolo, 2007a; 
Spagnuolo and Hoffman-Goetz, 2008a). However, these physiological alterations were 
not sufficient to increase AC formation and therefo, AE does not act as a promoter of 
colon carcinogenesis.  In support of this notion are the results which indicate that AE 
does not induce intestinal inflammation at a magnitude comparable to that induced by 
DSS. In fact, AE had no significant impact on any idicators of disease activity (e.g., 
mouse body weight at sacrifice, intestinal length) despite the impact on IL numbers and 
apoptotic protein expression. However, that repeated bouts of AE did not promote AC 
formation does not exclude AE as potentially contributing to AC or tumour formation. 





exhaustive swim exercise was provided prior to AOM injection. Hoffman-Goetz et al. 
(1994) found that timing of exercise training (befor  vs. after injection with the MMT 66 
line) affected the number of lung tumour metastases in Balb/c mice. Thus, the timing of 
exercise challenge may be crucial to the onset of AC and/or tumour formation. In further 
support of this hypothesis are the following observations: 1) cholic acid administered 
during the initiation phase, but not post initiation, increased ACF formation and tumour 
incidence (Baijal et al., 1998) and 2) DSS treatment that proceeded AOM injection 
resulted in 100% tumour incidence compared to 0% when DSS preceded AOM injection 
(Tanaka et al., 2003). It is possible that AE challenge given prior to AOM injection may 
result in greater AC formation compared with AE given post AOM injection. Together 
these findings suggest that the timing of AE may be crucial in influencing the formation 
of AC although this remains to be tested empirically.   
Following DSS or AE challenge and AOM injection in mice, there was evidence 
of IL death as levels of caspase 3 increased and overall IL numbers decreased. Levels in 
IL of the anti-apoptotic protein Bcl-2 were also reduced following DSS treatment. There 
was no observed effect on IL numbers or apoptotic proteins with bLf treatment in mice 
given AOM followed by DSS or AE treatment. Although dietary bLf was not associated 
with changes in these cell death measures, given th large physiological effects of DSS 
and AE, this lack of effect was not unexpected.  In a on-AOM model, bLf did not 
influence IL death, or caspase 3 protein levels following DSS (Spagnuolo and Hoffman-
Goetz, 2008b) and AE (Spagnuolo and Hoffman-Goetz, 2008a) exposures. However, 
there are also reports that bLf or its metabolites promotes both apoptosis (Mader et al., 





shows that at a 2.0% dose for a duration of 12 d, dietary bLf did not affect IL death in 




In summary, although bLf has been previously shown to favour small anti-
inflammatory responses following exposure to either DSS or AE, it was not able to 
attenuate DSS-induced increases in AC formation in mice.  DSS but not AE challenge 
given after injection with AOM was associated with ncreased AC numbers in mouse 
colon. Dietary bLf did not affect IL death in mice subjected to either DSS or AE 
protocols following AOM injection nor did it alter protein levels of pro-apoptotic 
(caspase 3) and anti-apoptotic (Bcl-2) proteins. These findings indicate that the dose and 
duration of bLf provided in this study were not sufficient to protect against aberrant crypt 
formation in mouse colon.  Further studies will be needed to determine if higher intakes 
or longer durations of bLf exposure affects AC formation in mouse colon following 





Chapter 8: Discussion 
 
8.1. Overall Findings 
 
 
The purpose of the series of experiments described in this thesis was to determine 
the effects of dietary bovine lactoferrin (bLf) on cytokine levels and apoptosis in mouse 
intestinal lymphocytes (IL) in: 1)  a normal,  non-inflamed state, 2) following repeated 
bouts of acute exercise (AE), and 3) following dextran sulfate sodium (DSS) induced 
intestinal inflammation. An additional objective was to characterize the ability of bLf to 
protect the intestinal mucosa following DSS and AE challenge and on aberrant crypt 
formation when these two protocols were administered following carcinogen (AOM) 
injection. Overall, the results indicate that administration of dietary bLf in mice favours 
an anti-inflammatory cytokine environment mainly through reduced IL levels of TNF-α 
and NFκB. In addition, bLf decreased the levels of the anti- poptotic protein Bcl-2, 
increased cytochrome c levels, and increased surface expression of phosphatidylserine in 
mouse IL suggesting a role for this dietary protein in the induction of apoptosis. 
Importantly, bLf did not protect the murine intestinal mucosa against DSS-induced 
structural alterations or the formation of aberrant crypts.  
 
8.2. Induction of Intestinal Inflammation 
 
The induction of intestinal inflammation was achieved by the addition of DSS to 
the drinking water of mice for 4 consecutive days. Evidence for the effectiveness of DSS 





shortened intestinal length, increased spleen weight, intestinal bleeding and reduced body 
weights at time of sacrifice. Moreover, distinct characteristics of inflammation, such as 
the appearance of gross morphological alterations and the infiltration of leukocytes 
within the intestinal compartment were observed following DSS treatment. 
Administration of DSS to elicit intestinal inflammation is a widely utilized protocol 
(Strober et al., 2002) and was effective in the resarch described herein. Acute strenuous 
exercise has also been suggested as an inducer of intestinal inflammation (Marshall, 
1998; Shek and Shephard, 1998) but the exact exercise regimen (i.e., speed, duration and 
frequency of administration) has not been experimentally determined. A protocol 
involving three repeated bouts of acute exercise was used, as others (e.g., Hoffman-Goetz 
and Spagnuolo, 2007a; Hoffman-Goetz et al., 2008; Heer et al., 1987; Concordet and 
Ferry, 1993; Nieman et al., 2005; Nieman et al., 2007a) have shown that repeated intense 
aerobic exercise in rodents or in humans is associated with increases in circulating 
leukocytes and inflammatory cytokines as well as apoptosis, cellular necrosis, and tissue 
pathologies ranging from thymus to intestine.  However, the acute exercise regimen used 
in this research did not induce intestinal inflammation in mice. This conclusion is based 
on the findings that exercise did not result in tissue damage, immune cell infiltration, 
increases in aberrant crypts or cause any changes i the aforementioned disease indicators 
(i.e., shortened intestinal length, intestinal bleeding and reduced body weight at sacrifice).  
Intestinal homeostasis is maintained by various regulatory mechanisms such as 
antioxidant defenses and anti-inflammatory cytokines (Papadakis and Targan, 2000).  
Exposure to stimuli that overcome either regulatory mechanism is one way by which 





that tissue damage caused by inflammation occurs concurrently with increases in either 
anti-inflammatory cytokines or antioxidants. For example, elevated concentrations of IL-
10 mRNA coincided with increased disease activity and numbers of immune cells in the 
colon of mice treated with DSS (Egger et al., 2000). In athletes following a cycle race, 
lymphocyte concentrations of the antioxidant SOD were elevated along with increases in 
markers for oxidative stress and tissue damage (e.g., urate and malonaldehyde in plasma 
and carbonyl content in lymphocytes) (Tauler et al., 2006). The increases in cellular 
defenses are suggestive of a host adaptive mechanism whereby cellular responses to 
protect or limit against damage are initiated. When these adaptive responses are 
overwhelmed by external stimuli the result may be tissue damage. Conversely, an 
increase in either anti-inflammatory cytokines or antioxidants could limit the onset of 
inflammation (Niess et al., 1999). Findings from this thesis research indicate that the 
exercise regimen resulted in increased oxidative stres , as measured by increased plasma 
concentrations of 8-iso prostaglandin F2α, increased levels of IL-10 in mouse IL, and 
elevated IL levels of HSP 70, but exercise did not cause observable intestinal tissue 
damage or infiltration of immune cells. It is thus possible that the increases in IL-10 and 
HSP 70 that accompanied exercise were able to prevent any tissue damage that may have 
resulted from the increased oxidative stress.  
The proposed hypothesis by which exercise induces inflammation includes 
intestinal tissue damage followed by bacterial translocation (Marshal, 1998; Shek and 
Shephard, 1998). Indeed, the presence of bacteria is suggested to be the stimulus 
necessary for the induction of inflammation (Strober et al., 2002). This is supported by 





not develop intestinal inflammation (Elson et al., 2005), 2) antibiotic administration 
alleviates inflammation (Sartor, 2004) and 3) Crohn’s disease in humans occurs in the 
colon and terminal ileum which has the highest bacterial content (Kelsall, 2008). Thus, 
the inflammation inducing protocol must be able to alter mucosal permeability in order to 
expose the commensal flora to the underlying immune network (Kelsall, 2008).  The 
most direct method to increase intestinal permeability is to induce death of the intestinal 
epithelial cells (IEC) (Farhadi et al., 2003). DSS but not AE resulted in gross changes in 
intestinal histology and the recruitment of immune cells. This indicates that the exercise 
protocol used was not sufficient to cause any observable morphological damage to the 
intestinal barrier. This does not exclude the possibility that alterations in more subtle 
intestinal permeability function (e.g., altered antigen uptake or changes in junction zones) 
occurred following exercise. Future studies would be needed to explore this. However, 
because the exercise regimen did not cause observabl  physiological alterations in mouse 
intestine suggestive of inflammation (i.e., infiltration of immune cells) it is probably 
unlikely that damage to the epithelial barrier occurred.  That the exercise regimen did not 
induce intestinal inflammation may be related to the inability of any exercise-associated 
stress to counter endogenous intestinal protective mechanisms. Future studies would be 
needed whereby the exercise regimen would be titrated to determine the duration, 
intensity and frequency of the work that are associated with IEC death and intestinal 
inflammation. 
In further support of the conclusion that the exercise protocol used here did not 
result in intestinal inflammation is the observation that IL underwent cell death via 





apoptotic protein levels of caspase 3, decreases in ant -apoptotic protein levels of Bcl-2 in 
mouse IL, and reduced IL numbers, which together suggest apoptotic cell death. Indeed, 
apoptosis of lymphocytes following exhaustive or stenuous exercise is a common 
observation (Hoffman-Goetz and Quadrilatero, 2003; Mooren et al., 2002; Wang and 
Huang, 2005). The significance of the apoptotic process in lymphocyte removal is that it 
provides a controlled mechanism of cell death in which inflammation does not proceed 
(Verstege et al., 2006). If IL death following exercise were to occur via a necrotic 
pathway, as it was demonstrated to occur following DSS treatment [i.e., increased percent 
of Annexin V-/PI+ (necrotic)] then pathological inflammation would most likely ensue.  
Indeed, inflammation following necrotic death has been reported (Renes et al., 2002; 
Schulze-Bergkamen et al., 2006; Gibson, 2004). Thus, it was not surprising that the 
exercise regimen used in this study did not induce inflammation in the intestine as 
necrotic IL death with repeated treadmill exercise was not detected. This result is 
consistent with Mooren et al. (2002) who did not observed necrotic death in peripheral 
blood lymphocytes of volunteers subjected to exhaustive exercise. Since inflammation 
occurs following necrotic and not apoptotic death, DSS, and not AE induced intestinal 
inflammation would be expected.   
Given the role of lymphocytes in intestinal mucosal defenses, such as tumour 
surveillance and protection against infection (Kunisawa et al., 2007) the loss of IL may 
have detrimental consequences for the individual. An alternative view is that IL loss (via 
apoptosis) following exercise is an adaptive mechanism by which the intestine protects 
against the development of inflammation. If, for example, exercise caused tissue damage 





subsequently the activation of the intestinal lymphocytes. Evidence for the involvement 
of lymphocytes in intestinal inflammation, is their presence in increased numbers in the 
inflamed mucosa of patients with IBD (Muller et al., 1998). Moreover, the mechanism of 
therapeutic action of sulfasalazine in IBD patients was by increasing apoptosis of 
intestinal lymphocytes (Doering et al., 2004; Mudter and Neurath, 2007). Therefore, it 
may be that by effectively removing lymphocytes through apoptotic processes prior to 
intestinal damage, any ensuing inflammatory response may be less damaging as fewer 
immune cells would be present to react to bacterial antigen.  
 
8.3. Dietary bLf and Inflammatory Cytokines  
 
 
The balance between pro- (TH1) and anti- (TH2) inflammatory cytokines is central 
to immunological homeostasis. During intestinal inflammation there is an increased 
production of pro-inflammatory cytokines that favours the activation and recruitment of 
immune cells.  bLf has been shown to alter the cytokine milieu, including a decrease in 
TNF-α and an increase in IL-10, during inflammatory responses within the intestinal 
epithelium (Togawa et al., 2002a; 2002b). Similarly, decreased TNF-α and increased IL-
10 were reported in the plasma of rats following bLf administration (Hayashida et al., 
2004). Theoretically, the source of the cytokines could be from epithelial or immune cells 
located in muscle, the splanchnic bed, or lymphoid compartments (e.g., thymus, spleen, 
or intestine) (Bagby et al., 1996). However, whether t  cytokine changes caused by bLf 
were as a result of effects directly on IL were notpreviously described in literature. 
Therefore, one objective of this thesis research was to examine the effects of dietary bLf 





A novel finding of this research was that dietary bLf administration resulted in a 
decrease in TNF-α levels directly within mouse IL which may be relatd to the observed 
decrease in levels of NFκB.  Since NFκB is a transcription factor partly responsible for 
the production of TNF-α, one mechanism to reduce TNF-α levels is by inhibiting the 
ability of NFκB to bind to DNA.  Indeed, evidence from the literatu e suggests the 
inhibition of NFκB leads to reduced TNF-α production and that this may be due to altered 
DNA binding. For example; Haversen et al. (2002) repo ted that Lf binds to the TNF-α 
promoter region in monocytes, thus preventing NFκB-DNA interactions and reducing 
TNF-α production. A similar effect was found with gliotoxin, a potent NFκB inhibitor. 
Intraperitoneal injection of gliotoxin in mice treat d with DSS decreased the expression 
of TNF-α and improved disease activity scores (Herfarth et al., 2000); the action of 
gliotoxin was attributed to its ability to decrease th  DNA binding activity of NFκB (Li 
and Bever, 2001). Therefore, the bLf induced reductions in TNF-α may be related to 
decreased activity of NFκB potentially through modifying NFκB-DNA interactions.  
Another potential mechanism by which TNF-α may be reduced is by directly 
interfering with NFκB activation. NFκB is bound to the IκB inhibitory protein in the 
cytoplasm and requires an external signal to liberate it from its inhibitor. The binding of 
TNF-α to the TNF-receptor (TNFR) results in the recruitment of TRAF2, a specialized 
adaptor protein, which participates in IKKβ activation. The activation of IKKβ in turn 
phosphorylates the IκB inhibitory protein and releases active NFκB (Baud and Karin, 
2001).  Thus, decreasing the extent of NFκB activation could occur by preventing TNF-α 
binding to the TNFR. Although there is evidence that bLf binds to a number of cell 





binds to the TNFR. Alternatively, increasing the con entration or preventing the 
degradation of the inhibitory protein could also decrease active NFκB levels. Although 
no studies have directly demonstrated the ability of bLf to impart such properties, 
Minekawa et al. (2004) found that human breast milk increased IκB concentrations in 
intestinal epithelial cells. This resulted in decreas d NFκB signaling. Thus increased IκB 
concentrations may be a mechanism by which NFκB levels (and thus TNF-α) are reduced 
by dietary bLf.  
The effects of dietary bLf on IL-10 concentration in mouse intestinal lymphocytes 
were less clear.  Although bLf administration was not associated with increased IL levels 
in healthy mice (i.e., experiment 1), IL-10 levels during DSS induced intestinal 
inflammation were reduced when mice were supplemented with bLf. Egger and 
colleagues (2000) suggested that elevated IL-10 mRNA with DSS treatment is a 
physiological compensation mechanism whereby the cell att mpts to protect itself from 
the external stress. Thus, a reduction of IL-10 (as ob erved in this research with bLf 
administration during DSS treatment) may imply that bLf lessens the cellular requirement 
for a compensatory response. Indeed, similar effects were reported by Haversen et al. 
(2003) in which the numbers of CD4+/IL-10 producing cells were decreased in the colon 
of DSS treated mice given human Lf. It is possible that the requirement of less IL-10 is 
related to the “anti-inflammatory” environment imparted by bLf. This is partially 
supported by the findings of this research that bLf decreased TNF-α levels in mouse IL. 
Lower levels of TNF-α may be indicative of a lessening of the inflammatory response. 
Therefore, less TNF-α may reduce the requirement for the TH2 (anti-inflammatory) 





2000). Although further work is needed to address the mechanism of this response, the 
results presented are, at least suggestive of, possible anti-inflammatory properties of bLf.  
In summary, dietary bLf reduces TNF-α levels in IL and may lessen the 
compensatory (IL-10) host response to inflammation. The pathway by which bLf reduces 
TNF-α appears to be associated with decreased NFκB concentrations; whether the 
decreased levels of NFκB is by altering the ability of NFκB to bind to DNA or interfering 
with signals that activate NFκB remain to be elucidated. The finding that bLf biases 
toward anti-inflammatory responses make it an attractive therapy in the potential 
treatment of inflammatory disorders. 
 
8.4. Dietary bLf, Intestinal Lymphocyte Apoptosis, and Inflammation 
  
An objective of this research was to determine the eff ct of dietary bLf on 
apoptosis of mouse IL. Given the observations that bLf altered apoptotic proteins to 
favour cell death within the intestinal epithelium during carcinogenesis (Fujita et al., 
2004a; 2004b) it was hypothesized that dietary bLf would induce similar results in mouse 
IL during inflammation.  The importance of the apoptotic process in the pathogenesis of 
IBD is highlighted by the observations that patients with IBD exhibit increased numbers 
of activated CD4+ and CD8+ IL within their inflamed colonic tissue (Muller et al., 1998) 
and that IL isolated from inflamed mucosa exhibit apoptotic resistance (Sturm et al., 
2004; Boirivant et al., 1999; Levine and Fiocchi, 2001).   
The defective response of IL to apoptosis may be related, in part, to altered levels 
of apoptotic proteins. In support of this are the following observations in T cells isolated 





concentrations of the pro-apoptotic protein Bax (Itoh et al., 2001).  The manipulation of 
these proteins may lead to increased apoptosis and possible alleviation of (or reduction 
in) the extent of inflammation.  In the present research, bLf fed mice had decreased levels 
of the anti-apoptotic protein Bcl-2 with no change in levels of the pro-apoptotic protein 
Bax. This finding suggests that the Bcl-2/Bax ratio decreases with bLf exposure and, 
further, that this dietary protein potentially leads to increased mitochondrial outer 
membrane permeability (MOMP) and activation of the apoptotic machinery.  In support 
of the observation that bLf may alter MOMP is the finding that dietary bLf increased 
cytoplasmic protein levels of cytochrome c. This protein is located on the mitochondrial 
inner membrane and once in the cytoplasm is vital to the formation of the apoptosome 
which activates caspase 3 (Adams and Cory, 2002). These observations coupled with the 
observed increase in Annexin V expression (which binds to phosphatidylserine) with bLf 
administration indicate that apoptotic death of IL may occur and that this is through 
mitochondrial associated pathways. A similar effect was noted by Mader et al. (2005; 
2007) who demonstrated that Jurkat T cells incubated with bLfcin had reduced levels of 
Bcl-2 and increased concentrations of cytochrome c and caspase 3. Collectively, these 
results imply that bLf modification of the mitochondrial anti-apoptotic protein Bcl-2 may 
be one mechanism by which mouse IL death is promoted. 
Given the numerous proteins capable of regulating mitochondrial outer membrane 
permeability (e.g., Bcl-XL, Bak, Bad…etc) (Youle and Strasser, 2008) a decreased level 
of Bcl-2 does not represent the only mechanism by which mitochondrial membrane 
permeability will be altered. Nevertheless, several investigators have demonstrated the 





expression of Bcl-2, and following cecal ligation ad puncture, the following findings 
were noted: 1) decreased intestinal epithelial cellapoptosis and reduced caspase 3 
concentrations that correlated with enhanced survival (Coopersmith et al., 2002) and 2) 
enhanced lymphocyte survival in the spleen and thymus that increased survival rates of 
the mice (Hotchkiss et al., 1999). Conversely, reduc  Bcl-2 concentrations induced by 
missense RNA resulted in increased apoptosis of gastric cancer cells (Hao et al., 2007).  
Therefore, although anti-apoptotic Bcl-2 is not theonly protein involved in the regulation 
of apoptosis, increased levels of Bcl-2 are associated with less cell death and decreased 
concentrations are associated with greater cell death. Thus, the ability of bLf to decrease 
Bcl-2 may be an important mechanism of regulating IL apoptosis.  
The finding that bLf affected apoptotic proteins to favour apoptotic cell death was 
not, however, associated with reductions in mouse IL numbers. This is contrary to the 
original hypothesis that bLf would induce apoptosis of activated IL and thus offer 
intestinal protection during inflammation. It is tempting to speculate, that the inability of 
bLf to reduce IL numbers during inflammation was asociated with the inability of bLf to 
protect the intestinal mucosa. However, that reduce IL numbers were not observed with 
bLf treatment may be explained by the findings that bLf did not increase IL levels of 
caspase 3, the primary executioner caspase.  Given decreased protein levels of Bcl-2 and 
increased cytochrome c protein levels with bLf supplementation, the inability of bLf to 
reduce IL numbers may reflect the time of tissue sampling; alterations in mitochondrial 
membrane permeability may have not yet resulted in the activation of caspase 3. In fact, 
the kinetics of apoptosis is such that alterations in mitochondrial permeability occur 





apoptosis and the cross-sectional nature of this experiment may explain the lack of both 
increased caspase 3 protein levels and reduced IL numbers.  
 
8.5. Dietary bLf, Mucosal Protection, and Clinical Implications 
   
During or following periods of intestinal inflammation, therapeutic interventions 
should result in alleviation of disease symptoms and the restoration of homeostasis. 
Whether in patients with IBD, or in athletes suffering from gastrointestinal distress, 
successful recovery from tissue damage would include repair of the intestinal epithelium 
and the restoration of the epithelial barrier function.  To evaluate whether the alterations 
in IL apoptosis or inflammatory cytokine levels following bLf treatment resulted in direct 
mucosal protection intestinal histology was examined.  Treatment with DSS was 
associated with severe intestinal inflammation characterized by the occurrence of several 
disease indicators (shortened intestinal length, intestinal bleeding and decreased body 
weight at sacrifice). Mice supplemented with bLf enriched diets showed no alleviation of 
these disease symptoms; moreover, bLf did not prevent DSS-induced mucosal tissue 
damage or the recruitment of immune cells to the mouse intestinal mucosa.  The inability 
of bLf to protect the mucosa may be related to the ov rwhelming stress induced by DSS.  
Indeed, DSS has been associated with several alterations following treatment which 
include direct cell cytotoxicity (Cooper et al., 1993), alteration in bacterial microflora 
(Okayasu et al., 1990) and upregulation of adhesion m lecules that favour lymphocyte 
recruitment (Ni et al., 1996).  It is also possible that the lack of effects of bLf in this DSS 
model is related to the mode of DSS induced IL death.  Although apoptotic death of IL 





necrotic. If bLf affects IL death through the mitoch ndrial pathway of apoptosis, as 
suggested by the findings of this research and by those of Mader et al. (2005; 2007), than 
the modifying effects of bLf on apoptosis would have little impact on DSS induced 
necrotic death.  
Numerous studies have shown that inflammation promotes and accelerates the 
formation of aberrant crypts (AC) and colonic tumours (Tanaka et al., 2001; Onose et al., 
2003). Mice were subjected to tumour initiation events (i.e., AOM injection) and then 
exposed to DSS in an attempt to mimic inflammation as a promoter of tumourigenesis. 
The findings of this research demonstrate that bLf did not prevent or reduce the formation 
of AC nor did it attenuate the DSS-induced increase in AC numbers. The lack of bLf 
effect was most likely related to the inability of this dietary protein to significantly 
influence DSS-induced alterations and thus not attenuate the detrimental physiological 
consequences of inflammation (i.e., tissue damage).  
Dietary bLf, which has been shown to reduce TNF-α, NFκB and Bcl-2 and 
increase cytochrome c, may thus have limited ability to significantly influence the 
intestinal immune system during periods of severe inflammatory stress. The clinical 
importance of these findings are that dietary bLf, at least in the concentration and 
duration provided in this thesis research, may not be useful in the treatment of IBD or 
colon carcinogenesis. Dietary bLf may also not be sufficient as a supplement to prevent 
the gastrointestinal distress associated with strenuous exercise. The administration of 5% 
DSS for 4 days in drinking water resulted in severe int stinal damage and may represent 
an extreme sequelae of inflammation. The inability of dietary bLf to impart mucosal 





exercise induced gastrointestinal distress or in the relapsing and remitting bouts of 
intestinal inflammation associated with IBD. Therefor , given the results of this study it 
would not be recommended that bLf be used as a supplement for athletes experiencing 
bowel distress or in those suffering from IBD. However, clearly these suggestions would 
need to be tested empirically both in a clinical population and experimentally.  
Athletes are known to supplement their diets to improve performance and 
potentially prevent against the onset of the gastrointestinal distress that accompanies 
exercise. Froiland et al. (2004) reported 89% of Division 1 athletes used supplements of 
which 12.6% used whey protein. Whey proteins have been found to increase lean muscle 
mass and strength compared to placebo controls in humans (Candow et al., 2006) and 
elevated lymphocyte glutathione concentrations and increased peak power during a 30s 
isokinetic cycling sprint (Lands et al., 1999).  Although the benefits of whey protein 
ingestion are noted there is a paucity of data on the direct effects of bovine lactoferrin on 
the bowel distress associated with exercise.  There is evidence, however; that exogenous 
administration of bovine colostrum (BC), which is the first milk produced after 
parturition, can impart beneficial immune modulatory effects in athletes. Crooks et al. 
(2005) showed increased IgA concentrations in the saliva of distance runners following 
supplementation with BC. In trained cyclists completing a high intensity exercise 
regimen, the exercise associated reductions in serum levels of IgG2 were attenuated with 
BC treatment; decreased incidence of upper respiratory tract illness were also reported 
(Shing et al., 2007).  Supplementation with other dietary components has also been 
shown to influence immune function in athletes.  Administration of quercetin, a dietary 





post exercise plasma levels of IL-8 (pro-inflammatory) and IL-10 (anti-inflammatory) in 
trained cyclists following 3 consecutive days of exhaustive exercise (57% of maximal 
work rate) (Nieman et al., 2007a); decreased incidece of upper respiratory tract 
infections with quercetin supplementation have also been observed (Nieman et al., 
2007b). Collectively, these studies demonstrate a potential for nutritional 
supplementation in improving the health of athletes through the modulation of immune 
function.  Whether the immune effects of dietary bLf observed in this research are 
associated with improved health in athletes, however, r quires further clinical 
examination.  
An overall effect of bLf in providing intestinal mucosal protection during DSS 
treatment, or the carcinogenesis process was not observed, nonetheless bLf had modest 
activity on cytokines and apoptotic proteins and DSS as originally hypothesized. As 
presented in Figure 2.3, the original hypothesis was that addition of bLf during an 
inflammatory state would shift the cytokine milieu from a TH1 to a TH2 environment and 
would induce apoptosis of activated IL. Although, levels of IL-10 were not affected, the 
observed decrease in TNF-α does support a role for dietary bLf in promoting an anti-
inflammatory cytokine environment. In addition, dietary bLf was shown to significantly 
decrease levels of the anti-apoptotic protein Bcl-2 and increase cytochrome c levels in 
mouse IL. These changes in apoptotic protein levels suggest an increased potential for 
bLf to cause IL apoptosis. Thus, Figure 2.3 has been modified to reflect the findings of 
this research and is presented below as Figure 8.1. The important changes are highlighted 
in the figure and figure legend. The legend has been adjusted as follows: apoptotic IEL 





been changed to LPL with increased likelihood for apoptosis. In addition, since dietary 
bLf reduced TNF-α and had no effect on IL-10 the legend label TH2 cytokines has been 
replaced with reduced TH1 cytokines.  
 









TH1 Cytokines Reduced TH1 Cytokines
LPL Activated lamina propria 
lymphocyte





* Activated dendritic cell
bLf Bovine lactoferrin
Intraepithelial lymphocyte with increased
likelihood for apoptosis






















































There are limitations to the research described in this thesis. These include, the 
nature of the data obtained from Western blotting techniques, the quantification of few 
apoptotic proteins and cytokines, the small number of time points analyzed, the use of 
mice, the small variations in dose and duration of bLf treatments tested, the small sample 
size and the limited number of inflammatory markers quantified.  
Firstly, the technique of Western blotting allows for protein levels to be 
determined relative to experimental controls. Thus, it is not a definitive method of 
quantifying actual cellular protein concentrations.  Furthermore, Western blotting does 
not quantify levels of messenger RNA (mRNA); as such, this technique does not provide 





directly in cellular functions and thus proteins are more relevant in the assessment of 
biological activity.  
Second, apoptosis is controlled and regulated by several proteins. The 
experiments of this thesis quantified only certain indicators of apoptosis (caspase 3, Bcl-
2, Bax, cytochrome c, externalization of phosphatidylserine via Annexin V+) in mouse 
IL.  Inclusion of other apoptotic proteins could have provided additional information. For 
example, measuring caspase 8, caspase 9 or caspase 12 may have provided insight as to 
whether apoptosis was carried out by the extrinsic, intrinsic or the endoplasmic reticulum 
pathway, respectively (Hoffman-Goetz et al. 2005).  As such, better inferences would be 
made about the mode of apoptotic death. However, given the central role of caspase 3 in 
the execution of many apoptotic pathways (i.e., intrinsic and extrinsic pathways), the 
importance of Bcl-2 and cytochrome c in mitochondrial associated apoptosis (van Loo et 
al., 2002) and the importance of phosphatidylserine externalization in the signaling of 
apoptotic death (Vermes et al., 1995), the markers used in this research are valuable in 
the overall assessment of apoptosis.  
Third, there are many cytokines involved in intestinal inflammation, such as IL-7 
and IL-4, which are TH2 cytokines and IFN-γ, IL-1β and IL-8, which are TH1 cytokines 
(Papadakis and Targan, 2000). Furthermore, the redundant nature of the cytokine network 
implies that more than one cytokine can perform a particular function (Goldsby et al., 
2003). For example, IL-1β is similar to TNF-α in that it imparts comparable cellular 
functions such as activation of macrophages, up-regulation of adhesion molecules and 
increasing vascular permeability and is also important in IBD pathogenesis (Neuman, 





into the potential immunomodulatory nature of dietary bLf.  However; IL-10 and TNF-α 
are important cytokines that are central to events that occur in intestinal inflammation 
(MacDermott, 1996; Williams, 2001). The importance of IL-10 was highlighted by 
Lindsay et al. (2004) who demonstrated that DSS induce  intestinal damage was reduced 
upon IL-10 addition. The importance of TNF-α has been demonstrated by several 
investigators (Baert et al., 1999; van Dullemen et al. 1995) who reported reduced 
inflammation upon the addition of anti-TNF-α antibodies. Therefore, the information 
gained by examining the effects of bLf on IL-10 and TNF-α, not only provides insight 
into important immunomodulatory mechanisms but, also builds a solid framework for 
future investigations.  
Another potential limitation of this research was that only a limited number of 
time points were analyzed during each experiment. For example, IL were isolated and 
analyzed prior to and post DSS administration and three time points were analyzed in the 
exercise study (prior to, immediately following, and 24 h post the acute exercise 
protocol).  Apoptosis is a kinetic process that proceeds over several minutes or several 
hours (Huppertz et al., 1999).  The results presented here provide only cross-sectional 
data of what may potentially be occurring. To overcome this limitation and obtain an 
overall picture of any apoptotic pathway would involve sampling at many time points 
(i.e., 2h, 4h, 8h…etc post exercise or DSS). However, th  data presented in this research 
provide a starting point for later experiments on the kinetics of apoptosis and bLf.  
 Given that this was a diet study, dose and duration of exposure play a large role in 
determining the physiological response.  Any modifications of these dietary parameters 





lower doses) of bLf or increasing the exposure time could have resulted in more drastic 
(or more subtle) alterations in apoptotic and/or inflammatory cytokine levels.  
Nevertheless, the results build upon previous work which demonstrated that 2.0% bLf 
protected against AOM induced aberrant crypt formation (Sekine et al., 1997a; 1997b) 
and also provide a solid framework for future studies involving dietary bLf and intestinal 
inflammation. 
 Another potential limitation of this research was the small number of 
inflammatory measures. A common method of measuring i flammation is the 
quantification of myeloperoxidase (MPO), an enzyme located within neutrophils. Since 
neutrophils are the first cell to the site of injury they are frequently measured as 
indicators of inflammation (Lu et al., 2006). Limited amount of intestinal tissue 
prevented the use of MPO analysis in determining inflammation. Another common 
method of measuring inflammation is quantifying plasma levels of C-reactive protein. 
However, since this would not have measured inflammtion directly within the intestine 
this method was not performed. Therefore, the use of an H&E stain (a common 
histological stain) allowed for measures of inflammation directly within the intestine 
using small amounts of tissue and was also able to analyze, to some degree, the extent of 
neutrophil infiltration. Although, this was the sole measure of inflammation it provides 
important and relevant information. 
Given the low sample size (i.e., between 9-16 mice per group in these 
experiments) there is a potential limitation regarding statistical power. Power is defined 
as the probability that the statistical test will reject a false null hypothesis (Blair and 





level of significance (Blair and Taylor, 2008). Given the constant level of significance 
established at the onset of the experiments (α=0.05) the main factor influencing statistical 
power in these experiments is sample size. Thus in the statistical analysis performed in 
this thesis it is possible that the values which approached significance (e.g., bLf effects 
onTNF-α in experiment 3: p=0.10 or bLf effects on cell count in experiment 2: p=0.06) 
could have been considered significant if the sample size, and thus power, were 
increased. However, the sample size was calculated based on several factors including: 
power (at 80%), level of significance (α=0.05) and estimated mean difference (based on 
previous experimental data).  In addition, time andbu getary constraints limit the ability 
of increasing sample size to values much greater than 16 mice per group. Therefore, the 
statistical analysis performed on the experimental data provides both relevant and reliable 
interpretations. 
 Finally, the use of mice as an experimental model has its own limitations since it 
is not a given that similar treatment effects would occur in humans or other animal 
species. A major advantage of using a single inbred mouse strain (C57BL/6) is the small 
genetic variability between animals (Festing, 1999). However, the results obtained in this 
thesis research are limited in generalizability to even other inbred mouse strains. Melgar 
et al. (2005) noted that when subjected to similar concentrations and durations of DSS 
exposure C57BL/6 mice had more severe intestinal damage and increased disease activity 
scores compared to Balb/c mice. Although the reason for this difference is not known, it 
was suggested that the C57 strain was more susceptible to DSS-induced cellular damage 





would occur similarly in other mouse strains is notknown; generalizations to humans are 
even more problematic. 
 
8.7. Future Research 
 
 Apart from the quantification of additional apoptotic and cytokine proteins future 
studies could involve modifications of both the exercise regimen and the DSS protocol. 
The altered exercise regimen might involve higher wo k intensities and longer durations 
in an attempt to induce observable intestinal structural alterations. This may allow for 
greater inferences to be made into the potential use of bLf as a supplement for athletes 
who experience gastrointestinal distress following strenuous exercise. Conversely, 
alterations in the DSS protocol would include decreasing the concentration of DSS (For 
example, from 5% to 3%) or reducing the exposure time (For example, from 4 to 3 days) 
in an attempt to lessen the degree of inflammatory damage.  Additional studies would 
include increasing the dose and duration of dietary bLf administration to determine if 
varying exposures would influence apoptotic and inflammatory cytokine levels 
sufficiently to provide intestinal protection.  Finally, future research could focus on 
determining the mechanism by which bLf reduces TNF-α and NFκB. This may be 
achieved by examining if bLf affects: 1) the DNA bind ng activity of NFκB, 2) the 






8.8. Conclusions  
 
 
 In conclusion, the results presented in this thesis research show that 2.0% bovine 
lactoferrin provided in the diet to mice reduces the levels of TNF-α and NFκB in mouse 
IL following DSS and AE challenge. The repeated bouts of acute exercise protocol 
resulted in oxidative stress, increased cellular adptive responses (HSP 70), and increased 
host compensatory mechanisms (IL-10), but did not iduce intestinal inflammation; DSS 
treatment in contrast, was effective at causing severe intestinal inflammation. Overall, 
dietary bLf treatment was associated with mouse IL apoptosis evident through increased 
expression of phosphatidylserine on the external leaf et of the IL membrane (as measured 
by Annexin V+-FITC binding), increased levels of cytochrome c and decreased levels of 
the anti-apoptotic protein Bcl-2. Bovine lactoferrin nduced modifications in both 
cytokine and apoptotic protein levels in mouse IL but did not protect the intestinal 
mucosa from DSS induced alterations. Moreover, when AE or DSS were applied as 
potential promoters of colon carcinogenesis (i.e., post AOM injection), dietary bLf did 
not prevent the formation of aberrant crypts nor did it prevent the DSS-induced increase 
in aberrant crypts.  Therefore, dietary bovine lactoferrin results in only limited changes in 
cytokines to favour anti-inflammatory responses, and poptotic proteins to favour pro-
apoptotic events. Moreover, these modifications do not appear to contribute to the direct 
mucosal protection against inflammation or inflammation as a promoter of colon 
carcinogenesis. However, the experimental design may not have been powerful enough to 
detect a dietary effect given the small sample sizetested. Thus further research, with 
greater mice per group, would be required to fully determine whether bLf can protect the 





treatment of inflammatory bowel diseases, or as a supplement to athletes is not 
recommended. Yet the results from these experiments are promising and offer some 
optimism that the anti-inflammatory effects may be considered in the array of clinical and 
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Appendix I - List of Abbreviations 
 
8-iso-PGF2α – 8-iso Prostaglandin F2α 
24 h POST – sacrifice 24 hours following cessation of the final exercise bout 
AC – aberrant crypts 
ACF – aberrant crypt foci 
ACTH - adrenocorticotropic hormone 
AE – acute exercise 
AIF – apoptosis inducing factor 
ANN – annexin  
ANOVA – analysis of variance 
AOM – azoxymethane  
APAF-1 – apoptotic protease activating factor-1 
ATP – adenosine triphosphate 
AU – arbitrary densitometric units 
BC – bovine colostrum 
bLf – bovine lactoferrin 
CAR – carrageenan  
CD – Crohn's Disease 
CDC – chenodeoxycholic acid 
CORT – corticosterone 
CTL – control  
d – days 





DFF – DNA fragmentation factor 
DMH – 1,2-dimethylhydrazine   
DNA – deoxyribonucleic acid 
DSS – dextran sulfate sodium  
endo G – endonuclease G 
EC – epithelial cell 
EIA – enzyme immunoassay  
ER – endoplasmic reticulum 
Fas L – Fas ligand  
FITC – fluorescein isothiocyanate 
GALT – gut associated lymphoid tissue  
GC – glucocorticoids 
GSH – glutathione 
GSSG – oxidized glutathione 
h – hours 
hLf – human lactoferrin 
H & E – hematoxylin and eosin  
HSP – heat shock protein 
Ig – immunoglobulin 
IBD – inflammatory bowel disease 
IEC – intestinal epithelial cells  
IEL – intraepithelial lymphocytes 





IKK β – I kappa β kinase  
IL- – interleukin 
IL – intestinal lymphocytes  
IMM – sacrifice immediately after the final exercise bout 
IR – ischemia reperfusion 
Lf – lactoferrin  
Lfcin – lactoferricin 
LP – lamina propria 
LPL – lamina propria lymphocytes 
LPS – lipopolysaccharide 
mRNA  - messenger RNA 
mbTNF-α – membrane bound protein  
MLN – mesenteric lymph nodes  
MMP – mitochondrial membrane permeability 
MOMP – mitochondrial outer membrane permeability 
MPO – myeloperoxidase 
NFκB – nuclear factor κ B  
NK – natural killer cells 
NSAID – non-steroidal anti-inflammatory drug 
PBL – peripheral blood lymphocytes 
PE – phycoerythrin  
PI – propidium iodide 





PP – Peyer’s patches  
PVDF – polyvinylidene fluoride 
RNA – ribonucleic acid 
ROS – reactive oxygen species 
SDS – sodium dodecyl sulfate 
SED – sedentary mice 
SEM – standard error of the mean 
SMA – superior mesenteric artery  
SOD – superoxide dismutase 
tBid – truncated Bid protein 
TBST – tris-buffered saline tween 
TCR – T-cell receptor  
TF – transcription factor 
TNBS - trinitrobenzenesulfonic acid  
TNF-α – soluble tumor necrosis factor-α  
TNFR – tumor necrosis factor receptor 
TRADD – TNFR associated death domain 
TRAF – TNF receptor associated factor 






Appendix II - Strenuous Exercise Assessment 
 
 Mice were run on a treadmill according to a protocl outlined by Hoffman-Goetz 
and Quadrilatero (2003) which demonstrated increased oxidative stress and elevated 
plasma levels of the stress hormone corticosterone.  This published protocol consisted of 
a 10 min warm-up followed by a single session of 90 min of continuous exercise (30 min 
at 22 m·min-1, 2°slope; 30 min at 25 m· in-1, 2°slope; 30 min at 28 m· in-1, 2°slope) and 
a 5 min deceleration period. Oxygen consumption values (VO2 max) when performed at a 
0° slope were 68%, 74% and 80% at 22 m·min-1; 25 m·min-1; 28 m·min-1, respectively 
(Quadrilatero and Hoffman-Goetz, 2005). The increased slope (2° slope) and the repeated 
administration of this protocol (3 bouts separated by 24 h rest periods) would further add 
to the work intensity required by the mice to complete the exercise regimen. Furthermore, 
toward the completion of the exercise bouts, the mice required encouragement to run and 
this was achieved by gentle prodding with a nylon brush. In no instance was a mouse able 
to complete the entire exercise regimen (i.e., all three bouts) without this encouragement.  
Therefore, it is suggested that the exercise protocol used in this research was at a 








Appendix III - Lactoferrin Absorption 
Methods 
Mice were sacrificed by sodium pentobarbital (0.06-0.08 ml) overdose. Blood 
was collected immediately by cardiac puncture into a 1 ml syringe containing 0.08ml of 
heparin. Plasma was obtained following centrifugation (6 min, 1500g) and frozen at -20 
°C for Lf analysis. Bovine Lf was analyzed in plasma samples using a commercially 
available ELISA kit (Bethyl Laboratories, Montgomery Texas, USA) according to the 
manufacturer’s protocol.  The reported sensitivity of the kit was from 7.8ng/ml to 
500ng/ml. Blood hemoglobin was analyzed by a clinical veterinary laboratory 
(University of Guelph) with an Advia 120 Hematology Analyzer.  
 
Results 
Blood hemoglobin (Hg) and red blood cell counts were not significantly affected 
by the dietary lactoferrin condition (Table A1).  Bovine lactoferrin was not detected in 
plasma samples. 
 
Table A1: Analysis of blood from mice receiving 0%, 0.2%, or 2.0% bovine lactoferrin. 
Group RBC (1012)/L Hemoglobin (Hg) (g/L) 
0 % bLf 8.4 ± 0.1 136.4 ± 1.2 
0.2 % bLf 8.7 ± 0.5 134.5 ± 7.9 









To exclude the possibility that lactoferrin, an iron binding protein, induces anemia 
(i.e., iron deficiency) the blood concentration of hemoglobin (Hg) was measured.  Hg 
concentrations are commonly used to detect anemia and v lues less than 110 g/L indicate 
iron deficiency (Hernell and Lonnerdal, 2002). Dietary bLf did not alter Hg 
concentrations in the blood compared to controls nor did it reduce Hg values below the 
lower limit. That bLf did not induce anemia is similar to other observations involving 
bLf. For example, Paesano et al. (2006) reported increased Hg concentrations in pregnant 
women following bLf supplementation. Hernell and Lonnerdal (2002) showed that 
formula fortified with bLf did not influence Hg levls in infants. Therefore, the findings 
of this study suggest that dietary bLf does not result in a state of iron deficiency.  
In agreement with other investigators (Kuhara et al., 2000; Wang et al., 2000; 
Wakabayshi et al., 2004), plasma bLf was not detectd using an ELISA technique. It is 
possible that the commercially available ELISA used lacked the sensitivity to detect bLf 
at very low concentrations (i.e., the floor for detection using the ELISA kit was 7.8 
ng/ml). However, Wakabayashi et al. (2004) using a more sensitive SELDI affinity mass 
spectroscopy technique (which is sensitive at pmol/g concentrations) were also unable to 
detect Lf or its fragments in the portal blood of rats following oral administration through 
drinking water. Digestion of bLf results in functional fragments such as bovine Lfcin and 
these are detectable in the feces of rats at pmol/g levels (Kuwata et al., 2001). Bovine Lf 
survives gastric transit within humans and is excreted in the feces (Troost et al., 2001). 
Given equipment and time constraints, fecal bLf was not quantified. Collectively, these 





gastrointestinal tract and may not be taken up into the circulation in detectable 
concentrations. In support of this suggestion is the following evidence: First, Lf was 
absorbed by villous columnar epithelial cells, macrophages, intraepithelial lymphocytes 
and lamina propria lymphocytes throughout the pig small intestine; bLf was detected 
within the cytoplasm of exfoliating, apoptotic epithelial cells (Kitagawa et al., 2003).  
Second, CaCo-2 intestinal epithelial cells took up bLf in vitro with highest concentration 
near the nucleus (Ashida et al., 2004); receptors fr lactoferrin have been identified on 
numerous mammalian immune cells including neutrophils (Deriy et al., 2000) and 
lymphocytes (Mazurier et al., 1989). Taken together, bLf may not enter into the 
circulation but may exert its functionality directly within the gastrointestinal tract.  
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Appendix IV - Representative Flow Diagrams 
 
 

















































Intestinal lymphocytes incubated with Annexin-FITC and Propidium Iodide (PI) (gated 

































































































16 8.9350 2.34441 .58610 7.6858 10.1842 3.82 13.62
16 12.2756 3.33230 .83308 10.5000 14.0513 4.69 17.60
15 12.0093 4.62612 1.19446 9.4475 14.5712 6.46 21.70





N Mean Std. Deviation Std. Error Lower Bound Upper Bound














Squares df Mean Square F Sig.
 
 





-3.34063* 1.24843 .028 -6.3687 -.3126
-3.07433 1.26907 .050 -6.1524 .0038
3.34063* 1.24843 .028 .3126 6.3687
.26629 1.26907 .976 -2.8118 3.3444
3.07433 1.26907 .050 -.0038 6.1524














(I-J) Std. Error Sig. Lower Bound Upper Bound
95% Confidence Interval






























































Mean Std. Deviation N
 
 
Tests of Between-Subjects Effects
Dependent Variable: Concentration_Prostanes
6253803.656a 5 1250760.731 3.153 .013
35057039.1 1 35057039.12 88.375 .000
5505140.667 2 2752570.334 6.939 .002
246056.335 1 246056.335 .620 .434














of Squares df Mean Square F Sig.

















-538.3120* 181.81576 .012 -974.7290 -101.8950
-706.1812* 201.77281 .002 -1190.5017 -221.8608
538.3120* 181.81576 .012 101.8950 974.7290
-167.8692 184.66422 .637 -611.1235 275.3850
706.1812* 201.77281 .002 221.8608 1190.5017














(I-J) Std. Error Sig. Lower Bound Upper Bound
95% Confidence Interval
Based on observed means.



























































Tests of Between-Subjects Effects
Dependent Variable: Concentration_CORT
506608.707a 5 101321.741 7.754 .000
13973966.1 1 13973966.07 1069.376 .000
79344.814 1 79344.814 6.072 .016
326658.781 2 163329.391 12.499 .000














of Squares df Mean Square F Sig.
R Squared = .347 (Adjusted R Squared = .302)a. 
 
 






-143.3144* 29.76878 .000 -214.5343 -72.0945
-14.3284 33.22605 .903 -93.8195 65.1628
143.3144* 29.76878 .000 72.0945 214.5343
128.9860* 32.99924 .001 50.0375 207.9346
14.3284 33.22605 .903 -65.1628 93.8195














(I-J) Std. Error Sig. Lower Bound Upper Bound
95% Confidence Interval
Based on observed means.






















































Mean Std. Deviation N
 
 
Tests of Between-Subjects Effects
Dependent Variable: PIposANNneg
355.773a 3 118.591 3.364 .033
1018.493 1 1018.493 28.895 .000
55.829 1 55.829 1.584 .219
269.549 1 269.549 7.647 .010














of Squares df Mean Square F Sig.
















































Mean Std. Deviation N
 
 
Tests of Between-Subjects Effects
Dependent Variable: PIposANNpos
272.104a 3 90.701 2.271 .103
3121.820 1 3121.820 78.164 .000
68.859 1 68.859 1.724 .200
173.655 1 173.655 4.348 .047














of Squares df Mean Square F Sig.




























































Mean Std. Deviation N
 
 
Tests of Between-Subjects Effects
Dependent Variable: CytC
.943a 5 .189 .863 .512
28.368 1 28.368 129.700 .000
.087 1 .087 .400 .530
.436 2 .218 .997 .375














of Squares df Mean Square F Sig.













.2145 .15195 .342 -.1511 .5802
.1040 .14030 .740 -.2336 .4417
-.2145 .15195 .342 -.5802 .1511
-.1105 .14457 .726 -.4584 .2374
-.1040 .14030 .740 -.4417 .2336














(I-J) Std. Error Sig. Lower Bound Upper Bound
95% Confidence Interval





















































Tests of Between-Subjects Effects
Dependent Variable: CytC
.951a 3 .317 5.955 .002
8.998 1 8.998 168.958 .000
.431 1 .431 8.091 .007
.369 1 .369 6.923 .012














of Squares df Mean Square F Sig.




























































Mean Std. Deviation N
 
 
Tests of Between-Subjects Effects
Dependent Variable: AC
9454.825a 5 1890.965 4.989 .002
68696.165 1 68696.165 181.247 .000
141.819 1 141.819 .374 .545
8517.545 2 4258.773 11.236 .000














of Squares df Mean Square F Sig.














.9048 7.65884 .992 -17.9451 19.7546
-33.1667* 8.12658 .001 -53.1677 -13.1656
-.9048 7.65884 .992 -19.7546 17.9451
-34.0714* 7.84405 .000 -53.3771 -14.7657
33.1667* 8.12658 .001 13.1656 53.1677














(I-J) Std. Error Sig. Lower Bound Upper Bound
95% Confidence Interval
Based on observed means.
The mean difference is significant at the .05 level.*. 
 
 
 
 
 
